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Most cancer-related deaths are due to metastasis formation, the ability of cancer 
cells to break away from the primary tumor site, transmigrate through the endothelium, 
and form secondary tumors in distant areas.  Many studies have identified links between 
the mechanical properties of the cellular microenvironment and the behavior of cancer 
cells.  Cells may experience heterogeneous microenvironments of varying stiffness 
during tumor progression, transmigration, and invasion into the basement membrane.  In 
addition to mechanical factors, the localization of RNAs to lamellipodial regions has 
been proposed to play an important part in metastasis.  This dissertation provides a 
quantitative evaluation of the biophysical effects on cancer cell transmigration and RNA 
localization. 
In the first part of this dissertation, we sought to compare cancer cell and 
leukocyte transmigration and investigate the impact of matrix stiffness on transmigration 
process. We found that cancer cell transmigration includes an additional step, 
	  
‘incorporation’, into the endothelial cell (EC) monolayer.  During this phase, cancer 
cells physically displace ECs and spread into the monolayer.  Furthermore, the effects 
of subendothelial matrix stiffness and endothelial activation on cancer cell incorporation 
are cell-specific, a notable difference from the process by which leukocytes transmigrate. 
Collectively, our results provide mechanistic insights into tumor cell extravasation and 
demonstrate that incorporation into the endothelium is one of the earliest steps. 
In the next part of this work, we investigated how matrix stiffness impacts RNA 
localization and its relevance to cancer metastasis.  In migrating cells, the tumor 
suppressor protein, adenomatous polyposis coli (APC) targets RNAs to cellular 
protrusions.  We observed that increasing stiffness promotes the peripheral localization of 
these APC-dependent RNAs and that cellular contractility plays a role in regulating this 
pathway.  We next investigated the mechanism underlying the effect of substrate stiffness 
and cellular contractility. We found that contractility drives localization of RNAs to 
protrusions through modulation of detyrosinated microtubules, a network of modified 
microtubules that associate with, and are required for localization of APC-dependent 
RNAs.  These results raise the possibility that as the matrix environment becomes stiffer 
during tumor progression, it promotes the localization of RNAs and ultimately induces a 
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Chapter 1: Introduction and Background  
1. Introduction 
 Cancer is a major health concern that affects millions of people worldwide.  The 
main contributing factor to the deadliness of the disease is cancer metastasis, the ability 
of cancer cells to break away from the primary tumor site, migrate through the 
vasculature, transmigrate through the endothelium, and then form secondary tumors in 
distant areas of the body.  Thus far, much research has been dedicated to analyzing 
cancer cells’ molecular and biochemical capabilities, but less is known about regulation 
and localization of genetic factors during transmigration and how mechanical properties 
of the microenvironment influence metastasis formation.   
 There are many steps where the mechanical properties of the extracellular matrix 
influence cell behavior during the metastatic cascade.  As tumors progress, they display 
desmoplasia, a fibrotic state characterized by increased deposition, increased post-
translation modifications of extracellular matrix proteins, and altered organization [1, 2].  
This increases local matrix stiffness and ultimately leads to a phenotype promoting 
migration away from the tumor [3].  Similarly, once the tumor cell migrates away from 
the primary tumor, it encounters mechanical properties within the blood stream.  Blood 
vessel stiffness likely varies based on tissue location and type.  The effects of stiffness 
are relevant in the context of cancer metastasis from primary tumor formation, to 
transmigration, and finally to secondary tumor formation.  The effects of subendothelial 
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matrix stiffness and mechanisms governing cancer cell transmigration, however, were 
poorly understood prior to our work.   
 On a more molecular level, we wanted to understand the role of localized RNAs 
in the context of cancer and their response to extracellular matrix stiffness.  During 
cellular migration, cells polarize such that at the leading edge, actin polymerization and 
formation of new adhesions drive the cellular extensions forward.  At the trailing edge, 
contractile forces and adhesion disassembly propel the cell forward [4].  Localized 
mRNAs are prominently observed during this process.  RNAs accumulate at sites of new 
integrin engagement [5], at lamellipodia [6, 7], and at sites of early or persistent 
protrusion formation [8, 9].  Localization of RNAs in lamellipodial regions has been 
proposed to play an important role during metastatic progression [10], however, the 
identity and functional significance of these localized mRNAs has been investigated only 
in few cases [11].  Furthermore, mRNA localization at adhesion sites is influenced by 
mechanical tension, which is adjusted by cells as a function of the mechanical properties 
of the cell environment [5].  The objective of this dissertation was to understand the 
mechanisms and effects of matrix stiffness on cancer cell transmigration and mRNA 
localization. 
 In the first part of our objective, we examined the mechanisms of cancer cell 
transmigration and how it is affected by subendothelial matrix stiffness.  We formed 
endothelial cell monolayers on extracellular matrix coated (ECM) hydrogels.  The 
stiffness of the matrix was varied to in order to mimic physiological tissue and 
vasculature stiffness.  We found that cancer cell transmigration is unique from leukocyte 
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transmigration, and that it includes an additional step, incorporation into the endothelium 
(Chapter 2).  Secondly, we found that it was independent of matrix stiffness and 
endothelial cell activation (Chapter 2) for melanoma cells and breast cancer cells.  
Pancreatic cells, however, were sensitive to endothelial cell activation and subendothelial 
matrix stiffness.  These results indicate that the place where cells exit the blood stream is 
cell specific.  It is likely a combination of cell-specific properties such as adhesion 
molecules and their sensitivity to extracellular matrix stiffness that determines homing 
mechanisms of cancer cells. 
Our next objective was to gain a better understanding of molecular factors 
involved in cancer metastasis.  We decided to focus on RNA localization and the effect of 
matrix stiffness on RNA localization.  In one pathway, the tumor suppressor protein 
Adenomatous Polyposis Coli (APC) is required for localization of RNAs at cell 
protrusions.  The APC-dependent localization pathway was the focus of our work.  
Interestingly, we found that substrate stiffness enhances RNA localization (Chapter 3).  
We hypothesized that increased actomyosin contractility contributed to localization.  We 
found that myosin II inhibition reduced localization on stiff substrates and that increasing 
contractility on soft substrates (with lysophosphatidic acid (LPA)) induces RNA 
localization (Chapter 3).  The subset of RNAs we were examining is located at the tips of 
detyrosinated microtubules.  Thus, our next goal was to examine the effect of substrate 
stiffness and contractility on microtubule detyrosination (Chapter 4).  We found that 
contractility enhances microtubule detyrosination and that detyrosinated microtubules are 
necessary and sufficient for RNA localization.  Finally, we wanted to look at the 
	   4 
interplay between actomyosin contractility and detyrosinated microtubules (Chapter 4).  
We found that the effects of myosin II inhibition (reduced RNA localization) could be 
recovered by increasing the amount of detyrosinated microtubules.  Similarly, we found 
that on soft substrates inhibiting detyrosinated microtubules could reverse RNA 
localization after increasing contractility. Thus, actomyosin contractility through 
modulation of the detyrosinated microtubule network drives RNA localization to cellular 
protrusions.  Likely, this effect is mediated through RhoA and a downstream effector 
mDia that signals the formation of detyrosinated microtubules.  The results of this 
research have implications in cancer metastasis.  We envision a scenario where as the 
microenvironment stiffens during tumor progression, it drives the localization of 
RNAs to cellular protrusions where they may play roles in cancer cell adhesion and 
migration, and ultimately promote the metastatic phenotype. 
1.2. Background: Cancer cell transmigration and RNA localization 
1.2.1 Cancer Metastasis 
Cancer is a public heath concern that affects people all over the world. In the 
United States alone, 1 in 4 deaths is attributed to cancer [12].  The cause of death 
attributed to primary tumors accounts for only 10% of cancer death, while the remaining 
90% are caused by secondary tumors [13].  In particular, cancer metastasis, the ability of 
cancer cells to break away from the primary tumor site, enter the lymph and/or blood 
vessels, circulate through the body and invade surrounding tissue where they then form 
secondary tumors is the main contributing factor to the deadliness of the disease.  
However, diagnosis of cancer is usually not made until it becomes life-threatening and 
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the cancer has already metastasized.  Therefore, it is critical to emphasize research that 
will lead to improved diagnostic and therapeutic targets for the disease.   
 
1.2.2 Cancer Cell Transmigration 
 One of the main steps in the metastatic cascade is the adhesion of tumor cells to 
the endothelium lining the blood vessels, transmigration through the endothelial cell 
monolayer, and migration into the basement membrane.  Immune cells routinely 
transmigrate through the endothelium to reach sites of injury and inflammation.  The 
signaling mechanisms underlying this process are well characterized [14].  The 
mechanisms governing cancer cell transmigration, however, are less understood.  In 
principle, the general process of extravasation is presumed to be the same.  In the first 
step, cells loosely adhere to the endothelium, an event that is mediated by endothelial 
expression of selectins [14].  Due to the slack attachment, the cells are still pulled along 
by the blood flow, resulting in a rolling motion across the endothelial surface.  This 
process is called ‘rolling”.  Eventually cells form a tight attachment to the endothelium 
using specific receptors.  Then, they subsequently transmigrate through the endothelial 
cell barrier in a process called diapedesis [14]. 
 The function of the endothelium in cancer cell transmigration is a crucial aspect 
because it can actively modulate extravasation by allowing or blocking adhesion [15-17].  
As a main pathway of tumor-endothelial interaction, adhesion receptors and integrins 
facilitate tumor-cell invasion.  During the rolling process, tumor cells use adhesion 
molecules to loosely tether to the endothelium.  Several groups have found that tumor 
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cells express ligands for E-selectin [18-20].  The expression of E-selectin ligands 
correlates with a high potential of bone metastases [18, 19].  E-selectin is a receptor that 
becomes expressed by endothelial cells upon exposure to inflammatory cytokines and 
helps mediate the rolling process.  N-cadherin has also been identified as another 
molecule to mediate the rolling of breast cancer cells and also been identified to play a 
role during the transmigration step [21].   To facilitate tight adhesion to the endothelium, 
cancer cells use integrins.  Expression of αvβ3 integrin has been shown to be associated 
with the metastatic potential of tumor cells [15].  Furthermore, animal models have 
shown that αvβ3 integrin on melanoma cells enhances interactions with vascular 
endothelial adhesion molecule-1 (VCAM-1) [22, 23]. Other adhesion molecules have 
also been identified to facilitate tumor adhesion to the endothelium.  Galectins are one 
group that has been identified on tumor cells to increase metastatic potential by 
increasing their adhesion to endothelial cells [24, 25].  While many adhesion molecules 
have been identified to play a role during transmigration, the actual process of diapedesis 
of tumor cells through the endothelium still remains elusive. 
 During the process of diapedesis, leukocytes cross the endothelium without 
damaging its integrity.  Leukocytes can either move between endothelial cells in a 
paracellular route, or through the endothelial cell itself, in a transcellular route.  For 
cancer cells, the route of transmigration through the endothelium is largely unknown.  It 
is also unknown whether tumor cells leave the endothelium intact or induce apoptosis in 
neighboring endothelial cells.  Based on this, one of the goals of this dissertation was to 
examine the mechanism of cancer cell transmigration through the endothelium.   
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 Another question that remains largely unanswered is what signals guide tumor 
cells to extravasate.  For leukocytes, they are guided by inflammatory cytokines such 
tumor necrosis factor alpha (TNF-α) which is produced by stromal cells.  Additionally, 
we have shown previously that leukocytes are mechanosensitive to the subendothelial 
matrix stiffness and increase their transmigration rates with stiffer subendothelial matrix 
stiffness [26, 27].  It is currently unknown how cancer cells respond to subendothelial 
matrix stiffness and chemokines such as TNF-α; thus another goal of this dissertation was 
to elucidate these questions. 
 
1.2.3 Cellular mechanotransduction 
Most cells in multicellular organisms are attached to much softer environments 
than the glass and plastic materials that are commonly used in vitro.  Most common 
attachment sites for cells such as the extracellular matrix have elastic moduli between 10-
10,000 Pa [28, 29].  Consequently, cell functions as well as morphology depend strongly 
on the substrate stiffness. 
As cells migrate, they probe elasticity as they anchor and pull on their 
surroundings.  Such processes are dependent on myosin-based contractility and 
transcellular adhesions to transmit forces to the substrates [30].  Cell-exerted forces 
promote a feedback loop of inside-outside-in signaling that couples to the elasticity of the 
extracellular microenvironment to intracellular responses [30].  Therefore, cells alter their 
behavior based on the substrate they are plated on.  For example, NIH 3T3 fibroblast 
cells alter their spreading behavior, exertion of traction forces, as well as their motility on 
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soft flexible polyacrylamide gels compared to stiffer substrates [31, 32].  Substrate 
stiffness also affects the motility of smooth muscle cells [33], mouse fibroblasts [34], as 
well as neutrophils [35, 36].  Fluorescence imaging also reveals more F-actin 
organization and stress fiber formation on increasingly stiff substrates in fibroblasts.  
Focal adhesions are also affected by the stiffness of the matrix.  On soft gels (<1kPa), 
fibroblast cells show diffuse and dynamic adhesion complexes.  On stiff gels, cells show 
stable adhesions similar to those observed on glass [31].   
Furthermore, evidence implicates a role of signaling in stiffness sensing.  
Tyrosine phosphorylation of many proteins, including paxillin, is enhanced on stiff 
substrates [31].  However, inhibition of actomyosin contractions largely eliminates focal 
adhesions and stimulation of contractility drives integrin aggregation into adhesions [37].  
Additionally, myosin inhibitors such as the myosin II inhibitor, blebbistatin, have 
provided evidence of the role of contractility in substrate sensing [31, 38].  Myosin II has 
a well-established role on rigid substrates in adhesion and cytoskeletal organization [37, 
39], spreading [39], as well as cell tension [40].  Activator proteins of the Ras 
superfamily, especially Rho subfamily members, are known to regulate the cytoskeleton, 
cell growth and contractility.  Rho stimulated contractility drives stress fiber and focal 
adhesion formation and upregulation of alpha smooth muscle actin correlates with 
contractility on rigid substrates [37, 41].   
Cancer cells also respond to the mechanical properties of their microenvironment.  
Ample evidence implicates alterations in the signaling pathways that regulate the 
response of cells to microenvironmental cues as critical events in tumor initiation, 
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progression, metastasis, and perhaps tumor dormancy [42].   Additionally, the increase in 
tumor tissue rigidity due to the accumulation of dense, cross-linked collagen matrix 
locally is a hallmark of cancer progression in soft tissues [1].  It has been shown that 
cancer cells modulate their gene expression in response to the mechanical properties of 
the substrate [43-45].  For example, the lung carcinoma cell line, A549 responded to 
culture on soft polyacrylamide gels by expressing the differentiated epithelial marker E-
cadherin and decreasing the expression of the mesenchymal transcription factor Slug 
[44].  Additionally, ECM stiffness promotes invasion and metastasis.  ECM stiffness 
promotes invadapodia formation and intensifies cancer invasion by driving focal 
adhesion assembly [3].  Since cells alter their behavior from morphology, to gene 
expression, to migration in response to extracellular matrix stiffness, it is a very 
important parameter to take into consideration.  Specifically, a stiffened ECM promotes 
metastasis by fostering properties such as proliferation, angiogenesis, and motility and 
invasion.  The interplay between localized RNAs and the stiffened matrix may be a 
contributor to the progression of metastasis.   
 
1.2.4 RNA Localization 
 The ability to form pseudopodial protrusions is closely related to cancer cell 
invasiveness and metastatic properties.  A number of asymmetrically localized RNAs 
have been observed in pseudopodial protrusions or at the leading edge of migrating cells 
[7, 46].  In some cases the evidence suggests that they have a functional role in cell 
migration [11, 47].  Furthermore, deregulation of RNA binding proteins involved in 
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localization pathways has been implicated in cancer metastasis [10, 48, 49].  Therefore, 
to gain a better understanding of molecular factors that influence cancer metastasis, we 
decided to focus on RNA localization in migrating cells.  The next sections focus on the 
regulation of RNA localization, and RNA localization pathways in migrating cells.  
Subcellular localization of mRNAs can give rigorous control over where protein 
products are synthesized and operate.  Localized mRNAs are present in a wide range of 
cell types and they play central roles in many cellular events.  The asymmetric 
distribution of mRNAs was first visualized when in-situ hybridization techniques were 
used to detect β-actin mRNA in embryos [50].  Since then, high-throughput approaches 
have allowed for identification of numerous localized RNAs and revealed that it is more 
common than previously assumed.  In Drosophila embryos, for example, 70% of 
expressed RNAs were classified as asymmetrically distributed [51].  Recent high-
throughput screens have also identified hundreds of mammalian RNAs are enriched in 
protrusions of fibroblasts [8], in neuronal processes [52, 53], or on spindles [54].  These 
studies indicate that mRNA localization has a prominent role in the spatial recognition of 
gene activity.   
There are many advantages to localizing RNAs rather than proteins.  Transport 
costs are reduced because many proteins can be translated from a single mRNA 
molecule.  Transporting mRNAs also prevents proteins from acting prematurely before 
they reach the appropriate site.  Localization of mRNAs can also facilitate incorporation 
of proteins into macromolecular complexes by generating high local protein 
concentrations and then allowing the co-translation of different subunits.   Lastly, a major 
	   11 
advantage of mRNA targeting is that it allows control of gene expression in both space 
and time.  For example, it allows activation of localized mRNA translation specifically at 
their destination, in response to certain extracellular cues [55]. 
 
1.2.5 Cellular Mechanisms Underlying mRNA Localization 
The targeting of RNAs involves multiple steps.  The cellular “address” of 
transcripts, or ‘zip code’, is encoded by cis-acting elements in the RNA, or localization 
elements.  Usually, these elements are located in the 3’ untranslated region (UTR), but in 
some cases can be found in the 5’UTR or in the coding sequence.  Depending on the 
nature of the factor they bind, localization elements can consist of single stranded 
stretches or double-stranded stem loops [56].  Localization elements are recognized by 
specific RNA-binding proteins (RBPs) that often function in RNA localization and 
translation regulation.  While the molecular mechanisms underlying the recognition of 
zip codes by RBPs has remained difficult to find, there has been some progress in 
identifying specific patterns or structures.  For example, the RBP ZBP1 recognizes a 54-
nucleotide (nt) sequence that contains two RNA motifs to target β-actin mRNA in 
fibroblasts [57, 58].   
There are three different mechanisms that are thought to contribute to mRNA 
localization after their transcription: (i) localized protection from degradation, (ii) 
diffusion-coupled entrapment, and (iii) directed transport along a polarized cytoskeleton 
(Figure 1.1).  Localized protection from degradation occurs when non-localized RNAs 
are degraded and the localized RNAs are protected and has been observed in Drosophila 
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[59].  The mechanisms governing protection of certain RNAs from degradation are 
unknown.  Diffusion coupled local entrapment occurs when RNAs freely diffuse and are 
entrapped at specific sites.  Diffusion coupled entrapment of mRNA transcripts plays a 
role in restricting the transcripts to the germ plasm in Drosophila and embryos [60].  
Motor-based transport along the cytoskeleton seems to be the predominant mechanism in 
animal cells.  This is because it provides a rapid method for translocation of large 
ribonucleoprotein complexes through the crowded cellular environment.  In mammalian 
oligodendricytes and neurons, mRNAs are bound to microtubule motors that switch 
between periods of motion in the plus and minus end directions [61-63].  Some RNAs 
may even associate with microtubule and actin based motors [64].  
Once RNAs are transported, they are usually ‘anchored’ at their destination to 
prevent diffusion away from the site of need.  In the case of Drosophila oocytes, xenopus 
oocytes, and dividing yeast cells, static anchoring relies on cortical actin and actin 
binding proteins [65-67].  Other mechanisms that involve anchoring have also been 
discovered.  In migrating fibroblasts, accumulation of transcripts depends on 
Adenomatous polyposis coli (APC) [8].   When no ‘anchor’ is present, localization can 
be maintained by short bursts of active transport [68].    
In order to produce proteins locally, translation suppression is needed to avoid 
mRNAs being translated before delivery to their specified site.  Translational repressors 
associate with transport RNPs by binding RNA regulatory sequences and blocking 
translation.  Phosphorylation of the repressor at the destination stage can decrease their 
affinity for the RNAs, allowing the RNAs to be translated at the localization site.  The 
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RNA binding protein, ZBP1 has been shown to exhibit this behavior [69].  Expressing a 
non-phosphorylatable form of ZBP1 reduces β-actin RNA accumulation at the cell 
periphery.   
Taken together, these mechanisms ensure tight regulation of mRNA localization 
within the cell. 
  













Figure 1.1.   There are three distinct mechanisms underlying mRNA localization.  (A) 
Localized protection from degradation (B) Diffusion-coupled local entrapment (C) 
Directed transport along a polarized cytoskeleton.  In (A) localized RNAs are protected 
from degradation machinery whereas non-localized transcripts are not.  In (B) mRNAs 
diffuse to their destination and are locally entrapped.  In (C) mRNAs are recognized by 
trans-acting factors in the nucleus.  When exported to the cytoplasm, cytoplasmic factors 
recruit molecular motors to facilitate transport along the cytoskeleton.  Once at their 
destination, RNAs are anchored and their translation is activated.  Figure adapted from 
[70]. 
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1.2.6 RNA Localization during Migration 
  As cells migrate, there is the establishment of front-back cell polarity.  
Particularly, in mesenchymal-like cells, the front portion of the cell is protrusive and 
characterized by a network of actin filaments while the back end is retractile towards the 
cell body in the direction of migration.  Most of the proteins that are asymmetrically 
distributed between the front and back of the cell are associated with the actin 
cytoskeleton [71].  For example, actin is polymerized at the leading edge by formins and 
the actin nucleating factors Arp2/3.  Similarly, mRNAs are differentially distributed in 
the rear and leading edge of a migrating cell [7, 8, 72].   Through using a fractionation 
approach to separate the cell bodies from the protrusions in transwell plates, laser-capture 
dissection, or microfluidic chamber-mediated isolation, over 700 protrusion localized 
RNAs have been identified in neurons, cancer cells, astrocytes, and fibroblasts [8, 73-76].  
There are at least two main pathways that localize RNAs to protrusions in migrating 
cells: (1) ZBP1-mediated localization and  (2) APC-dependent localization pathway.     
 
 1.2.6.1 ZBP1-mediated localization   
To date, the localization of β-actin mRNA to the leading edge is one of the most 
studied pathways in migrating cells.  A crucial factor is the RNA-binding protein ZBP1 
(zip code binding protein 1 (ZBP1) (also called IMP1 in humans, or CRD/BP in mice)), 
which associates with β-actin RNA during transcription in the nucleus and accompanies it 
to the cytoplasm [77].   It is localized in the protrusions of fibroblasts and myoblasts, and 
in the growth cone of neurons [78, 79].  The localization of β-actin requires the presence 
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of serum and activation of Rho GTPase and Rho downstream effector myosin IIB [7, 77, 
78, 80, 81].  Recent evidence suggests that β-actin mRNA may rely on both actin and 
microtubules for transport, perhaps in different stages [82, 83].  The microtubule motors 
KIF11 and KIF5A have been shown to play roles in the transport of β-actin mRNA [83, 
84].  ZBP1 binds β-actin mRNA in the nucleus, suppresses translation, and mediates its 
transport [69, 72, 81, 82].  Once at the destination, β-actin mRNA is anchored at its 
destination on actin filaments through EF1α, which is a translation elongation factor and 
an actin binding protein [85].  The translation of β-actin mRNA at the leading edge is 
regulated by Src kinase that phosphorylates ZBP1/IMP1 causing the dissociation from 
the mRNA [69].  Once ZBP1/IMP1 has been dissociated from the RNA, translation 
initiates.   
 Another example of protrusion-localized mRNAs mediated by ZBP1 is the 
transcripts encoding the actin polymerization nucleator Arp2/3 complex.  The Arp2/3 
protein complex regulates the actin cytoskeleton and is localized to the leading edge in 
migrating cells [86].  All of the RNAs encoding the seven subunits of the Arp2/3 
complex are localized n primary chicken embryo fibroblasts and primary human foreskin 
fibroblasts [7].  This suggests a mechanism for facilitating protein complex assembly 
through local translation or even co-translation assembly [7].  The protrusion localization 
is dependent on serum, actin and microtubule cytoskeleton, and activation of Rho and 
myosin II [7, 87].   
 
	   17 
1.2.6.2 APC Localization Pathway 
 In addition to β-actin mRNA, and the Arp2/3 mRNAs, a pathway targets 
numerous RNAs to the protrusions in migrating cells and depends on the tumor 
suppressor adenomatous polyposis coli (APC) for accumulation in the protrusions [8] 
(Figure 1.2).  The APC localization pathway in migrating fibroblasts is the focus of 
this dissertation.   
Using a fractionation scheme to isolate the cell bodies from the protrusions, about 
50 transcripts were found to be enriched in the protrusions of NIH/3T3 cells using a 
genome wide approach [8].  At the tips of protrusive areas, APC associates with multiple 
RNAs, including Discoidin Domain Receptor 2 (Ddr2), which will be the main focus for 
this dissertation.  Many of the RNAs discovered were found to encode for proteins 
involved in various functions including membrane trafficking, cytoskeletal organization, 
microtubule-based transport and RNA metabolism.  When comparing the transcripts, no 
structural motifs appeared to be shared among them, suggesting that their localization 
signals are defined by a combination of primary sequences and higher order structure.   
Furthermore, it was found that these transcripts are stably anchored in the protrusions and 
do not exchange rapidly with free cytoplasmic RNA molecules.   It was also found that 
they do not associate with P-bodies, focal adhesions, or cortical actin or actin stress 
fibers.  However, it was found that they associated with microtubules.  The fact that the 
transcripts appeared to be relatively stable over time, led to the conclusion that the 
transcripts associate with stable microtubules which are post-translationally modified.  
Specifically, it was found that they associated with detyrosinated (or Glu) microtubules 
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(Figure 1.2).  At the ends of detyrosinated microtubules, APC also associates with 
proteins such as FMRP and PABP1 to form APC-containing ribonucleoprotein 
complexes (Figure 1.2) [8, 88].  The translation of APC-associated mRNAs is regulated 
by the RNA-binding protein Fus/TLS which promotes translation in the protrusions [88]. 
  













Figure 1.2. APC dependent RNA localization pathway.  RNAs are stably anchored at the 
plus ends of detyrosinated microtubules.  Their anchoring requires the tumor suppressor 
protein adenomatous polyposis coli (APC) for anchoring.  APC also associates with 
proteins such as FMRP and PABP1 to form APC-containing ribonucleoprotein 
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1.2.7 APC-associated RNAs 
 Transport of these mRNAs to the cellular leading edge is dependent on the APC 
protein, which plays a role in anchoring the mRNAs to the plus ends of detryrosinated 
MTs.  These mRNAs have previously been identified to be isolated to protrusions in 
various cell types based on genome wide screens.  The proteins that they encode are also 
implicated in processes relating to cellular migration and metastatic progression.  
Therefore, localization or not of these RNAs might have functional relevance.  
 
1.2.7.1 Rab13 
 During epithelial morphogenesis, the development and organization of cell 
symmetry requires the assembly of functional tight junctions.  Epithelial polarity also 
depends on the continuous sorting of proteins and lipids into distinct cell surface 
domains.  A family of small GTPases, Rab proteins, is involved in regulating tight 
junction dynamics.  Recent work suggests that RAB13 regulates the assembly of 
functional tight junctions and the role of Rab13 in polarized vesicular transport from the 
trans-Golgi network to the cell surface is distinct from other Rab proteins [89-91].  
Functional tight junctions play a crucial role in regulating paracellular transport across 
cells and maintenance of epithelial polarity.  Modulations of tight junction structure and 
function have been shown in epithelial tumorgenesis, mostly the loss of cellular polarity 
and paracellular permeability [92].  Furthermore, it has been shown that RAB13 is 
required for epithelial cell scattering, one of the first major steps in metastasis [92].  
RAB13 knockdown has been shown to reduce spread of cancer cells in vivo and reduces 
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cancer cell migration and invasion in vitro[93]. RAB13 mRNA has also been found in 
breast cancer protrusions [75]. 
  
1.2.7.2 Pkp4 
 PKP4, or plakophilin 4/p0071 is a member of the armadillo family of proteins.  
PKP4 is located at desmosomes and adherens junctions playing a regulatory role in the 
dynamics of intermediate filaments and actin cytoskeletal assemblies [94, 95].  PKP4 
also have been shown to localize to the cytoplasm where it acts as a regulator for the 
small GTPase RhoA [95].   The Pkp4 mRNA has been shown to be localized in 
protrusions of mouse astrocytes [76], NIH3T3 cells [8], and MDA-MB-231 metastatic 
breast cancer cells [75].  Furthermore, PKP4 is associated with different steps in 
carcinogenesis [94, 96-98].  Knockdown of PKP4 has been shown to affect the migratory 
properties of epithelial cells [94]. 
 
1.2.7.3 Ddr2  
This dissertation focuses mainly on the localization of Ddr2 RNA as 
representative APC-dependent RNA.  Discoidin domain receptor 2, or DDR2, is a 
homodimeric tyrosine-kinase collagen receptor that binds to triple-helical collagen fibers.  
When DDRs bind to collagen, it becomes activated and serves as an initiator for many 
signaling pathways [99].  One of the common outcomes after DDR activation is an 
increase in metalloproteinase secretion and collagen rearrangement [100-103].  
Therefore, DDR2 has been associated with metastasis during tumor progression [100].  It 
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has recently been investigated that DDR2 stabilizes SNAIL1 to facilitate breast cancer 
metastasis [104].  A recent study by Afonso et al. showed that DDR2 regulates neutrophil 
chemotaxis in 3D [105].  
 
1.2.8 RNA localization and disease 
During many human disease pathologies, RNA localization pathways become 
defective.  RNA localization pathways have been identified in neuromuscular and 
neurodegenerative diseases as well as in cancer.  In the genetic disorder spinal muscular 
atrophy (SMA), the mutation leading to the disease occurs in the SMN1 gene encoding 
the survival of motor neuron protein (SMN).  Several studies have demonstrated that 
SMN is localized to axonal projections and that its loss leads to impaired trafficking and 
translation, suggesting that mRNA localization defects contribute to SMA pathogenesis 
[106, 107].  Additional examples include trinucleotide repeat expansion disorders 
(TREDS), in which abnormal repeat amplifications either causes RNA gain or loss 
functions that affect normal RNA localization.  A prominent example of this is fragile X 
syndrome (FXS), a genetic disorder that represents the most common form of inherited 
mental retardation [108].  Expansion of the CGG repeats in the 5’UTR of the FMR1 gene 
leads to transcriptional silencing and loss of function of the protein FMRP [108].  FMRP 
controls synaptic plasticity in response to external stimuli.  FMRP disruption causes 
defects in mRNA trafficking and translation regulation in dendrites and these functions 
are also disrupted in FXS [108-110].   
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In addition to muscle and neurodegenerative diseases, flawed mRNA localization 
is also involved in cancer.  One of the hallmarks of cancer is the loss of normal cell 
polarity, which is thought to be a causative event leading to tissue disorganization, 
invasion and metastasis.  Taking into account that mRNA localization pathways help 
regulate and maintain normal cell polarity, disruption of these pathways could be an 
initiating event in tumorgenesis.  In one mouse study, it was shown that the loss of 
function of the translational regulatory protein, CPEB, led to a loss of cell polarity due to 
defects of targeting ZO-1, a tight junction protein [111].  CPEB plays a direct role in the 
apical localization of ZO-1 mRNA, a process that is important for proper tight-junction 
targeting of ZO-1 protein for the maintenance of epithelial cell polarity.  These findings 
are intriguing because deregulated expression and localization of ZO-1 is associated with 
poor prognosis in breast cancer patients [112].  Additionally, RNA binding proteins 
(RBPs) with known roles in mRNA localization have been shown to have clear functions 
in cancer.  Members of the IGF-II mRNA-binding Proteins (IMP) family of RBPs are 
overexpressed in multiple cancers and have been shown to have oncogenic potential 
[113-115].  In transformed cells, IMP proteins can reside within RNP granules that are 
targeted to podosomes or invadopodia (actin rich protrusions that can degrade the 
extracellular matrix and are thought to enable cancer cell invasion) [116].  In HeLa cells, 
depletion of IMP factors led to a disruption of invadopodia formation and to a reduced 
expression of mRNAs that are involved in cellular adhesion [117].  mRNA pathways 
involving APC are also disrupted during cancer progression.  Loss of function of the 
APC tumor suppressor protein is a main event in colorectal cancer progression.  APC 
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associated mRNAs have also been identified in protrusions of metastatic MDA-MB-231 
cells [75].  
 
1.2.9 Microtubule Post-Translational Modifications: Microtubule 
Detyrosination (Glu-MT) 
 The focus of this dissertation is on the APC-dependent RNA localization pathway 
in migrating cells.  APC-dependent RNAs are localized to the tips of the protrusions in 
fibroblasts at the ends of detyrosinated microtubules (Glu-MT) [8].  Thus, this next 
section focuses on the post-translational modification that gives rise to detyrosinated 
microtubules and their diverse functions within the cell. 
 Tubulin and microtubules are subject to post-translation modifications (PTM).  
Many of these modifications are found concurrently, leading to a diverse population of 
microtubules.  Post-translation modifications affect not only the dynamics, but also their 
organization and interaction with cellular components.  Tubulin PTMs are found in all 
types of cells.  Tubulin may be modified as soluble dimer or in a microtubule.  There are 
many PTMs that can take place, such as detyrosination, acetylation, glutamylation, and 
phosphorylation to name a few [118]. 
 In the case of detyrosinated microtubules, the posttranslational modifications are 
associated specifically with tubulin polymerized in microtubules.  Newly-synthesized α-
tubulin contains a terminal tyrosine.  The terminal tyrosine is removed by an unknown 
cytosolic carboxypeptidase to expose a glutamate.  The tubulin tyrosine ligase (TTL) then 
tyrosinates detyrosinated tubulins released from the microtubules.  TTL rapidly and 
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exclusively adds the tyrosine back to the soluble α/β-tubulin dimers such that newly 
assembled microtubules are primarily tyrosinated MTs [119-121]. 
Detyrosinated microtubules are considered to be more stable microtubules as they 
can persist for hours before turnover.  They are much less dynamic than tyrosinated 
microtubules.  However, it is important to note that the Glu-tubulin does not confer 
stability to the MTs rather that it is the stable microtubules that accumulate Glu-tubulin 
[122-124].  Factors have been identified that regulate the selective stabilization of 
microtubules.  LPA, for one, has been shown to induce Glu-MT formation and that Rho-
GTPase is sufficient for the stabilization of MTs [124, 125]. 
The interactions of proteins with tyrosinated/detyrosinated MT define distinct 
cellular compartments and generate a platform for cellular signaling by regulating protein 
interactions with MTs [126].  For example, although the plus-end tracking protein EB1 
binds MT independent of tyrosination, other plus-end tracking proteins require both EB1 
and tyrosinated tubulin to localize to MT plus ends [127].  Tyrosination also affects the 
activity of spastin, a MT severing protein [128].  It preferentially cleaves deytrosinated 
MT, despite the association of detyrosinated MT with longevity.  The 
detyrosination/tyrosination cycle also recruits molecular motors.  Kinesin-1 preferentially 
binds to detyrosinated microtubules over tyrosinated MT, possibly enabling it to 
preferentially move various cargos along detyrosinated MT [129]. 
 Detyrosinated microtubules play a role in an array of cell functions, and this 
dissertation explores the relationship between detyrosinated microtubules and RNA 
localization. 
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1.2.10 Conclusions 
 Cancer metastasis is a complex process that requires cells to undergo a range of 
changes as they migrate away from the primary tumor, invade the blood stream, and form 
secondary tumors at distant sites.  Cancer cell transmigration through the endothelium 
plays a critical role in metastasis formation.   It is evident that this process may share 
similarities with leukocyte transmigration.  Thus, this thesis aims to dissect the 
mechanism of cancer cell transmigration through the endothelium and mechanical and 
biochemical factors that may influence transmigration.  Since protrusion formation is a 
fundamental step in cancer migration and invasion, we decided to focus on localized 
RNAs and understand how they may play a role in metastasis formation.  Specifically, as 
cancer progresses, the primary tumor becomes stiffer compared to healthy tissue.  Thus, 
we aim to understand how matrix stiffness influences RNA localization and how this 
might play a role in metastasis. 
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Chapter 2: Mechanisms of Cancer Cell Transmigration† 
2.1 Introduction 
Cancer metastasis occurs when tumor cells fragment from the primary tumor site, 
enter the blood and lymph vessels, and spread to distant bodily organs.  This process is 
one of the main contributing factors to the deadliness of cancer [130, 131].  Once 
metastatic cancer cells have entered the blood stream, they must cross the endothelial cell 
(EC) barrier before invading the tissue beneath in a step known as extravasation.  Most 
tumor cells arrest by nonspecific binding of coagulation factors and by size restriction in 
capillary beds [132].  In some cases, specific ligands on tumor cells have been correlated 
with an increased metastatic potential [15, 133, 134].  Thus far, significant research has 
been dedicated to analyzing the biochemical and molecular capabilities of cancer cells 
[135-137], but the underlying mechanism of cancer cell extravasation through the 
endothelium remains largely unknown.  Cancer cells have been observed to migrate 
through the EC cell body [138], and through endothelial cell-cell junctions without 
destroying the EC layer [139].  However, conflicting research has also shown that cancer 
cells do not leave the endothelium intact following extravasation [140-143].  It is 
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important to note that these studies used different tumor cell lines, as well of different EC 
lines and in vitro methods, so it is possible that different combinations of various types of 
tumor cells and ECs may lead to diverging mechanisms of extravasation.   
There are three proposed methods of cancer cell migration through the 
endothelium: (a) cancer cells may migrate through the EC body [138], (b) cancer cells 
may induce EC apoptosis [141, 142] and (c) cancer cells may migrate through endothelial 
cell-cell junctions without permanently destroying the EC layer [139].  In recent years, 
research has also shown that cancer cells also exert forces on ECs that push them deeper 
into the extracellular matrix during transmigration [144, 145], and that the endothelium 
enhances cancer cell migration [146].  These findings suggest that cancer migration 
through the endothelium is a complex process that requires further investigation to 
elucidate its mechanistic course. 
Leukocytes routinely transmigrate through the endothelium and underlying layers 
of the vasculature to reach tissue sites of inflammation, infection, or injury.  This is a 
well-characterized process that relies on localized biochemical signals.  In leukocyte 
trafficking, the endothelium acts as a selective barrier that greatly reduces the invasion 
rate [147].  During an immune response, the chemokine tumor necrosis factor alpha 
(TNF-α) is produced by stromal cells, and the localized exposure of ECs to TNF-α 
upregulates adhesion molecules such as intercellular adhesion molecule-1 (ICAM-1) on 
the surface of the endothelium.  Furthermore, in addition to molecular changes, TNF-α 
also significantly alters the structural properties of the endothelium, which induces 
softening, actin realignment, and an increase in overall permeability [26, 148].  An 
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additional factor that enhances leukocyte transmigration is the subendothelial matrix 
stiffness and mechanical properties of the endothelium.  These vary during vascular 
homeostasis and in pathological conditions [26].  Neutrophils are able to mechanosense 
their microenvironment [26, 36, 149-151], and neutrophil transmigration increases as 
subendothelial matrix stiffness increases due to EC myosin light chain kinase (MLCK)-
mediated contractile forces [26].  All of these changes in the EC monolayer facilitate 
leukocyte transmigration during an immune response. 
Since leukocytes routinely transmigrate through the EC layer, it is presumed that 
metastatic cancer cells may share many of the same mechanisms. However, these 
mechanisms have yet to be investigated in greater detail. For example, the involvement of 
chemokines in tumor-endothelial interactions and their effects on cancer cell migration 
are not well understood [152]. Even more, the significant molecular and structural 
changes that take place in the endothelium following TNF-α treatment may enhance 
metastatic cancer cell transmigration. It also remains to be seen how cancer cell 
extravasation varies with subendothelial matrix stiffness.  As observed with leukocytes 
[26], it is possible that cancer cell transmigration may increase with increasing substrate 
stiffness.   Cancer cells have also been observed to push ECs into the extracellular matrix 
during extravasation, indicating that the mechanical properties of the ECM may play an 
important role.  Taken together, these results indicate that both the activation status of the 
endothelium and subendothelial matrix stiffness may influence cancer cell extravasation. 
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2.2 Materials and Methods 
2.2.1 Preparation of polyacrylamide gel substrates 
Thin polyacrylamide gels were prepared on glass coverslips according to the 
method first described by Wang and Pelham [153] and described in detail in our previous 
publications [26, 36, 154-157].  Briefly, 280 kPa (15% acrylamide + 1.2% bis 
acrylamide) and 0.87 kPa (3% acrylamide + 0.1% bis acrylamide) gels were created and 
coated with 0.1mg/mL fibronectin (Sigma-Aldrich) as previously described [26].  
Characterization of the Young’s modulus of the gels was accomplished by atomic force 
microscopy and dynamic mechanical analysis, while analysis of surface-bound 
fibronectin was accomplished by immunofluorescence [36, 156].  For experiments on 
glass, 22x22 mm coverslips (Fisher Scientific) were coated with 0.1 mg/mL fibronectin 
for 2 hours at room temperature. 
 
2.2.2 Cell culture 
Human umbilical vein endothelial cells (Lifeline Cell Technology) were cultured 
as previously described [158]. MDA-MB-231 metastatic breast cancer cells (ATCC) and 
A375 melanoma cells (ATCC) were cultured in DMEM, 10% FBS and 1% penicillin 
streptomycin. SW1990 pancreatic cancer cells (ATCC) were cultured in DMEM, 10% 
FBS, and 50 ug/mL gentamicin.  HUVECs (passages 2-5, 4x105 total) were plated onto 
fibronectin-coated glass coverslips or polyacrylamide gels and grown for approximately 
48 hours, at which point a monolayer formed.  Cells were treated with control media or 
25 ng/mL tumor necrosis factor-α (TNF-α) for the final 24 hours prior to experiments.  In 
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some experiments, HUVECs were transfected with VE-cadherin-GFP (VEcadGFP) using 
an adenovirus (AdV), which was received as a generous gift from Dr. William 
Luscinskas (Harvard Medical School). Dr. Luscinskas’s lab has previously described the 
procedure for construction of the VEcadGFP plasmid and transference to an adenovirus 
expression vector [159].  HUVECs were plated onto fibronectin-coated polyacrylamide 
gels or glass coverslips and given 1-2 hours to spread, and 3 µL of AdV-VEcadGFP were 
added to the cells with 2 mL media per substrate.  HUVECs were then cultured to 
monolayer formation as described above.  Monolayers were washed with PBS prior to 
adding additional HUVECs or tumor cells (1x105 cells total) to the apical surface of the 
22x22 mm monolayer.  To distinguish between the HUVEC cells within the monolayer 
and the additional cells added to the monolayer, added HUVECs or MDA-MB-231 cells 
were stained with the lipophilic DiIC16 dye (1 µM) in suspension for 5 minutes at room 
temperature, followed by centrifugation and a PBS wash.  
 
2.2.3 Live cell imaging and analysis 
 Live cell microscopy was completed in an enclosed microscope stage incubator 
at 37°C, 5% CO2 and 55% humidity using an inverted microscope (Olympus IX71). 
Images were captured with either a QImaging Retiga-SRV charge-coupled device (CCD) 
digital camera (QImaging Corporation) using IPLab software (Becton, Dickinson and 
Company), or with a a QImaging Rolera-MGi CCD digital camera (QImaging 
Corporation) using Slidebook software (version 4.2.0.9; Intelligent Imaging Innovations).  
Phase contrast, differential interference contrast (DIC), and/or fluorescence timelapse 
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images were captured using either a 20x/0.45 NA Ph1 objective or a 60x/1.42 NA oil 
objective.  The fraction of incorporated cells (HUVECs or MDA-MB-231) was 
calculated by dividing the number of cells that became incorporated at any time during 
the timelapse sequence by the total number of phase-white cells above the monolayer in 
the initial frame of the sequence.  The time to complete incorporation was calculated 
using the difference between the time when the cell first began to spread into the 
monolayer and the time when the cell reached maximum spreading area within the 
monolayer.  
 
2.2.4 Interference reflection microscopy 
Interference reflection microscopy (IRM) was used to detect surface-to-surface 
interference between light rays reflected from the substrate/medium interface and those 
from the medium/cell interface, as described in our previous work [160-162].  In this 
technique, the intensity of the light is a measure of the proximity of the cell to the glass 
surface, such that areas of the membrane closest to the surface appear dark and those 
further away appear brighter.  Therefore, IRM is an optimal method when evaluating 
cellular attachment, adhesion, and spreading behavior [160-162].  For spreading 
experiments, 1x105 MDA-MB-231 cells were plated onto 22x22 mm fibronectin-coated 
glass coverslips in HUVEC media, resulting in observation of single cells.  For these 
experiments, an inverted microscope (Olympus IX71) with a 60x/1.42 NA oil objective 
lens and a 100 W mercury lamp (Olympus; used at wavelength 561) was used in 
combination with a CCD camera (Retiga SRV camera, QImaging) for image capture.  
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Experiments were performed in an enclosed microscope chamber which maintained 
culture conditions at 37 °C, 50% humidity, and 5% CO2.  During cell spreading, one 
frame was recorded every 5 seconds over a period of 1 hour for N=5 independent 
experiments.  For statistical evaluations of spreading areas, images were analyzed using 
ImageJ (National Institutes of Health) software.  The cell-boundaries were traced by hand 
and area was calculated using ImageJ routines.  Areas of MDA-MB-231 cells spreading 
into a HUVEC monolayer were also traced by hand and compared with single cells 
spreading onto the endothelium-free coverslip. 
 
2.2.5 Confocal Imaging  
A total of 1x105 MDA-MB-231 cells were transfected with 10uL of CellLight 
Actin-GFP (Life Technologies) according to manufacturer’s protocol and allowed to 
incubate for 24 hours.  After 24 hours, infected MDA-MB-231 cells were introduced to a 
confluent HUVEC monolayer and allowed to incorporate for 15 hours.  Following 
incorporation, cells were fixed in 4% paraformaldehyde and stained using Texas-Red 
Phalloidin (Invitrogen).  Z-stack images were collected using a Zeiss LSM 710 confocal 
microscope with a 63x oil objective.  
 
2.2.6 Statistical analysis 
Statistical analysis was completed by using a Student t-test between pairs of data, 
or by using ANOVA for groups of data, where P<0.05 indicated statistical significance. 
After ANOVA, multiple comparisons were done using Turkey’s honestly significant 
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difference criterion.  All measurements are reported here in the format mean ± standard 
error. 
2.3 Results 
2.3.1 Incorporation into the endothelium is the first step in metastatic cancer cell 
transmigration 
MDA-MB-231 metastatic breast cancer cells were introduced onto the apical 
surface of an EC monolayer and monitored as they interacted with the endothelium 
(Movie S1).  Initially, MDA-MB-231 cells were bright white and spherical in contrast to 
the underlying phase-darkened and flattened endothelium (Figure 2.1A).  Within several 
hours, the MDA-MB-231 cells began to incorporate into the endothelium, in a process 
that ranged on average from 40 to 60 minutes (Figure 2.1B) and was visually distinct 
from neutrophil transmigration through the endothelium (Figure 2.C).  Specifically, it 
appeared that the ECs adjacent to the site of incorporation were physically displaced, 
creating voids for the MDA-MB-231 cell to spread onto the underlying matrix (Figure 
2.1A), whereas neutrophils squeezed through the endothelium without disrupting the 
monolayer (Figure 2.1C).  Some ECs detached from the underlying matrix, rounded up 
and became spherical following incorporation of MDA-MB-231 cells into the monolayer 
(Figure 2.2).  However, incorporation of MDA-MB-231 cells into the endothelium 
occurred more slowly, with a smaller slope of “spreading area vs. time”, and had a lower 
final cellular area compared to MDA-MB-231 cells spreading onto an endothelium-free 
fibronectin-coated substrate (Figure 2.3D), indicating that the endothelium did not favor 
incorporation of the cancer cell, but rather limited overall spreading area.  Furthermore, 
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MDA-MB-231 cell incorporation into the endothelium occurred more slowly, with a 
smaller slope of “cumulative incorporation vs. time”, in comparison to ECs incorporating 
into a monolayer of ECs (Figure 2.3A).  Thus, it is likely that incorporation of MDA-
MB-231 cells into the endothelium occurs by a different mechanism than native ECs 
spreading into the same endothelium. A375 melanoma cells and SW1990 pancreatic cells 
were also introduced to the apical surface of the endothelium.  Similarly to MDA-MB-
231 cells, the melanoma cells and pancreatic cells began to incorporate into the 
endothelium in a process that lasted approximately 15 minutes and 50 minutes 
respectively.  A375 cancer cells incorporated into the monolayer at a much faster rate 
compared to metastatic breast cancer cells and their incorporation dynamics closely 
resembled that of native ECs spreading into the EC monolayer.  A375 melanoma cells 
had a final fraction of incorporation that resembled ECs spreading into ECs, while 
SW1990 cancer cells had a much lower fraction of incorporation compared to all groups 
(Fig 2.3C).  Furthermore, confocal images (Fig 2.4A) revealed that after 15 hours of 
incorporation, MDA-MB-231 (green) cells displaced ECs (red) by spreading between 
adjacent ECs.  Orthogonal projections show that MDA-MB-231 cells are in fact 
spreading between ECs and not migrating underneath them during incorporation (Fig 
2.4B). 
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Figure 2.1 (A) Phase contrast image of MDA-MB-231 cells (bright white) atop a human 
umbilical vein endothelial (HUVEC) monolayer. Scale bar is 20 µm. (B) MDA-MB-231 
cell (black arrows) begins to incorporate into the endothelium, as indicated by its change 
in phase contrast microscopy from bright white to darkened. Scale bar is 20 µm and 
applies to all images in panel B. Length of time after plating MDA-MB-231 cells on the 
endothelium is indicated in the upper right corner of each image in hour:minute:second 
format. The final percentage of incorporation for this experiment was 95%. (C) Phase 
contrast image sequence of a neutrophil transmigrating through a TNF-α-activated 
endothelium. Scale bar is 20 µm and applies to all images in panel C. Length of time 
after plating neutrophils on the endothelium is indicated in the upper right corner of each 
image in hour:minute:second format. 
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Figure 2.2. MDA-MB-231 incorporation causes detachment and rounding of some 
endothelial cells. Phase contrast (left) and DiIC16 fluorescence (right) images of MDA-
MB-231 cells plated onto an untreated HUVEC monolayer, at timepoints immediately 
after plating (top) and after 16 hours of interaction with the endothelium (bottom). Red 
arrows point to phase-white cells that do not emit fluorescence; these are endothelial cells 
that have been forced out of the monolayer and thus have detached and become rounded. 
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Figure 2.3. Incorporation of MDA-MB-231 does not depend on whether the endothelium 
is activated by TNF-α. (A) Cumulative fraction of ECs or MDA-MB-231 cells (231), 
SW1990 (1990), and A375 cells incorporated into the endothelium as a function of time 
after plating. Data points represent mean ± SEM for at least 3 independent experiments 
(N>20 cells for each experiment). (B) Final fraction of MDA-MB-231 cells incorporated 
into the untreated or TNF-α-treated endothelium after 15 hours. Bars represent mean, 
while error bars represent SEM of at least 3 independent experiments. P>0.05 between 
these values indicates there is no statistical difference (n.s.). (C) Final fraction of MDA-
MB-231 breast cancer cells, ECs, A375 melanoma cells, and SW1990 pancreatic cells 
incorporated into the endothelium after 15 hours.  Bars represent mean, while error bars 
represent SEM of at least 3 independent experiments. (*) indicates significance (P<.05) 
when compared to ECs. (D) Plot of spreading area versus time reveals differences in 
spreading dynamics for MDA-MB-231 cells spreading onto a fibronectin-coated 
coverslip (“single cells”) or into an untreated endothelium (“into monolayer”). 
 
  






























Figure 2.4. Confocal images reveal that MDA-MB-231 cells do not migrate underneath 
ECs during the incorporation process.  (A) A representative MDA-MB-231 (green; 
Actin-GFP) cell infected with GFP-actin is shown spreading into a HUVEC monolayer 
(red; Phalloidin).  Orthogonal projections are shown. (B) Schematic showing that a 
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2.3.2 Activation of the endothelium by TNF-α does not affect incorporation dynamics 
of breast cancer and melanoma cells 
 Activation of the endothelium is a key step in the leukocyte adhesion cascade, and 
our previous work has demonstrated that leukocyte transmigration depends heavily on the 
activation status of the endothelium [26, 154, 163].  Activation of the endothelium by 
TNF-α not only upregulates adhesion molecules such as ICAM-1 and vascular cell 
adhesion molecule-1 (VCAM-1), but also increases EC contractility [155] and reduces 
EC barrier function [148].  Therefore, our next goal was to determine whether 
incorporation of metastatic breast cancer cells into the endothelium required the ECs to 
be activated.  Intriguingly, we found that the cumulative fraction of incorporation versus 
time of MDA-MB-231 cells was similar, regardless of whether the ECs were treated with 
TNF-α (Figure 2.3A).  In addition, the final fraction of cells that incorporated into a TNF-
α-activated endothelium after 15 hours was not different from the fraction incorporated 
into an untreated endothelium (Figure 2.3B).  Finally, the time required to complete 
incorporation (from a rounded sphere to a flattened cell within the endothelium) was not 
dependent on whether the endothelium was treated with TNF-α (Figure 2.7C).  Similar to 
breast cancer cells, the fraction of incorporation of A375 melanoma cells into ECs was 
comparable, regardless of whether the ECs were treated with TNF-α (Figure 2.5).  These 
results suggest that some metastatic cancer cells are able to complete the early stages of 
extravasation, even in the absence of an inflammatory stimulus.  However, the fraction of 
incorporation after 15 hours for SW1990 pancreatic cells was statistically different 
between untreated ECs and those treated with TNF-α (Figure 2.6).  SW1990 cells 
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incorporated at a much faster rate and higher fraction in TNF-α treated ECs compared to 
untreated ECs. 
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Figure 2.5. (A) Cumulative incorporation of A375 melanoma cells into untreated and 
TNF-α treated endothelium after 15 hours. Data points represent mean ± SEM for at least 
3 independent experiments (N>20 cells for each experiment). (B) Final fraction of 
incorporation after 15 hours for untreated and TNF-α treated endothelium. Data is not 
significant (n.s.) (P>0.05). 
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Figure 2.6. (A) Cumulative incorporation of SW1990 cells into untreated and TNF-α 
treated endothelium after 15 hours. Data points represent mean ± SEM for at least 3 
independent experiments (N>20 cells for each experiment). (B) Final fraction of 
incorporation after 15 hours for untreated and TNF-α treated endothelium. (*) indicates 
significance when compared to untreated ECs (P<0.05). 
  
	   44 
2.3.3 Incorporation is independent of subendothelial matrix stiffness for breast cancer 
and melanoma cells 
 Our previous work has also demonstrated that leukocyte transmigration depends 
on the mechanical properties of the matrix below the endothelial cells [26, 154].  Stiffer 
subendothelial matrices promote myosin light chain kinase dependent EC contractility, 
leading to intercellular gaps and enhanced leukocyte transmigration [26, 154].  Therefore, 
our next goal was to establish whether metastatic breast cancer cell incorporation into the 
endothelium was dependent on subendothelial matrix stiffness.  Unlike neutrophil 
transmigration, which increases with subendothelial matrix stiffness, the dynamics of 
MDA-MB-231 cell incorporation into the endothelium were similar for soft (0.87 kPa), 
intermediate (280 kPa), and very stiff (glass; 50 GPa) subendothelial substrates (Figure 2. 
7A). In addition, the final incorporated fraction of MDA-MB-231 into the endothelium 
was independent of subendothelial substrate stiffness (Figure 2.7B). and the total time 
required to complete transmigration was independent of subendothelial substrate stiffness 
(Figure 2.7C).  A375 melanoma cells incorporated into soft, intermediate, and very stiff 
subendothelial matrices with similar incorporation dynamics and final fraction of 
incorporation to breast cancer cells (Figure 2.8).  SW1990 pancreatic cells displayed a 
different behavior from the melanoma cells and breast cancer cells.  When SW1990 cells 
were plated on soft and intermediate substrates, they displayed a similar level of 
incorporation dynamics and final fraction of incorporation after 15 hours (Figure 2.9).  
However, when allowed to incorporate on very stiff matrices (glass; 50GPa), they 
displayed a much lower fraction of incorporation and slower incorporation rate. While 
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subsequent steps of the metastatic cascade may depend on matrix stiffness, our results 
indicate that the early stages of breast cancer cell extravasation and melanoma 
extravasation occur irrespective of the mechanical properties of the matrix below the 
endothelium while pancreatic cell incorporation changes on very stiff substrates. 
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Figure 2.7. Incorporation of MDA-MB-231 does not depend on subendothelial matrix 
stiffness. (A) Cumulative fraction of MDA-MB-231 cells incorporated into endothelial 
cells on a fibronectin-coated 0.87 kPa or 280 kPa polyacrylamide gel, or glass (50 GPa). 
Data points represent mean ± SEM for at least 3 independent experiments (N>20 cells for 
each experiment). (B) Final fraction of MDA-MB-231 cells incorporated into the 
(untreated) endothelium as a function of subendothelial matrix stiffness. Bars represent 
mean, while error bars represent SEM of at least 3 independent experiments. P>0.05 
between these values indicates there is no statistical difference (n.s.). (C) Time for MDA-
MB-231 cells to complete incorporation is independent of the mechanical properties of 
the matrix below the endothelial cells. Endothelial cells on fibronectin-coated glass 
coverslips (50 GPa) or polyacrylamide gels (0.87 kPa or 280 kPa) were left untreated 
(noTNF) or treated with TNF-α (TNF). No statistical difference in incorporation time was 
measured as a function of subendothelial matrix stiffness or endothelial cell treatment 
(P>0.05).  
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Figure 2.8. (A) Cumulative fraction of A375 cells incorporated into endothelial cells on a 
fibronectin-coated 0.87 kPa or 280 kPa polyacrylamide gel, or glass (50 GPa). Data 
points represent mean ± SEM for at least 3 independent experiments (N>20 cells for each 
experiment). (B) Final fraction of A375 cells incorporated into the (untreated) 
endothelium as a function of subendothelial substrate stiffness. Bars represent mean, 
while error bars represent SEM of at least 3 independent experiments. P>0.05 between 
these values indicates there is no statistical difference (n.s.).  
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Figure 2.9 (A) Cumulative fraction of SW1990 cells incorporated into endothelial cells 
on a fibronectin-coated 0.87 kPa or 280 kPa polyacrylamide gel, or glass (50 GPa). Data 
points represent mean ± SEM for at least 3 independent experiments (N>20 cells for each 
experiment). (B) Final fraction of SW1990 cells incorporated into the (untreated) 
endothelium as a function of subendothelial substrate stiffness. Bars represent mean, 
while error bars represent SEM of at least 3 independent experiments. (*) indicates 
statistical difference between groups (P<0.05).  
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2.3.4 Endothelial cells do not express VE-cadherin along borders with incorporated 
cancer cells 
 Vascular endothelial cadherin (VE-cadherin) is one of the key homophilic 
adhesion molecules expressed by ECs at cell-cell borders in a confluent monolayer. The 
integrity of the endothelium as a vascular barrier is heavily dependent on the proper 
functioning of VE-cadherin adhesion molecules [164, 165].  As ECs incorporated into a 
healthy confluent endothelium, GFP-VE-cadherin was expressed by all ECs neighboring 
the incorporated DiIC16-labeled EC (Figure 2.10A), indicating that addition of new ECs 
onto the monolayer did not disrupt the integrity of the EC junctions.  We next sought to 
identify possible changes in VE-cadherin morphology following incorporation of MDA-
MB-231 cells into the endothelium.  Strikingly, ECs neighboring incorporated DiIC16-
labeled MDA-MB-231 cells did not express GFP-VE-cadherin at borderlines with the 
MDA-MB-231 cells, though they continued to express GFP-VE-cadherin at junctions 
with other ECs (Figure 2.10B).  These results indicate that the early stage of cancer cell 
extravasation not only affects VE-cadherin-dependent cell-cell adhesion, but may also 
provide an easily accessible route of extravasation for other circulating tumor cells.  
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Figure 2.10. Endothelial cells do not express VE-cadherin along borders with 
incorporated cancer cells. DiIC16-labeled HUVECs (A) or MDA-MB-231 (B) were 
plated onto endothelial cells expressing VE-cadherin-GFP (VE-cad-GFP). Images were 
captured following incorporation of each cell type. Scale bar is 10 µm and applies to all 
images in this figure.  
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2.3.5 Cancer cell incorporation initiates by dislocating VE-cadherin at endothelial cell 
junctions 
 Prior to the onset of MDA-MB-231 incorporation into the endothelium, we 
observed intact GFP-VE-cadherin at the EC junction directly below the MDA-MB-231 
cell (Figure 2.11A; red arrows).  This was in direct contrast to the MDA-MB-231 cells 
that incorporated into the endothelium at earlier timepoints, where GFP-VE-cadherin was 
not expressed by neighboring ECs (Figure 2.11A; yellow arrows).  The first step of 
incorporation created a disruption in GFP-VE-cadherin at the EC junction directly below 
the MDA-MB-231 cell, leading to formation of a small (~2 µm2) hole in the EC junction 
(Figure 2.11B; red arrow).  A second small hole sometimes formed (Figure 2.11B; two 
red arrows) before the void became significantly larger (~33 µm2 at T=6:35) and cleared 
the area of part of the body of the EC.  Finally, what began as a small gap in the GFP-
VE-cadherin propagated into a huge hole in the endothelium, which became occupied by 
the MDA-MB-231 cell (Figure 2.11B).  We also observed significant displacement and 
restructuring of GFP-VE-cadherin at nearby EC-EC junctions (Figure 2.11B; yellow 
arrows). 
  
	   52 
 
Figure 2.11. Cancer cell incorporation initiates by dislocating VE-cadherin at endothelial 
cell junctions. DiIC16-labeled MDA-MB-231 were plated onto endothelial cells 
expressing VE-cadherin-GFP (VE-cad-GFP). (A) Shown are differential interference 
contrast (DIC), DiIC16 (red) fluorescence, and VE-cadherin-GFP (green) fluorescence, 
and overlay images. At this timepoint, one MDA-MB-231 has already incorporated into 
the endothelium (yellow arrows), and the VE-cadherin-GFP is still intact in the location 
directly below another MDA-MB-231 cell that has not yet begun to incorporate (red 
arrows). (B) Fluorescence timelapse sequence of a DiIC16-labeled MDA-MB-231 cell 
(red) incorporating into an endothelium expressing VE-cadherin-GFP (green). Length of 
time after plating MDA-MB-231 cells on the endothelium is indicated in the upper right 
corner of each image in hour:minute format. Scale bar in panel A (DIC image) is 10 µm 
and applies to all images in this figure.  
	   53 
2.4 Discussion 
 Cancer metastasis continues to be a leading cause of death in cancer patients [130, 
131], and one of the critical steps regulating metastasis is extravasation from the 
vasculature.  While the mechanisms regulating this process are unclear, the endothelium 
is known to play an important role, acting as either a barrier to some cancer cells, or a 
promoter of invasive capability in other cancer cells including MDA-MB-231 [144, 166]. 
EC apoptosis and clearance from the basement membrane have previously been reported 
as side effects during cancer cell extravasation [141, 142].  Similarly, ovarian tumor cell 
spheroids displace mesothelial cells during intercalation into the submesothelial space 
[145].  We demonstrate that in our in vitro model, most metastatic breast cancer cells 
clear a space in and appear to become part of the endothelium (without forming VE-
cadherin dependent adherens junctions with the ECs), in a process we term 
“incorporation.”  We were able to observe this process for multiple metastatic cancer 
lines, including MDA-MB-231 breast cancer cells, A375 melanoma cells, and SW1990 
pancreatic cells.  Notably, this process occurs independently of the activation status of the 
endothelium or subendothelial matrix stiffness for some cell types, even though these are 
both important regulators of leukocyte transmigration [26, 154].  
Our data indicates that incorporation into the endothelium represents the first step 
in extravasation.  Thus, we suggest that cancer cell transmigration is a two-step process 
in which the cells must first incorporate into the endothelium before completing the 
second step of migration beneath the endothelium and into the basement membrane or 
even continuing into the basement membrane without migrating beneath the ECs.  
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Indeed, partial retraction of the ECs and incorporation of tumor cells has been observed 
in vivo [167, 168] and for mesenchymal stem cells (MSCs) [169, 170].  However, 
previous studies with MSCs have shown that this step depends heavily on the activation 
status of the endothelium and the use of VCAM-1 to facilitate transmigration [169-171]. 
In our work, which is relevant for low-flow conditions such as in the capillaries, we 
found that incorporation occurs independently of the activation status of the endothelium 
for breast cancer cells and melanoma cells.  In contrast, studies have shown that 
fibrosarcoma cells displayed increased intravasation rates into an inflamed endothelium 
[172] and our results indicate that SW1990 pancreatic cells had increased incorporation 
into the endothelium following endothelial activation.  Breast tumor cells lack β2 
integrins, which are a ligand for ICAM-1 on the endothelium [173].  Following activation 
of the endothelium, melanoma cells did not show an increase in incorporation.  It has 
been shown the co-culture of melanoma cells with ECs leads to LFA-1/ICAM-1 receptor 
couple during transmigration [174].  Therefore, it is likely that there was no difference 
between activated and untreated ECs because the melanoma cells were increasing ICAM-
1 expression even without the presence of TNF-α.  These factors may account for the 
differences observed between leukocytes, MSCs and pancreatic tumor cells. SW1990 
cells on the other hand, have been shown to increase adhesion to mesothelial cells 
following incubation with TNF-α, and that ICAM-1 an important adhesion molecule for 
pancreatic cancer cells [175].  Further study is necessary to dissect the exact mechanisms 
of pancreatic cell incorporation.  Additionally, tumor cells are capable of attaching to 
leukocytes by expressing ICAM-1.  The leukocytes then act as a linker, connecting the 
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tumor cells to the endothelium, and enabling firm adhesion and subsequent 
transmigration [21].  In vivo, cancer cells may use this mechanism to localize to sites of 
inflammation or infection.    
Although all the metastatic tumor cells observed in this study incorporated into 
the endothelium, there was a significant difference between the fractions of 
incorporation.  A375 melanoma cells incorporated into the endothelium significantly 
more than MDA-MB-231 cells and SW1990 cells and their incorporation dynamics 
closely resembled that of native ECs spreading into a monolayer.  SW1990 tumor cells 
on the other hand, incorporated at a significantly lower rate.  There are multiple factors 
that can account for these differences.  It is likely that the tumor cells each use their own 
distinct set of adhesion molecules and signaling pathways.  Indeed, it has been shown 
that co-culture of melanoma cells with ECs induces LFA-1/ICAM-1 receptor couple 
during transmigration [174].  
Additionally, we observed that tumor cell incorporation does not depend on the 
subendothelial matrix stiffness.  Subendothelial matrix stiffness varies between 
homeostasis and pathological disease and likely also depends on vasculature location. 
When plated on stiffer substrates in vitro, the endothelium has a hyper-contractile 
phenotype that leads to intercellular gap formation [26, 27].  Thus, it would be expected 
that cancer cells would transmigrate more on stiffer substrates.  However, despite these 
observations, the cumulative fraction of tumor cells that incorporates remains 
approximately the same independently of subendothelial matrix stiffness and the 
subsequent hyper-contractility of the EC monolayer for the melanoma cells and breast 
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cancer cell lines.  This indicates that the tumor cells do not take advantage of the hyper-
permeability of the endothelium.  However, as they migrate beyond the vasculature and 
into tissues, matrix stiffness may become an important modulator of metastasis; indeed, 
previous reports have indicated that the matrix stiffness governs 3D cancer cell migration 
[176].  The pancreatic cells displayed a different behavior when they incorporated in EC 
monolayers with varied subendothelial matrix stiffness.  On soft and intermediate 
matrices, they displayed similar rates and fraction incorporations.  On very stiff 50GPa 
matrices, incorporation was reduced.  Most stiffness’ that cells feel are between 10Pa-
10000Pa [28].  50GPa is well outside the physiological range, so it is possible that the 
cells altered their incorporation behavior based on the very stiff substrate.  To dissect the 
mechanism of why pancreatic cells displayed a decrease of incorporation fraction on very 
stiff subendothelial matrices would require further study. 
Stephan Paget’s ‘seed and soil hypothesis’ has been used to explain the non-
random patterns of metastasis formation to visceral organs.  Certain tumor cells (the 
seed) have a propensity to metastasize to particular organs (the soil) in the body.  Based 
on our results, subendothelial matrix stiffness does not play a role in determining where 
cancer cells initially exit the blood stream.  Furthermore, our work suggests that ligands 
that are upregulated during inflammation do not play a role in determining where cancer 
cells exit the blood stream, at least in vasculature with low shear stress rates. 
During incorporation, ECs do not express VE-cadherin along borders with cancer 
cells, but continue to express VE-cadherin with neighboring ECs.  VE-cadherin was 
significantly restructured during the incorporation process, indicating that the addition of 
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tumor cells disrupted the integrity of the monolayer.  Additionally, this disruption may 
provide an easily accessible route for other incorporating cancer cells.  Incorporation 
initiated by creating a small hole in the VE-cadherin between ECs.  As incorporation 
progressed, the hole became much larger, creating a void for the cancer cell to spread 
onto the underlying fibronectin-coated matrix beneath.  These results are consistent with 
others that have shown that during leukocyte transendothelial migration, a transient gap 
forms between the ECs, allowing the leukocyte to migrate through, before closing the 
VE-cadherin junctions [177, 178].  It remains to be seen whether the endothelium would 
reform junctions as the cancer cell completes extravasation.  From our work, it is evident 
that the incorporation process damages the endothelium since tumor cells physically 
displace and/or detach ECs during incorporation. Thus, tumor cells damage the 
endothelium during incorporation, whereas leukocytes and even MSCs appear to leave 
the endothelium intact in most cases. 
Elucidating the mechanistic underpinning for cancer cell diapedesis will be 
critical in order to understand cancer metastasis and its progression.  Significantly, our 
results show that cancer cell transmigration includes an additional step, incorporation into 
the endothelium, and that this process occurs independently of inflammation and 
subendothelial matrix stiffness for some cancer types.  Out of the cell lines tested, 
pancreatic cells displayed differences upon endothelium activation and showed a 
decreased fraction of incorporation on very stiff substrates. While here we specifically 
designed our in vitro model to focus on the early stages of cancer cell extravasation, 
future studies could be aimed at investigating subsequent stages of extravasation by 
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characterizing cancer cell incorporation into an EC monolayer on a 3D matrix through 
which the tumor cells can penetrate.  
 
2.5 Conclusions 
 In this Chapter, we explored mechanisms of cancer cell transmigration through 
the endothelium.  This process is intrinsically different from leukocyte transmigration.  
During leukocyte transmigration, cells squeeze between or through the endothelium and 
this process is dependent on subendothelial matrix stiffness and activation of the 
endothelium with TNF-α.  During cancer cell extravasation, however, it appears to 
include an additional step, which we term ‘incorporation’ into the endothelium.  This data 
suggests that cancer cell transmigration is a two-step process in which cancer cells first 
incorporate into the monolayer and then migrate under.   We also found that cancer cell 
incorporation occurs independently of matrix stiffness and endothelial activation for 
melanoma cells and breast cancer cells.  However, we found pancreatic cells are sensitive 
to subendothelial matrix stiffness and endothelial activation.  This indicates that homing 
mechanisms may be cell specific based on adhesion molecules they use and their 
sensitivity to matrix stiffness.  In conclusion, we found that cancer cell extravasation 
occurs by a very different mechanism from immune cells, and this result could have a 
significant impact on the cancer field. 
A fundamental step during cancer cell extravasation and invasion is the ability to 
form protrusive processes.  There are many proteins and RNAs that localize to 
protrusions in migrating cells.  Localization of RNAs in lamellipodial regions has been 
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proposed to play an important role during metastatic progression [179], however, the 
identity and functional significance of these localized mRNAs has been investigated only 
in few cases [8, 11].  Due to the fact that there is vast heterogeneity in cancer cells, we 
chose to do the next portion of the work in NIH 3T3 cells as a model system.  In the 
next two Chapters, we focus on the localization of RNAs at cellular protrusions and 
their potential significance during cancer metastasis. 
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Chapter 3: Effect of Substrate Stiffness and Contractility on 
APC-dependent mRNA Localization 
3.1 Introduction 
 RNA localization pathways direct RNAs to specific subcellular sites where they 
can produce proteins locally and affect many physiological functions.  Localized RNAs 
impact many processes such as cellular polarity [180, 181] and migration [11] .  Defects 
in localization have been associated with neurodegenerative disorders and cancer 
metastasis [108, 179].  Particularly in migrating cells there are at least two pathways that 
direct RNA localization to the leading edge (reviewed in Chapter 1).  In the APC-
dependent pathway, numerous RNAs are targeted to cellular protrusions in migrating 
fibroblasts and their anchoring depends on the tumor suppressor protein Adenomatous 
Polyposis Coli (APC) [8].  In cellular protrusions, specifically at the plus-ends of 
detyrosinated microtubules, APC associates with several RNAs such as Ddr2, Pkp4, and 
Rab13. 
Cellular protrusion extension has been proposed to be a critical step in directional 
migration [182].  As cells migrate, there are many signaling and cytoskeletal proteins that 
localize to the leading edge where they play important roles in the regulation of 
protrusion dynamics [182].  Additionally, at cellular protrusions, RNAs become 
localized.  At the same time, cells sense the extracellular matrix environment as they 
anchor and pull on their surroundings during migration.  Within tissues, cells encounter 
microenvironments that may range in rigidity from tens of pascals in soft tissue such as 
the brain, to gigapascals in the stiffest tissues such as bone [30].  When cells encounter 
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these differences in extracellular matrix stiffness, they alter their behavior, including their 
modes of migration and forces they exert on the matrix.  For example, NIH 3T3 
fibroblast cells alter their spreading behavior, exertion of traction forces, as well as their 
motility on soft flexible polyacrylamide gels compared to stiffer substrates [31, 183].  
However, it is currently unknown whether cells alter the localization of RNAs based on 
the extracellular matrix stiffness.  Since APC-dependent RNAs are localized to the 
protrusions of migrating fibroblasts, and some of the proteins they encode are involved 
migration, it is likely that their localization is sensitive to substrate stiffness. 
Microenvironmental stiffness has also been implicated in breast cancer cell 
invasion in vitro and metastasis in vivo, both of which may involve defective RNA 
localization [179].  In fact, in Chapter 1 we found that the effects of 
microenvironmental stiffness on cancer transmigration are cell-specific [184].  
Furthermore, mechanical tension has been shown to influence RNA localization at 
adhesion sites, which is adjusted by cells based on the mechanical properties of the 
microenvironment [5].  Additionally, traction force data has indicated that migrating 
fibroblasts have strong stresses at the leading edge, lateral protrusions and trailing edge 
[185, 186].  These areas, specifically at the lateral protrusions, are typically where APC-
dependent RNAs are localized [8].  Rho/ROCK pseudopodial activation has also been 
associated with RNA dynamics in tumor cells and Rho regulates β-actin localization 
through actomyosin interactions [6, 74].  Thus, it is possible that APC-dependent RNA 
localization can be affected by Rho actomyosin contractility and substrate stiffness.  This 
may have important implications in the context of cancer metastasis. 
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 Our study sought to investigate whether and how substrate stiffness affects APC-
dependent RNA localization.  We used polyacrylamide gels of physiologically relevant 
stiffness and combined it with fluorescent in-situ hybridization to visualize RNA 
distribution.  We analyzed RNA distributions from populations of cells and analyzed the 
effects of substrate stiffness and actomyosin contractility on RNA localization.  Our 
results indicate that stiffness enhances localization and loss of contractility reduces 
localization.  Overall, our analysis of APC-dependent RNA localization under various 
mechanical and molecular conditions offers new insights into how the mechanical 
environment and cellular contractility regulates RNA localization. 
 
3.2 Materials and Methods 
3.2.1 Polyacrylamide gel preparation 
Thin polyacrylamide gels were prepared on glass coverslips according to the 
method first described by Wang and Pelham [153] and described in detail in previous 
publications [26, 36, 154-157]. Briefly, 280 kPa (15% acrylamide + 1.2% bis 
acrylamide), 5 kPa (5% acrylamide + 0.05% bis acrylamide) and 1 kPa (3% acrylamide +  
0.2% bis acrylamide) gels were created and coated with 0.1mg/mL fibronectin (Sigma-
Aldrich) as previously described [26].  Characterization of the Young’s modulus of the 
gels was accomplished by atomic force microscopy and dynamic mechanical analysis, 
while analysis of surface-bound fibronectin was accomplished by immunofluorescence 
[36, 156]. 
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3.2.2 Cell Culture and Fluorescent In Situ Hybridization (FISH) 
NIH/3T3 cells were grown in DMEM supplemented with 10% calf serum, and 
penicillin, and streptomycin (Invitrogen), and sodium pyruvate.  Cells were plated on 
fibronectin-coated polyacrylamide gels for two hours and subsequently fixed in 4% 
paraformaldehyde for ten minutes.  Fluorescence in situ hybridizations (FISH) was 
performed using the Affymetrix QuantiGene ViewRNA assay according to 
manufacturer’s instructions.  
mRNA in situ hybridization allows for fluorescent detection of localized RNAs in 
cells.  The Affymetrix assay, in particular, is a non-radioactive method that allows for 
single molecule sensitivity.  A specific probe set, containing 40 oligo probes, hybridizes 
to the target mRNA as 20 oligo pairs.  Each oligo pair forms a platform for the formation 
of a signal amplification tree through a series of sequential hybridization steps.  Once the 
structure is assembled, it has the capacity to generate 400-fold signal amplification. 
Three RNAs were simultaneously visualized in these experiments: localized 
mRNA, non-localized mRNA, and 18S rRNA.  18S ribosomal RNA is the structural 
RNA for the small subunit of the eukaryotic cytoplasmic ribosomes, and thus is abundant 
throughout the cell.  Because of its abundance, the 18S probe is used to obtain the cell 
mask.  The non-localized mRNA probe acts as an internal control, and is a disperse RNA 
that is found throughout the cells.  In 3T3 cells, a probe against PolyA was used to detect 
poly-adenylated RNAs.  In this way, the general population of RNA distribution can be 
observed.  The ‘localized’ RNA probe used was against the APC-dependent Ddr2 RNA. 
In some cases, the cell masks obtained through the 18S RNA fluorescent staining 
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were used to measure cell areas using Imagej.   
3.2.3 Image Acquisition 
FISH images were obtained using a Leica SP8 confocal microscope (equipped 
with a HC PL APO 63x oil CS2 objective).  Maximum-intensity projections of Z-stacks 
were obtained; background subtracted, and analyzed using Image J.  In the case of PolyA 
staining, the nuclear mask was subtracted from the images because it has a high 
background signal in the nucleus.  In the case of soft substrates (1 kPa), the nuclear signal 
was subtracted from the PolyA channel and the RNA channel to take into account the 
rounded morphology of the cells.  When comparing soft (1 kPa) versus stiff substrates (5 
kPa, 280 kPa), the nuclear signal was also subtracted from the RNA channel and PolyA 
channel.   
The channel detecting the 18S probe was used to obtain a binary cell mask of the 
whole cell area.  Similarly, the channel detecting the nuclei was used to obtain a binary 
mask of the nuclear area.  The quantification was performed using a method developed 
called the Peripheral Distribution Index (PDI) that we adapted from Park et al.  [187].  
Using the PDI, the distance is calculated from the centroid of the nucleus to each RNA 
pixel, weighted for intensity, and divided by a hypothetical uniform distribution to 
normalize for cell morphology.  The second moment (𝜇!) of RNA pixels is calculated 
using the formula below where 𝑟! is the distance from centroid of the nucleus to each 
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To generate the hypothetical uniform distribution (𝜇!′), a binary cell mask image is 
generated and the second moment is calculated from each pixels coordinated within the 





Values of 1 mean that the RNAs are uniformly distributed; values less than 1 mean the 
RNAs are more centrally located, and values greater than 1 mean the RNAs are more 
peripherally distributed (see Figure 3.1).  
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Figure 3.1 The peripheral distribution index (PDI) is a way to quantify mRNA 
localization from a population of cells.  The distance is measured from the centroid of the 
nucleus to the RNA molecules (depicted in red) and divided by a hypothetical uniform 
distribution.  Values <1 have a central distribution; values =1 have a uniform distribution; 
and values >1 have a peripheral distribution. 
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3.2.4 Drug Treatments 
 Cells were treated with 50uM Blebbistatin (Sigma) for two hours or 10uM 
Y27632 (Sigma).  Control cells were treated with vehicle (DMSO).  In the case of LPA, 
cells were serum starved overnight and allowed to attach to gels for two hours before 
10uM lysophosphatidic acid (LPA) was added for two hours. 
 
3.2.5 siRNA Transfection 
NIH/3T3 cells were transfected with siRNA to a 40pmol final concentration with 
Lipofectamine RNAiMAX (Thermo Fisher Scientific, cat# 13778-150) according to the 
manufacturer’s instructions.  Cells were incubated for three days before being analyzed 
siRNAs used were as follows (Qiagen): 







Table 3.1. siRNAs used to perform knock-down experiments. 
 
3.2.6 Traction Force Microscopy 
Cell traction forces were measured by embedding 0.2um fluorescent beads in the 
upper surface of polyacrylamide gels.  Images were taken in the ‘stressed’ state with the 
cell attached to the substrate.  The cell was subsequently detached using trypsin and 
another image was taken in the ‘null’ state.  To correct for experimental drift, the imagej 
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plugin “align slices in stack” was used.  The displacement field was subsequently 
calculated using the particle image velicometry as previously described (PIV) [188].  
With the displacement field obtained through the PIV analysis, the traction force field 
was reconstructed by Fourier traction cytometry (FITC).  The PIV and traction force 
microscopy macros are available online and can be implemented in imagej.   
 
3.2.7 Statistical Analysis 
To establish significance between the internal control mRNA and the 
localized/experimental mRNA, the Wilcoxon signed-rank test was used with a p value < 
0.05.  To compare values between two groups, the Student’s t-test was performed with a 
p value < 0.05. 
 
3.3 Results 
3.3.1 Substrate stiffness enhances Ddr2 mRNA localization 
When NIH 3T3 mouse fibroblasts are plated on soft, fibronectin-coated 1 kPa 
gels, the cells remain round and not well spread out (Figure 3.2A).  On stiffer 5 kPa and 
280 kPa substrates, cells spread out more and form long protrusions (Figure 3.2A).  
These observations are consistent with previous results that observed cell spreading is 
increased on stiffer substrates [31, 183].  Using traction force microscopy, we measured 
cell traction forces on the substrates of varying stiffness.  Cells on stiffer substrates (5 
kPa and 280 kPa) had increased traction forces compared to soft 1 kPa gels.  To observe 
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RNA localization, FISH was performed.  Ddr2 was used as a representative APC-
dependent RNA.  On soft, 1 kPa gels, Ddr2 mRNA is diffuse throughout the cytoplasm.  
On 5 kPa gels, Ddr2 mRNA becomes more peripherally localized (Figure 3.2A; white 
arrows).  On stiff 280 kPa substrates, Ddr2 RNA is also localized to the periphery.  PDI 
analysis showed that on 1 kPa gels, there was no significant difference between PolyA 
and Ddr2 RNA distribution (Figure 3.2B).  On 5 kPa and 280 kPa gels, Ddr2 RNA is 
localized compared to the internal control.  These results indicate that Ddr2 RNA 
localization is mechanosensitive.   We hypothesized that the effects of RNA localization 
on stiffer substrates was due to increased cell contractility.  mRNA localization at 
adhesion sites is influenced by mechanical tension [5], which is adjusted by cells as a 
function of the mechanical properties of the cell environment.  Furthermore, several 
studies have shown that cytoskeletal tension is influenced by ECM stiffness [189-191].  
Thus it is possible that actomyosin contractility could account for the increased 
localization on stiffer substrates.   
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Figure 3.2.  (A) Representative images depicting FISH staining on polyacrylamide gels.  
Arrows point to areas where Ddr2 mRNAs (cyan) are peripherally localized on 5 kPa and 
280 kPa gels compared to PolyA staining (magenta). (B) Peripheral distribution index 
analysis shows that on 5 kPa and 280kpa Ddr2 mRNA is more localized compared to 
control PolyA staining (P<0.0001).  Error bars represent the mean with 95% confidence 
interval.  (C) Traction stress measurements indicate that cells exert more traction stress 
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3.3.2 Myosin II inhibition reduces Ddr2 RNA localization on stiff substrates 
  To test our hypothesis that increased contractility accounts for increased 
localization on stiff substrates, we wanted to see if we could reduce RNA localization by 
inhibiting actomyosin contractility.  One of the main regulators of cytoskeletal tension is 
the Rho family of GTPases.  Rho functions via Rho kinase (ROCK) to regulate myosin-II 
light chain phosphorylation through inhibitory phosphorylation of myosin phosphatase.   
Contractile tension within the actin cytoskeleton is generated by myosin II.  We used 
Y27632 and blebbistatin to reduce cell contractility.  Blebbistatin inhibits myosin II by 
blocking myosin in the actin-detached state and prevents rigid actomyosin cross-linking, 
thus reducing cell contractility [192].  Y27632 is a specific ROCK inhibitor that 
competes with ATP for binding to the catalytic site [193]. Traction force measurements 
indicated that Y27632 and blebbistatin reduced traction stresses, verifying the treatments 
reduced cell contractility (Figure 3.3C).  When FISH was performed, it was observed that 
both Y27632 and blebbistatin reduced Ddr2 RNA localization compared to vehicle 
(DMSO) treated cells on 5 kPa gels (Figure 3.3B).  Most of the Ddr2 RNAs were located 
towards the center of the cell and many cellular protrusions were devoid of Ddr2 staining 
(Figure 3.3A) that was observed in control (DMSO-treated) cells (Figure 3.3A).  
However, inhibiting actomyosin contractility did not completely abolish RNA 
localization when compared to PolyA RNA.   
To further confirm the effects of contractility on RNA localization, we knocked 
down myosin II using siRNA against myh9a (non-muscle myosin heavy chain) (Figure 
3.4B).  In si-control cells, RNAs were localized to the periphery.  In myosin II 
	   72 
knockdown cells, RNAs were more diffuse throughout the cytoplasm. PDI analysis 
showed that Ddr2 localization was reduced in knockdown cells compared to control 
siRNA (Figure 3.4C).  To confirm that this knockdown also reduced cellular contractility, 
traction force measurements were performed on 5 kPa gels.  Indeed, traction forces were 
reduced in myosin II knockdown cells compared to si-control cells.  These results 
indicate that actomyosin contractility plays a role in regulating Ddr2 RNA localization to 
cellular protrusions.   
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Figure 3.3.  (A) Representative images showing control treated cells show Ddr2 
localization at protrusions (white arrows) in control cells.  Blebbistatin and Y27632 
treated cells show more Ddr2 staining in the perinuclear regions and many protrusions 
are absent of Ddr2 RNAs (white arrows).  (B)  PDI analysis shows blebbistatin treatment 
reduces Ddr2 localization (P<0.001) and Y27632 also reduces localization (P<0.01) (C)  
Traction force measurements indicate blebbistatin and Y27632 lower cellular 
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Figure 3.4. (A) Representative images of control siRNA and myh9a siRNA treated cells. 
White arrows point to peripheral Ddr2 mRNAs. (B) Western blot shows reduction in 
myosin II with myh9a siRNA.  Tubulin content remains the same in control and myosin 
knockdown cells. (C) Myh9a siRNA treated cell show a reduction in Ddr2 RNA 
localization (P<0.01). (D) Cell average traction force measurements show that myosin II 
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3.3.3 LPA increases contractility and induces RNA localization on soft substrates 
 To further test the role of contractility in Ddr2 RNA localization, we treated cells 
on soft 1 kPa substrates with lysophosphatidic acid (LPA).  LPA is known to activate 
Rho and stimulates contraction of the actomyosin skeleton [37].  When cells were treated 
with LPA, they became more elongated (Figure 3.5A) and increased their spreading area 
(Figure 3.5D).  Traction force measurements also indicated that cells treated with LPA 
exerted more traction stress on average (70 Pa) compared to control (30 Pa) (Figure 3.5 
C).  To test the role of actomyosin contractility on Ddr2 RNA localization, we performed 
FISH on LPA treated cells.  Indeed, LPA treated cells showed peripheral distribution of 
RNAs compared to PolyA staining (Figure 3.5B).  Control cells showed diffuse staining 
and no localization.  These results indicate that it is possible to promote localization on 
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Figure 3.5 (A) Representative images showing cells on 1 kPa gels in control and LPA  
treated groups.  LPA treated cells become larger and more elongated with peripheral 
Ddr2 localization.  White arrows point to peripheral Ddr2 RNA localization. (B) PDI 
analysis shows Ddr2 RNA is localized compared to PolyA control (P<0.0001).  Bars 
represent the mean with 95% confidence interval. (C) Traction force measurements show 
that cells exert higher traction on 1 kPa substrates when treated with LPA (P<0.01, 
N=20).  Error bars represent SEM (D) Cell area measurements indicate that LPA-treated 
cells have a higher spreading area compared to control cells on 1 kPa substrates 
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3.4 Discussion 
 RNA localization is a tightly regulated event that is critical for many cellular 
functions.  A subset of RNAs, including Ddr2, is localized to the protrusions in migrating 
fibroblasts and is dependent on APC for anchoring at the ends of detyrosinated 
microtubules [8].  During migration, cells sense and respond to the mechanical properties 
of their environment and modulate their contractility accordingly.   The stiffness that 
cells feel in vivo situations, however, is much less than glass substrates.  However, little 
is known how mRNAs respond to substrate stiffness and cellular contractility.  In the 
current work, we hypothesized that increasing substrate stiffness and enhanced cellular 
contractility would play a role in Ddr2 RNA localization.  
 We chose to use polyacrylamide gels of different stiffness to see how cells alter 
RNA localization in response to the mechanical environment.  The use of this system 
offers many advantages including the ability to tailor the stiffness easily by changing the 
concentration of cross-linker, control the stiffness of gel independent of extracellular 
protein amount, and create gels of physiologically relevant stiffness.  In this work, we 
chose to vary the range of stiffness from 1-280 kPa in order to mimic the changes of 
tissue stiffness that occur throughout the body and during disease pathologies such as 
cancer.  For example, the stiffness of brain (0.1-1 kPa) is much less than that of bone (~2-
4 GPa) [194].  Furthermore, the stiffness of the primary tumor has been shown in many 
cases to be stiffer than normal tissue [189].   
On stiffer substrates, we saw an increase in Ddr2 RNA localization to the 
periphery.  We hypothesized that the increased actomyosin contractility on the stiff 
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substrates could account for this.  To verify this, we performed traction force microscopy 
to measure cellular traction forces on the different substrates.  Indeed, we observed 
higher traction forces on 5 kPa and 280 kPa substrates compared to the soft, 1 kPa 
substrates.  These findings and the values we obtained are in accordance with previous 
studies done with fibroblasts [183, 186].  It would be interesting in future studies to 
observe the distribution of traction forces with the localization of RNAs concurrently. 
Furthermore, it would also be interesting to see whether Ddr2 RNAs localize to the front 
or trailing edge of the cell during migration.  In migrating fibroblasts, the leading edge 
and sometimes the trailing edge have the highest localization of traction forces [183, 
186].  Additionally, since APC-dependent RNAs associate with Glu-MT that tend to 
orient themselves toward the leading edge of the cell, it is likely that APC-dependent 
RNAs localize to the leading edge during migration [195].  
In this work, we addressed the role of contractility and substrate stiffness in 
migrating cells.  However, this system may be relevant to other systems such as 
collective migration and tissue formation.  On stiff substrates, cells migrate away from 
one another whereas on soft substrates they merge together to form tissue-like structures 
[196].  While in this dissertation, we have mainly focused on the localization of Ddr2 
RNA that is involved in cell-substrate adhesion and migration; there are other APC-
dependent RNAs that may play a role in cell-cell junctions.  Pkp4 mRNA which encodes 
for the protein Plakophilin 4 is thought to be a component of desmosomes and adherens  
junctions [94].  Furthermore, myosin II contractility plays a role in tissue-like cell 
compaction.  It is likely to be responsible for the contraction of cell-processes during 
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tissue-like cell compaction and the formation of cell-cell adhesions [196].  In breast 
cancer cells, ZBP1/IMP1 targets RNAs not only to the leading edge, but also to cell-cell 
junctions (E-cadherin and β-actin) [197].  Taken together, it is possible that the same 
factors can target RNAs to different places depending on specific conditions or cell type. 
To address our hypothesis and evaluate the role of contractility in RNA 
localization, we performed a series of assays in which cells were plated on substrates of 
varying stiffness and treated with pharmacological drugs to target specific biophysical 
machinery.  On 1 kPa gels, LPA was used to activate RhoA.  However, LPA has multiple 
downstream effectors and it is possible that it could have other non-specific effects.  To 
further test the role of RhoA in the localization of RNAs a Rho activator could be used.    
It is interesting to note that inhibiting actomyosin contractility with blebbistatin, 
Y27632 and myosin knockdown did not completely abolish RNA localization.  Thus it is 
likely that RNA localization is mediated through interplay between the actin and 
microtubule cytoskeleton. Microtubules have been shown to regulate cell spreading 
based on substrate stiffness and cell contractility.  On soft matrices, microtubules are 
necessary to form dendritic extensions and on stiff substrates microtubules are 
necessary for polarization but not spreading [198].  Ddr2 RNA is known to associate 
specifically with detyrosinated microtubules and not with the actin cytoskeleton [8].  The 
actin and microtubule cytoskeleton coordinate in various physiological events and a 
dynamic balance between them is necessary for cell contractility, polarization and 
migration.  Cells in culture normally maintain high contractility and exert forces on rigid 
substrates using myosin II to contract actin fibers.  F-actin, myosin II, microtubules and 
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focal adhesions interact to mediate efficient cell migration [71, 199].  During migration 
the microtubule cytoskeleton becomes polarized with many of them detyrosinated with 
their plus ends preferentially facing the leading edge [195].  RhoA has also been shown 
to regulate microtubule activity.  In fibroblasts, the formation of stable, non-dynamic 
detyrosinated microtubules is induced by activation of RhoA and is mediated by its 
downstream effector mDia [200].  Thus it is likely that detyrosinated microtubules are 
involved in the localization of RNAs on stiffer substrates and their disruption might 
account for a reduction in localization upon actomyosin inhibition.  This might be a 
reason why inhibiting actomyosin contractility did not completely abolish RNA 
localization.  To completely abolish localization, it might be necessary to more directly 
reduce the amount of detyrosinated microtubules in the cell.  Based on this, we 
hypothesized that contractility influences RNA localization by affecting the detyrosinated 
microtubule network. 
Previous research has indicated that integrin binding and mechanical tension 
induce movement of RNAs and ribosomes to focal adhesions, but the identity of these 
RNAs was unknown.  It was also unknown how the microenvironment might influence 
RNA localization.  We show here for the first time that Ddr2 RNA localization is 
mechanosensensitive, and that substrate stiffness and contractility play a role in its 
localization to cellular protrusions.   
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3.5 Conclusions 
 In this Chapter, we focused on the localization of Ddr2 mRNA to cellular 
protrusions in fibroblasts.  We were interested in how RNA localization changes in 
response to the stiffness of the mechanical environment.   We saw that on stiffer 
substrates, Ddr2 RNA is localized to the protrusions and is diffuse in the cytoplasm on 
soft substrates.   We hypothesized the increased localization on stiffer substrates was due 
to the increased actomyosin contractility.  We saw that contractility plays a role in RNA 
localization, but inhibiting contractility does not completely abolish localization.  In the 
next Chapter, we specifically explore the effects of substrate stiffness on 
microtubule detyrosination, as well as the effects of contractility on detyrosinated 
microtubule structure.  Furthermore, we explore the connection between 
contractility and detyrosinated microtubule structure and molecular players that 
might be involved.   
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Chapter 4:  Role of Microtubule Detyrosination on mRNA 
Localization and Effect of Contractility on Microtubule 
Detyrosination 
4.1 Introduction 
 Microtubules contribute to the font-back polarity that is essential for directional 
migration in a variety of environments.  One way this is achieved is through the selective 
stabilization of microtubules towards the leading edge [195].  Because of their longevity, 
this subset of microtubules can be post-translationally modified by detyrosination or 
acetylation of tubulin.  These subsets of microtubules are longer-lived than their dynamic 
counterparts [201].   Specifically, APC-dependent RNAs associate with detyrosinated 
microtubules (Glu-microtubules (Glu-MT)) [8].  In Chapter 3, it was shown that substrate 
stiffness enhances Ddr2 localization and that modulating contractility through LPA or 
blebbistatin/Y27632 can enhance/reduce localization respectively.  It was hypothesized 
that contractility through the modulation of the detyrosinated microtubule network affects 
Ddr2 RNA localization.  Furthermore, another question we had was whether 
detyrosinated microtubules were sufficient themselves to induce localization.   
Detyrosinated microtubules occur when they are post-translationally modified by 
a tubulin carboxypeptidase (TCP) that removes the terminal tyrosine and exposes a 
glutamate (Figure 4.5).  The tyrosine is then replaced by tubulin tyrosine ligase (TTL).  
By knocking down TTL levels within the cell, the amount of detyrosinated microtubules 
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can be increased.  While the specific TCP is unknown for the removal of the terminal 
tyrosine, a chemical compound called parthenolide inhibits TCP and prevents formation 
of detyrosinated microtubules in cells [202]. 
Factors have been identified that contribute to the detyrosination of microtubules.  
Rho GTPase and its downstream effector the formin mDia are key factors in a 
microtubule stabilization pathway [200].  However, Rho only stimulates mDia in the 
presence of integrin and FAK signaling [203].  Extracellular matrix rigidity positively 
regulates Rho activity and FAK autophosphorylation [189].  It is likely that microtubule 
detyrosination may change with substrate stiffness and that this may affect RNA 
localization. Thus, this may lead to increased microtubule stabilization on stiff substrates 
and relate to increased RNA localization.   
This Chapter explores the changes of the detyrosinated microtubule network 
in response to substrate stiffness and contractility.  It also explores whether directly 




For immunofluorescence, cells were plated onto gels and were fixed with 4%PFA 
in PBS for 15 minutes, permeabilized with 0.2% Triton X-100 in PBS for 5 minutes, 
blocked with 3% BSA for 1 hour and incubated with primary antibodies (anti-Glu 
tubulin) overnight at 4˚C.  Coverslips were incubated with anti-α-tubulin for 1 hour.  
Primary antibodies used were anti-Glu-tubulin (Abcam, cat# ab48389; 1/250 dilution for 
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IF) and anti-α-tubulin (Sigma-Aldrich, cat# T6199; 1/1000 dilution). Secondary 
antibodies were conjugated with Alexa 488, 546 or 647 (Alexa Fluora series from 
Thermo Fisher Scientific, 1/200 dilution each).  Nuclei or whole cell area were stained 
with DAPI or cell mask blue stain, respectively. 
 
4.2.2 Western Blot 
To analyze drug treatment effects on microtubule detyrosination, cells were plated 
on cell culture plates and treated with 50uM blebbistatin, 10uM Y27632 or 5uM 
parthenolide before being lysed in 0.5% triton-x in RSB buffer and measured for protein 
concentration using the BCA assay.   The primary antibodies uses were anti-Glu-tubulin 
(Abcam, cat# ab48389, 1:2000 dilution) and anti-acetylated tubulin (Sigma, cat #T7451, 
1:20,000 dilution).  For western blot, the following secondary antibodies were used: anti-
rabbit (conjugated with IRDye 800CW, Li-cor, cat# 926-32213, 1/15000 dilution), anti-
mouse (conjugated with IRDye 680RD, Li-cor, cat# 926-68072, 1/15000 dilution). 
Western blot membranes were scanned with Odyssey (Li-Cor) and signal intensity was 
measured on image studio lite software. 
 
4.2.3 Drug Treatments 
Cells were allowed to spread for two hours before being treated with 5 uM 
parthenolide for two hours (Sigma-Aldrich, cat# P0667-5MG).   Cells were treated with 
LPA, Blebbistatin and Y27632 as described in Chapter 3. 
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4.2.4 siRNA transfection 
NIH/3T3 cells were transfected with siRNA to a 40 pmol final concentration with 
Lipofectamine RNAiMAX (Thermo Fisher Scientific, cat# 13778-150) according to the 
manufacturer’s instructions.  Cells were incubated for three days before being analyzed 
siRNAs used are listed in Table 4.1: 











Table 4.1. siRNAs used to perform knock-down experiments. 
4.2.5 Statistical Analysis 
To establish significance between the internal control mRNA and the 
localized/experimental mRNA, the Wilcoxon signed-rank test was used with a p value < 
0.05.  To compare values between two groups, the Student’s t-test was performed with a 
p value < 0.05. 
4.3 Results 
4.3.1 Substrate Stiffness Enhances microtubule detyrosination 
Our first question was to understand how substrate stiffness affects the Glu-MT 
network because APC-dependent RNAs are anchored at the plus-ends of detyrosinated 
microtubules [8].  Therefore, we examined the Glu-MT network on polyacrylamide gels 
of different stiffness.  Cells on soft, 1 kPA gels showed no defined detyrosinated 
microtubule network and mostly had diffuse staining present (Figure 4.1A).  However, on 
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1 kPa gels, the overall microtubule network appeared intact as stained with α-tubulin 
antibody.  On intermediate 5 kPa, and 280 kPa, about 70-80% of the cells showed a well-
defined Glu-MT network with several fibers immunostained with Glu-MT antibody 
(Figure 4.1B).  On soft substrates, Ddr2 mRNA is diffuse throughout the cytoplasm and 
this is accompanied by an absence of detyrosinated microtubules.  Similarly, on stiffer 
substrates, the higher percentage of cells showing an intact Glu-MT network is 
accompanied by Ddr2 localization.  These results indicate the substrate stiffness affects 
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Figure 4.1. (A) On soft 1 kPa substrates, Glu-MT staining is diffuse and there are no 
Glu-MT fibers stained with antibody while the overall tubulin network looks intact. On 5 
kPa and 280 kPa substrates, there are an increasing number of fibers stained with Glu-
MT antibody and they appear to have a ‘meshwork’ structure. (B)  On 1 kPa gels, no 
cells observed appeared to have a Glu-MT meshwork structure.  On 5 kPa and 280 kPa 
there was an increase in the number of cells (60-80%) that had a Glu-MT structure.  The 
number of cells is indicated by ‘N=’ above the bars. 
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4.3.2 Cell Contractility is required for the formation of a detyrosinated microtubule 
network 
Our next objective was to measure the effects of contractility on Glu-MT 
structure.  We showed that on soft 1 kPa substrates, cells increased peripheral 
localization of RNAs and tension upon treatment with LPA, thus we stained Glu-MT to 
examine the effect of LPA on the microtubules.  In control cells, none of the cells 
observed showed a defined meshwork structure, but in LPA treated cells approximately 
30% of cells showed defined Glu-MT fibers.  
We also showed that treatment with myosin II inhibitor blebbistatin or ROCK 
inhibitor Y27632 led to a decrease in RNA localization.  When detyrosinated 
microtubules were immunostained, we observed a decrease in the number of cells that 
showed a fibrous meshwork structure when treated with blebbistatin or Y27632.  Less 
than 30-40% of cells on 5 kPa and 280 kPa substrates showed stained Glu-MT fibers 
when treated with blebbistatin or Y27632 (Figure 4.3B).  Most of the stained Glu-MT in 
blebbistatin treated cells appeared to be localized in very thin protrusions far from the 
center of the cell (Figure 4.3A).  Blebbistatin treated cells showed an absence of Glu-MT 
in the perinuclear region whereas control cells had detyrosinated microtubules located in 
areas throughout the cell.  However, in blebbistatin treated cells the overall α-tubulin 
structure appeared intact, especially in the perinuclear region where there was Glu-MT 
staining absent (Figure 4.3A).  Similarly, Y27632 cells showed disruptions in Glu-MT 
structure.  There were many cells where there were very few (<5) fibers stained (Figure 
4.3A).   These results indicate that contractility is necessary for formation of a 
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detyrosinated microtubule meshwork. 
To test whether there was a decrease in detyrosinated microtubule protein levels, 
western blot was performed.  Previous reports have shown an increase in microtubule 
stability, specifically with acetylated microtubules (AC-MT), following actomyosin 
inhibition [204].  Acetylated microtubules are generated through post-translational 
modifications of a-tubulin and are also found on a more stable population of 
microtubules.   We examined both AC-MT levels and Glu-MT protein levels.  There was 
a decrease in the ratio of Glu-MT:tubulin levels in blebbistatin and Y27632 treated cells, 
even though its small magnitude did not reach statistical significance compared to control 
(Figure 4.4B).  Consistent with prior reports, there was also a small increase in AC 
tubulin:tubulin ratio, again though without reaching statistical significance against the 
control (Figure 4.4C).   Taken together, these results indicate that an intact Glu-MT 
network is necessary for RNA localization and that when it becomes disrupted (i.e. by 
reducing cell tension) RNA localization becomes disturbed.  
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Figure 4.2. (A) Representative images showing Glu-MT staining of LPA treated cells on 
soft substrates.  Control cells do not show a meshwork structure and LPA treated cells 
show several fibers stained with Glu-MT antibody.  (B)  LPA increases the percent of 
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Figure 4.3. (A) Representative images showing Glu-MT staining of control, blebbistatin 
and Y27632 treated cells on 280 kPa substrates. Control cells show several fibers stained 
with Glu-MT and blebbistatin and Y27632 show very few fibers stained.  (B) 
Blebbistatin and Y27632 treatments reduce the percent of cells that show a Glu-MT 
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Figure 4.4. (A) Representative western blots showing acetylated tubulin and 
detyrosinated tubulin concentrations with drug treatments.  Loading half of the control 
amount served as a loading control.  Cells were plated for 4 hours to serve as a control 
for parthenolide treated cells or two hours as a control for blebbistatin and Y27632 
treated cells.  (B) The ratio of detyrosinated/tubulin signal intensity.  Parthenolide 
(Parth.) treated cells showed a decrease in the ration and blebbistatin (Bleb) and Y27632 
(Y27) also showed a slight decrease (N=4).  Data was normalized to control. (C) The 
ratio of acetylated (AC) tubulin/tubulin signal intensity.  Blebbistatin and Y27632 treated 
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4.3.3 Detyrosinated microtubules are required for RNA localization at cell protrusions 
 We have showed that contractility reduces RNA localization, and that changes in 
contractility correlate with changes in the Glu-MT structure.  Another question we 
wanted to address was whether Glu-MTs were sufficient themselves to affect RNA 
localization or if contractility was also necessary to drive localization.  To do this, we 
modulated the Glu-MT amount within the cells  
 Since Ddr2 RNA localization is mislocalized on soft substrates, a question we had 
was whether increasing the amount of detyrosinated microtubules was sufficient to 
recover RNA localization.   TTL was knocked down using siRNA, thus increasing the 
amount of Glu-MTs within the cell (Figure 4.5).  PDI analysis was then used to assess the 
effect of Glu-tubulin levels on APC-dependent RNA localization.  Even though the cells 
retained similar morphology between control siRNA and TTL siRNA treated cells, PDI 
analysis showed an increase in peripheral RNA amounts (Figure 4.6A).  These results 
show that by increasing Glu-MT levels in cells, it is sufficient to recover RNA 
localization on soft substrates. 
Our next question was whether reduction of detyrosinated microtubules on stiff 
substrates was sufficient to mislocalize RNAs.  To test this, parthenolide was used to 
block TCP and reduce Glu-MTs within the cell (Figure 4.5).  In cells that were treated 
with parthenolide, the Ddr2 RNA distribution became more centralized compared to 
control cells (Figure 4.7).  Indeed, PDI analysis showed a reduction in peripheral RNA 
localization on both 5 kPa and 280 kPa substrates with parthenolide treatment. These 
results indicate that detyrosinated microtubules are required and sufficient for localization 
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of APC-dependent RNAs to cellular protrusions. 
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Figure 4.5. (A) An unknown tubulin carboxy peptidase (TCP) removes the terminal 
tyrosine from the alpha subunit to form stable detyrosinated microtubules.  TCP activity 
can be blocked with a drug called parthenolide.  Tubulin tyrosine ligase (TTL) adds the 
tyrosine back onto alpha subunit to create zmore dynamic, tyrosinated microtubules.  
TTL levels can be reduced using siRNA.  (B) Western blot showing how parthenolide 
and si-TTL modulate the detyrosinated microtubule levels.  Parthenolide decreases the 
amount of Glu-MTs and si-TTL knocks down TTL levels and increases the amount of 
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Figure 4.6 (A) Representative images showing si-control and si-TTL treated cells on soft 
1 kPa substrates.  Cells retained a round morphology, but si-TTL cells showed peripheral 
distribution of Ddr2 RNA.  (B) PDI analysis indicates that si-TTL cells have Ddr2 
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Figure 4.7. (A) Representative images showing Ddr2 RNA localization in control and 
parthenolide treated cells on 280 kPa gels.  Parthenolide treated cells have many 
protrusions that are absent of Ddr2 RNAs (white arrows) while control cells show Ddr2 
RNAs localized to the protrusions (white arrows).  (B) and (C) Parthenolide treatment 
reduces Ddr2 RNA localization compared to control (P<0.0001) on 5 kPa (B) and 280 
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4.3.4 The effect of contractility on localization is mediated through microtubule 
detyrosination 
Our next question was to address the relationship between contractility and 
microtubule detyrosination on RNA localization.  In Chapter 3, we showed contractility 
can both enhance and reduce RNA localization, but not does completely abolish 
localization.    In an effort to understand this relationship, we pre-treated cells with LPA 
and then blocked detyrosinated microtubules with parthenolide on soft substrates. When 
cells were pre-treated with LPA and then parthenolide (Figure 4.8A), they maintained a 
similar morphology to LPA treated cells.  However, the RNAs were located towards the 
perinuclear region in the center of the cell.  PDI analysis showed that there was no longer 
a significant difference between PolyA control RNA and Ddr2 RNA in 
LPA+parthenolide treated cells.  In control cells, RNAs were non-localized, and LPA 
induced localization.   
In order to further test the relationship between actomysoin contractility and 
detyrosinated microtubule structure, we knocked down TTL and treated cells with 
blebbistatin.  In si-TTL cells treated with blebbistatin, we observed less long and thin 
protrusions compared to blebbistatin treated cells alone (Figure 4.9A).  In si-control 
blebbistatin treated cells, many of the protrusions were devoid of RNAs compared to the 
control siRNA cells as observed in Chapter 3.  However, the si-TTL cells that were 
treated with blebbistatin still had Ddr2 RNA present in the protrusions (Figure 4.9A).  
They also showed a recovery in localization.  There was no significant difference 
between si-control and si-TTL cells treated with blebbistatin on 5 kPa and 280 kPa 
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substrates (Figure 4.9B,C).  This indicates that by increasing the amount of Glu-MT 
within the cell, the effects of reduced actomyosin contractility on RNA localization were 
recovered.  Thus, actoymosin contractility through modulation of the detyrosinated 
microtubule network regulates Ddr2 RNA localization to protrusions.   
To observe changes in the cytoskeletal network, detyrosinated microtubules were 
immunostained on 5 kPa and 280 kPa substrates.  In si-control cells, cells showed a 
meshwork structure of detyrosinated microtubules with several fibers stained with the 
antibody.  When si-control cells were treated with blebbistatin, there were many fibers 
that were absent from the perinuclear region and the overall meshwork structure appeared 
disrupted.  In Figure 4.10A, the zoom panel shows an area where the meshwork structure 
is absent when si-control cells are treated with blebbistatin.  The same area shows that the 
meshwork structure is still intact for the overall α-tubulin structure indicating that 
blebbistatin disrupted the Glu-MT network and not the overall microtubule network.  In 
si-TTL cells, there appeared to be more fibers stained with antibody compared to si-
control cells.  When si-TTL cells were treated with blebbistatin, there appeared to be a 
recovery in meshwork structure, with a higher percentage of cells (~70-80%) having a 
meshwork structure.  In Figure 4.10A, the zoom panel shows that si-TTL cells treated 
with blebbistatin still had a meshwork structure present in the perinuclear region unlike 
si-control cells treated with blebbistatin.  By increasing the amount of detyrosinated 
microtubules within the cell, the effect of blebbistatin on Glu-MT disruption was 
eliminated. 
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Figure 4.8. (A) Representative images show Ddr2 RNA FISH staining on 1 kPa gels.  
White arrows point to where RNAs are peripherally localized in LPA treated cells.  (B) 
PDI analysis of RNA localization shows that LPA induces localization (P<0.0001) and 
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Figure 4.9.  (A) Representative FISH images showing Ddr2 RNA staining in control 
siRNA, control siRNA + blebbistatin, TTL siRNA, and TTL siRNA + blebbistatin 
treated cells on 280 kPa gels.  In si-control and si-TTL treated cells, white arrows point to 
peripheral Ddr2 localization.  In si-control + blebbistatin treated cells, most of the RNA 
staining is located in the perinuclear region.  (B) On 5 kPa gels, si-control + blebbistatin 
treated cells show a reduction in RNA localization (P<0.001).  Si-TTL cells treated with 
blebbistatin did not show a reduction in RNA localization. (C) On 280 kPa gels, si-
control + blebbistatin treated cells show a reduction in RNA localization (P<0.05).  Si-
TTL cells treated with blebbistatin did not show a reduction in RNA localization.  Error 
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Figure 4.10.  (A) Representative images of Glu-MT and α-tubulin and in si-control, si-
control+blebbistatin, si-TTL and si-TTL+blebbistatin on 280 kPa gels.  The ‘Zoom’ 
panel in si-control+blebbistatin and si-TTL+blebbistatin represents a perinuclear area 
stained with Glu-MT or tubulin.  Si-control cells treated with blebbistatin showed an 
absence of a Glu-MT network in the perinuclear region, while the overall tubulin 
structure appeared intact.  Si-TTL cells treated with blebbistatin displayed a Glu-MT 
meshwork structure in the perinuclear region.  (B)  The graph depicts the percent of cells 
with a Glu-MT network for si-control (ctrl), si-control+blebbistatin (ctrl+bleb), si-TTL 
(TTL) and si-TTL+blebbistatin (TTL+bleb) for 5 kPa and 280 kPa substrates.  The N at 
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4.4 Discussion 
 In this work, we investigated the connections between cell tension, substrate 
stiffness and the microtubule network and how these factors might regulate RNA 
localization.  Our results indicate that the effects of contractility on RNA localization are 
mediated through the detyrosinated microtubule network.  On stiff substrates, cells have 
increased actomyosin contractility and this is regulated through the Rho/ROCK pathway.  
The increase in tension leads to the formation of a Glu-MT network that results in RNA 
localization to the protrusions.  It has been shown that Rho-GTPase is necessary for 
selective stabilization of microtubules, but that it does not bind directly to the 
microtubules [124].  Palazzo et al. showed that mDia is a downstream Rho effector 
implicated in regulating the microtubule stability in cells [200].  mDia interacts with 
three MT +TIP proteins, EB1, APC, and CLIP170, and EB1 and APC have been 
implicated in microtubule stability [203, 205, 206].  Thus, we suggest a working model 
for RNA localization in which RhoA activates the Rho/ROCK pathway and the formation 
of stable microtubules through mDia (Figure 4.11).  Based on this, future studies could 
focus on expressing a constitutively active form of mDia in cells and seeing if a recovery 
of RNA localization is observed after inhibiting contractility.  Additionally, experiments 
could see if on soft substrates, expressing an active form of mDia induces RNA 
localization. 
A negative feedback loop also exists between cytoskeletal tension and Rho. 
Inhibition of cell contraction has also been shown to lead to down regulated Rho levels 
[207]. We had shown that inhibiting actomyosin contractility on stiff substrates led to a 
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decrease in RNA localization.  This feedback signaling could account for the decrease in 
Glu-MT meshwork structure that was seen in blebbistatin and Y27632 treated cells and 
also for the decrease in RNA localization we saw in Chapter 3.  By reducing cell tension 
with blebbistatin or ROCK inhibitor, it led to a down regulation of Rho signaling and 
potentially mDia, thus affect detyrosinated microtubules and RNA localization.  
These results are interesting because previous reports have shown an increase in 
stable microtubule formation upon blebbistatin treatment [204].  However, they 
specifically showed an increase in acetylated tubulin, another post-translational 
modification of tubulin that exhibits stability [204].  Our western blots showed small 
decreases in Glu-MT levels within the cells and small increases in acetylated tubulin 
upon blebbistatin and Y27632 treatment.  However, our western blots were performed on 
rigid plastic cell culture plates.  It is possible that on softer substrates, we would observe 
a larger decrease in Glu-MT protein levels upon blebbistatin treatment.  Another 
possibility for the different results observed could be that we used a different 
concentration and treatment time of blebbistatin than in previous studies.   
Our work also has relevance in cancer metastasis.  During cancer progression, the 
tumor microenvironment becomes stiffer.  This biomechanical property is due to the 
largely cross-linked and oriented collagenous matrix [1].  The increased stiffness 
promotes invadapodia formation and enhances tumor cell invasion by driving focal 
adhesion assembly [208].  Increased tumor cell migration is highly driven by Rho-
GTPase activity that stimulates actin assembly and actomyosin contractility [209].  It is 
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possible that the localization of RNAs in the stiff microenvironment could be a promoter 
in metastatic cancer cell invasion.   
The regulation of Ddr2 RNA at cellular protrusions could also be a promoter in 
metastatic cancer cell invasion.  Ddr2 is a collagen receptor tyrosine kinase receptor that 
has been implicated in several cancer cell behaviors.  It has been observed to play a role 
in tumor angiogenesis, invasion and metastasis [104, 210, 211]. Additionally, it has been 
reported that Ddr2 is a critical regulator of the cancer cell epithelial to mesenchymal 
transition [212].    
In this work, we showed that matrix stiffness increases microtubule 
detyrosination.  Glu-MTs are also involved in cancer progression.  For instance, loss of 
TTL induces mesenchymal transition of breast cancer cells, which may contribute to 
metastatic potential and altered cell response [213].  Additionally, Glu-MTs have been 
found to be associated with dynamic membrane protrusions (termed microtentacles) that 
occur in detached metastatic cell lines and facilitate tumor cell reattachment and cell-cell 
adhesion [213, 214]. It is possible that there are localized RNAs at the ends of the 
microtentacles to help facilitate attachment and adhesion during processes such as 
transmigration.   
Before this work, the effects of the mechanical environment on RNA localization 
and microtubule stability were unknown.  It was also unknown how contractility and 
detyrosinated microtubules coordinate in regulating RNA localization to protrusions.  We 
show here that cell tension promotes a detyrosinated microtubule network which then 
results in peripheral RNA localization.  While we used fibroblasts as a model system to 
study the effects of the microenvironment on RNA localization, this work has 
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significance in cancer metastasis.  We envision a scenario where as tumor stiffness 
increases; it increases cell contractility and microtubule detyrosination and ultimately 
drives the localization of Ddr2 RNA to cellular protrusions where it then promotes a 
more metastatic phenotype.   
 
4.5 Conclusions 
 In summary, contractility influences RNA localization through modulation of the 
detyrosinated microtubule network.  In cells plated on increasingly rigid substrates, we 
observe an increase in the percentage of cells with an intact Glu-MT meshwork.  Further 
we see that increasing contractility through LPA induces Glu-MT meshwork formation 
and inhibiting contractility reduces the percent of cells with a Glu-MT network.  When 
we inhibit the formation Glu-MT through the use of parthenolide that blocks the TCP, we 
observe a decrease in RNA localization on stiff substrates.  By increasing the amount of 
detyrosinated microtubules on soft substrates by using TTL siRNA, we observe an 
increase in RNA localization.  These results indicate that detyrosinated microtubules are 
necessary and sufficient for Ddr2 RNA localization.  Our results together suggest that 
cell-substrate interactions play an important role in the localization of Ddr2 RNA to 
cellular protrusions.  These biophysical interactions may play an important role during 
disease pathologies such as cancer metastasis where the tissue microenvironment 
becomes stiffer during disease progression.   
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Figure 4.11. (A).  On stiff substrates, cells exhibit high contractility as depicted with 
actin stress fibers (red).  This leads to the formation of polarized, stable, detyrosinated 
microtubules (green arrows) and localization of APC-dependent RNAs (magenta) at 
cell protrusions.  (B) On soft substrates, cells exhibit low contractility and have 
dynamic microtubules (green) causing RNAs to be diffuse. (C) Proposed signaling 
cascade showing RhoA and its downstream effectors and their effects on localization.  
RhoA activates both ROCK and mDia leading to cell tension (through myosin light chain 
phosphorylation (MLC-P) and myosin movement along actin cytoskeleton) and 
detyrosinated microtubule formation respectively.  This in turn leads to RNA 
localization.  A feedback loop exists between cell tension and Rho such that a decrease in 
contractility causes Rho down regulation and subsequent disruption in detyrosinated 
microtubules and RNA localization.  
A B 
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Chapter 5: Summary and Future Directions 
5.1 Summary 
 Overall, in the work generated from this thesis project we have examined 
biophysical properties of cancer cell transmigration and mRNA localization.  We believe 
that these results can translate to further understanding cancer progression and cancer 
metastasis.  The main principles learned from this work are the following: 
 
Chapter 2: Mechanisms of Cancer Cell Transmigration 
1. Cancer cell transmigration may be a two-step process in which cancer cells first 
‘incorporate’ into the endothelium before subsequent invasion into the 
subendothelial matrix. 
2. Incorporation occurs independently of matrix stiffness and endothelial activation 
for melanoma cells and breast cancer cells.  Pancreatic cells transmigrate more 
with endothelial activation and on softer substrates.  Likely, the biophysical 
principles (i.e. subendothelial matrix stiffness) governing incorporation are cell-
specific.  
3. Incorporation initiates by dislocating VE-Cadherin at endothelial cell-cell 
junctions and disrupts it during incorporation. 
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Chapter 3: Effect of Substrate Stiffness and Contractility on APC-dependent mRNA 
Localization 
1. Matrix stiffness enhances APC-dependent RNA localization. 
2. Inhibiting actomyosin contractility reduces RNA localization on stiff substrates. 
3. Enhancing actomyosin contractility increases RNA localization on soft substrates. 
 
Chapter 4: Role of Microtubule Detyrosination on mRNA Localization and Effect of 
Contractility on Microtubule Detyrosination 
1. Detyrosinated microtubules are required and sufficient for RNA localization at 
cell protrusions. 
2. Substrate stiffness increases microtubule detyrosination. 
3. Contractility increases microtubule detyrosination. 
4. The effect of contractility on localization is mediated through microtubule 
detyrosination. 
 
In the first part of this work we examined mechanisms of cancer cell transmigration 
through the endothelium.  Leukocytes routinely transmigrate through the endothelium to 
sites of inflammation or injury.  However, we found that cancer cell transmigration is 
very different from this process.  In our previous work we found that this process was 
dependent on subendothelial matrix stiffness and endothelial activation with TNF-α and 
that leukocytes directly transmigrate through the endothelium [26, 27].  Cancer cells 
appear to have an additional step, namely incorporation into the endothelium.  Metastatic 
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cells may first incorporate into the endothelial monolayer and then migrate under the 
monolayer.  Additionally, this step occurs independent of matrix stiffness and endothelial 
activation for melanoma and breast cancer cells.  However, pancreatic cells incorporated 
more into softer subendothelial matrices and incorporated more under endothelial 
activation.  These data suggest that the incorporation into the endothelium is cell-specific.  
The mechanism of cancer cell extravasation is quite different from immune cells, and this 
result could have impact on the cancer field.   
In the next part of our work, we wanted to examine molecular mechanisms that might 
be involved in cancer metastasis.  We decided to focus on the localization of RNAs.  
Deregulation of localization pathways has been proposed to play an important part in 
cancer metastasis.  Furthermore, matrix stiffness increases as tumors progress and 
promotes a more metastatic phenotype.  Thus, we focused on the localization of RNAs on 
substrates of varying stiffness.  We focused on APC-dependent localization pathway in 
which RNAs are localized to protrusions in migrating fibroblasts at the ends of 
detyrosinated microtubules [8].  Since the APC-dependent pathway is well characterized 
in fibroblasts, we looked at RNA localization in this cell type.  Interestingly, we found 
that on soft 1 kPa substrates, Ddr2 RNA is diffuse throughout the cytoplasm and is 
localized to the periphery on stiffer 5 kPa and 280 kPa substrates.  Since the localization 
of these RNAs to the cell periphery corresponds with areas of higher traction forces in 
cells, we hypothesized that cellular contractility influences RNA localization.  To test this 
hypothesis, we used inhibitors of the Rho/ROCK pathway, one of the main regulators of 
cytoskeletal tension.  We found that inhibiting contractility reduced RNA localization 
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and enhancing contractility induced RNA localization.  These results indicate that 
actomyosin contractility through the Rho GTPase may regulate Ddr2 RNA localization. 
To further understand the mechanism of Ddr2 RNA localization to cellular 
protrusions, we investigated the relationship between contractility and detyrosinated 
microtubules.  Ddr2 RNA is likely associated with detyrosinated microtubules in 
protrusions [8].  We found that microtubule detyrosination increases with substrate 
stiffness.  Additionally, we found that inhibiting contractility reduces microtubule 
detyrosination and enhancing contractility induces microtubule detyrosination.  
Furthermore, we found that detyrosinated microtubules are required and sufficient for 
Ddr2 RNA localization.  We also found that when enhancing contractility with LPA and 
inhibiting Glu-MTs with parthenolide, that RNAs became mislocalized on soft substrates.  
When contractility was inhibited using blebbistatin, and cells were treated with TTL 
siRNA, we observed a recovery in RNA localization.  These results indicated that 
contractility through modulation of the detyrosinated microtubule network affect RNA 
localization.  Cell-substrate interactions are an important parameter to take into 
consideration.  We saw here that it influences microtubule detyrosination and RNA 
localization, which may ultimately impact cell behavior.  This work has relevance during 
disease pathologies such as cancer metastasis.  As the microenvironment becomes stiffer, 
it may induce localization of these RNAs to cellular protrusions and promote a more 
metastatic phenotype.   
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5.2 Future Directions 
 In the scope of this work we have investigated two aspects of cancer metastasis: 
cancer cell incorporation/transmigration and localization of RNAs to cellular protrusions.  
There are many future studies that could be done to further understand the role of 
localized RNAs in cancer metastasis as well as the mechanisms of cancer cell 
transmigration.  Below we have outlined some areas of future work that could build upon 
the data presented in this dissertation.   
 
5.2.1 RNA localization in metastatic cells 
 In this dissertation, we have studied the role of RNA localization in NIH 3T3 cells 
as a model system to see how matrix stiffness influences localization.  Future studies 
could use a breast cancer progression model to study RNA localization as a function of 
metastasis.  The MCF10A cell series is a breast cancer progression model composed of 
four different cell lines representing different stages of pre-malignant to invasive 
transformation [215-217].  The series was established from the immortalized mammary 
epithelial cell line MCF10A, which were derived from a patient with fibrocystic disease 
[218].  The MCF10A cells were transformed with Ras to generate the pre-malignant 
MCF10At.1k that forms benign hyperplastic lesions after introduction into immune 
compromised mice.  Passage of the MCF10At.1k through mice led to the isolation of the 
tumorigenic MCF10CA1h cells and the invasive, lung-colony forming MCF10CA1a 
cells.  Both of these cell lines give rise to tumors within days of introduction into mice 
[217, 219, 220].  These two tumorigenic cell lines, CA1a and CA1h have an activating 
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mutation in PIK3CA, which is mutated in approximately 30% of human breast cancer 
cases [221, 222].  Thus, the MCF10A series represents an advantageous model for 
assessing how intrinsic mutations associated with breast cancer progression alter RNA 
localization in cells with a similar genetic background.  Similarly, this model would 
allow for identification of RNA altercations during metastatic progression from normal 
breast epithelium (MCF10A) to invasive, lung colony forming MCF10CA1.   
 
5.2.2 Mechanical stretching to induce localization 
 In this dissertation we have tested the role of actomyosin contractility on the 
localization of RNAs to cellular protrusions by using siRNA, pharmacological 
treatments, and by plating cells on substrates of varying stiffness.  To more directly test 
the role of contractility and mechanical tension on RNA localization, cells could be 
mechanically stretched.  For example, on soft substrates where RNAs are mislocalized, it 
would be interesting to see if mechanical tension is sufficient to induce localization.  
Likely, this would be accompanied by an increase in detyrosinated microtubules as well.  
When randomly oriented cells become exposed to cyclic uniaxial stretch, they respond by 
aligning with their long axis in the direction of minimum strain [223, 224].  The 
microtubule and actin cytoskeleton also both realign significantly during stretch.  More 
specifically, detyrosinated microtubules form on the onset of cell polarization and are 
aligned with the axis of polarity in many cells types [225].  Thus, it is a reasonable 
hypothesis that mechanical stretching could induce localization on soft substrates through 
the formation of a polarized detyrosinated microtubule network. 
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5.2.3 RNA localization during transmigration and invasion 
During transmigration, cells adhere to the endothelium, and protrusion formation 
through the endothelium and into the basement membrane drives cellular migration from 
the blood stream into the underlying tissue.  Since protrusion formation is a fundamental 
step in transmigration, we believe localized mRNAs may be playing an intrinsic role in 
this process.  There have been genome wide screens that have identified protrusion 
localized RNAs in metastatic cancer cells [75].  It would be interesting to test whether 
these localized RNAs change when migrating through the endothelium or through 
different types of endothelium.  Additionally, it would also be interesting to observe 
RNAs during processes such as invadapodia formation and subsequent migration through 
the extracellular matrix.  Furthermore, studies have shown that cancer cells are able to 
switch between forms of migration depending on their environmental conditions [226].  
Mesenchymal type movement is characterized by elongated cellular morphology and 
requires extracellular proteolysis.  In amoeboid movement, the cells undergo active 
blebbing driven by actomyosin contractility consistent with a mechanism of cells 
squeezing through voids to deform the matrix.  Future studies could also investigate 
under which forms of migration RNAs localize and dissect their function. 
 
5.2.4 Cancer cell migration below the endothelium 
 In Chapter 2, we showed that cancer cells incorporate into the endothelium.  We 
hypothesize that this is a two-step process in which cancer cells first incorporate into the 
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endothelial monolayer before subsequent migration underneath the endothelium and into 
the basement membrane.  These assays were performed on rigid glass substrates or on 
polyacrylamide gels to allow manipulation of the mechanical properties of the 
microenvironment.  By using a collagen gel, it would allow subsequent migration 
underneath the monolayer.  By doing this, it would allow us to observe if cancer cell do 
in fact incorporate into the monolayer first before transmigration.  Another aspect that 
this might allow us to observe is whether the endothelium still becomes damaged during 
this process.  We observed that cancer cell incorporation appeared to damage the 
endothelial monolayer, probably due to loss of cell-cell contacts.  Perhaps because the 
tumor cells may rely more on proteases to break down the collagen gel during the 
incorporation process on a collagen gel, this would present less damage to the endothelial 
monolayer. 
 
5.4 Significance and Conclusion 
  In most cases, the primary tumor is not dangerous unless it is localized in a 
compromising site, such as the brain.  The major problem of cancer is its capability to 
spread to other sites.  In fact, the vast majority of cancer mortality is due to cancer 
metastasis. A mechanistic understanding of the different stages of metastasis is necessary 
to improve current therapies or create new ones.  In this dissertation we have studied 
mechanisms of cancer metastasis: transmigration and RNA localization.  We found that 
cancer cell transmigration is inherently different from immune cell transmigration.  It 
includes an additional step, which we call ‘incorporation’ into the endothelium.  This step 
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in the transmigration process has not been observed before and is a novel finding that 
could have a significant impact on the cancer field.  By finding out the specific 
mechanisms of cancer incorporation and transmigration, it may be possible to develop 
treatments to prevent these steps and inhibit the formation of secondary tumors. 
On a more molecular level, we focused on the localization of RNAs to cellular 
protrusions and their potential implications during the early stages of metastatic 
transformation using fibroblasts as a model.  Identifying factors that associate with 
either promoting cancer aggressiveness or suppressing it have the potential to serve as 
novel molecular targets for cancer therapy.  RNA binding proteins and their 
subsequent RNA localization targets have been implicated in metastasis.   In this 
dissertation we discovered important links between substrate stiffness, detyrosinated 
microtubules and RNA localization.  The effect of the mechanical properties of the 
matrix on the localization of RNAs is an aspect that had not been studied.  We found that 
matrix stiffness promotes the localization of RNAs.  It is possible that by identifying 
RNAs and RNA binding proteins that correlate with cancer aggressiveness, that they can 
serve as new targets for cancer therapy.  The field will benefit from further exploration on 
the mechanical properties of the matrix and how it affects RNA localization and it’s 
relationship to cellular behavior and its relevance to cancer metastasis. 
 
5.5 Author Contributions to Work 
	  
Chapter 2: Conceived and designed the experiments: Kimberly Strokam Susan Hamilla, 
and Helim Aranda-Espinioza. Performed the experiments: Kimberly Stroka and Susan 
	   119 
Hamilla Analyzed the data: Kimberly Stroka and Susan Hamilla. Contributed 
reagents/materials/analysis tools: Kimberly Stroka and Susan Hamilla. Wrote the paper: 
Kimberly Stroka, Susan Hamilla, and Helim Aranda-Espinoza 
 
Chapter 3 and 4: Conceived and designed the experiments: Susan Hamilla, Helim 
Aranda-Espinoza and Voula Mili.  Performed the experiments: Susan Hamilla.  Analyzed 
the data: Susan Hamilla.  Contributed reagents/materials/analysis tools: Susan Hamilla 
and Voula Mili.   
  
	   120 
Bibliography 
1. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, et al. Matrix 
crosslinking forces tumor progression by enhancing integrin signaling. Cell. 
2009;139(5):891-906. doi: 10.1016/j.cell.2009.10.027. PubMed PMID: 19931152; 
PubMed Central PMCID: PMCPMC2788004. 
2. Lopez JI, Kang I, You WK, McDonald DM, Weaver VM. In situ force mapping 
of mammary gland transformation. Integr Biol (Camb). 2011;3(9):910-21. doi: 
10.1039/c1ib00043h. PubMed PMID: 21842067; PubMed Central PMCID: 
PMCPMC3564969. 
3. Parekh A, Ruppender NS, Branch KM, Sewell-Loftin MK, Lin J, Boyer PD, et al. 
Sensing and modulation of invadopodia across a wide range of rigidities. Biophys J. 
2011;100(3):573-82. doi: 10.1016/j.bpj.2010.12.3733. PubMed PMID: 21281571; 
PubMed Central PMCID: PMCPMC3030182. 
4. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, et al. 
Cell migration: integrating signals from front to back. Science. 2003;302(5651):1704-9. 
Epub 2003/12/06. doi: 10.1126/science.1092053 
302/5651/1704 [pii]. PubMed PMID: 14657486. 
5. Chicurel ME, Singer RH, Meyer CJ, Ingber DE. Integrin binding and mechanical 
tension induce movement of mRNA and ribosomes to focal adhesions. Nature. 
1998;392(6677):730-3. doi: 10.1038/33719. PubMed PMID: 9565036. 
6. Latham VM, Yu EH, Tullio AN, Adelstein RS, Singer RH. A Rho-dependent 
signaling pathway operating through myosin localizes beta-actin mRNA in fibroblasts. 
Current biology : CB. 2001;11(13):1010-6. PubMed PMID: 11470405. 
7. Mingle LA, Okuhama NN, Shi J, Singer RH, Condeelis J, Liu G. Localization of 
all seven messenger RNAs for the actin-polymerization nucleator Arp2/3 complex in the 
protrusions of fibroblasts. J Cell Sci. 2005;118(Pt 11):2425-33. doi: 10.1242/jcs.02371. 
PubMed PMID: 15923655; PubMed Central PMCID: PMCPMC1283079. 
8. Mili S, Moissoglu K, Macara IG. Genome-wide screen reveals APC-associated 
RNAs enriched in cell protrusions. Nature. 2008;453(7191):115-9. doi: 
10.1038/nature06888. PubMed PMID: 18451862; PubMed Central PMCID: 
PMCPMC2782773. 
9. de Hoog CL, Foster LJ, Mann M. RNA and RNA binding proteins participate in 
early stages of cell spreading through spreading initiation centers. Cell. 2004;117(5):649-
62. PubMed PMID: 15163412. 
10. Natkunam Y, Vainer G, Chen J, Zhao S, Marinelli RJ, Hammer AS, et al. 
Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and 
neoplasms. Haematologica. 2007;92(2):176-83. PubMed PMID: 17296566. 
	   121 
11. Shestakova EA, Singer RH, Condeelis J. The physiological significance of beta -
actin mRNA localization in determining cell polarity and directional motility. Proc Natl 
Acad Sci U S A. 2001;98(13):7045-50. doi: 10.1073/pnas.121146098. PubMed PMID: 
11416185; PubMed Central PMCID: PMCPMC34620. 
12. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA: a 
cancer journal for clinicians. 2009;59(4):225-49. doi: 10.3322/caac.20006. PubMed 
PMID: 19474385. 
13. Weinberg RA. Cancer Biology and Therapy: the road ahead. Cancer biology & 
therapy. 2002;1(1):3. PubMed PMID: 12170761. 
14. Muller WA. Mechanisms of leukocyte transendothelial migration. Annu Rev 
Pathol. 2011;6:323-44. doi: 10.1146/annurev-pathol-011110-130224. PubMed PMID: 
21073340; PubMed Central PMCID: PMCPMC3628537. 
15. Voura EB, Ramjeesingh RA, Montgomery AM, Siu CH. Involvement of integrin 
alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma 
cells. Mol Biol Cell. 2001;12(9):2699-710. PubMed PMID: 11553709; PubMed Central 
PMCID: PMCPMC59705. 
16. Sandig M, Voura EB, Kalnins VI, Siu CH. Role of cadherins in the 
transendothelial migration of melanoma cells in culture. Cell Motil Cytoskeleton. 
1997;38(4):351-64. doi: 10.1002/(SICI)1097-0169(1997)38:4<351::AID-
CM5>3.0.CO;2-6. PubMed PMID: 9415377. 
17. Tremblay PL, Auger FA, Huot J. Regulation of transendothelial migration of 
colon cancer cells by E-selectin-mediated activation of p38 and ERK MAP kinases. 
Oncogene. 2006;25(50):6563-73. doi: 10.1038/sj.onc.1209664. PubMed PMID: 
16715142. 
18. Burdick MM, Chu JT, Godar S, Sackstein R. HCELL is the major E- and L-
selectin ligand expressed on LS174T colon carcinoma cells. The Journal of biological 
chemistry. 2006;281(20):13899-905. doi: 10.1074/jbc.M513617200. PubMed PMID: 
16565092. 
19. Hanley WD, Napier SL, Burdick MM, Schnaar RL, Sackstein R, Konstantopoulos 
K. Variant isoforms of CD44 are P- and L-selectin ligands on colon carcinoma cells. 
FASEB journal : official publication of the Federation of American Societies for 
Experimental Biology. 2006;20(2):337-9. doi: 10.1096/fj.05-4574fje. PubMed PMID: 
16352650. 
20. Napier SL, Healy ZR, Schnaar RL, Konstantopoulos K. Selectin ligand 
expression regulates the initial vascular interactions of colon carcinoma cells: the roles of 
CD44v and alternative sialofucosylated selectin ligands. The Journal of biological 
chemistry. 2007;282(6):3433-41. doi: 10.1074/jbc.M607219200. PubMed PMID: 
17135256. 
	   122 
21. Strell C, Lang K, Niggemann B, Zaenker KS, Entschladen F. Surface molecules 
regulating rolling and adhesion to endothelium of neutrophil granulocytes and MDA-
MB-468 breast carcinoma cells and their interaction. Cellular and molecular life sciences 
: CMLS. 2007;64(24):3306-16. doi: 10.1007/s00018-007-7402-6. PubMed PMID: 
17994288. 
22. Garofalo A, Chirivi RG, Foglieni C, Pigott R, Mortarini R, Martin-Padura I, et al. 
Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented 
experimental metastases. Cancer research. 1995;55(2):414-9. PubMed PMID: 7529137. 
23. Okahara H, Yagita H, Miyake K, Okumura K. Involvement of very late activation 
antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis 
factor alpha enhancement of experimental metastasis. Cancer research. 
1994;54(12):3233-6. PubMed PMID: 7515767. 
24. Glinsky VV, Glinsky GV, Rittenhouse-Olson K, Huflejt ME, Glinskii OV, 
Deutscher SL, et al. The role of Thomsen-Friedenreich antigen in adhesion of human 
breast and prostate cancer cells to the endothelium. Cancer research. 2001;61(12):4851-7. 
PubMed PMID: 11406562. 
25. Glinsky VV, Huflejt ME, Glinsky GV, Deutscher SL, Quinn TP. Effects of 
Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated 
homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast 
carcinoma cells. Cancer research. 2000;60(10):2584-8. PubMed PMID: 10825125. 
26. Stroka KM, Aranda-Espinoza H. Endothelial cell substrate stiffness influences 
neutrophil transmigration via myosin light chain kinase-dependent cell contraction. 
Blood. 2011;118(6):1632-40. doi: 10.1182/blood-2010-11-321125. PubMed PMID: 
21652678; PubMed Central PMCID: PMCPMC3156049. 
27. Stroka KM, Levitan I, Aranda-Espinoza H. OxLDL and substrate stiffness 
promote neutrophil transmigration by enhanced endothelial cell contractility and ICAM-
1. J Biomech. 2012;45(10):1828-34. doi: 10.1016/j.jbiomech.2012.04.011. PubMed 
PMID: 22560286; PubMed Central PMCID: PMCPMC3376185. 
28. Bao G, Suresh S. Cell and molecular mechanics of biological materials. Nature 
materials. 2003;2(11):715-25. doi: 10.1038/nmat1001. PubMed PMID: 14593396. 
29. Wakatsuki T, Kolodney MS, Zahalak GI, Elson EL. Cell mechanics studied by a 
reconstituted model tissue. Biophys J. 2000;79(5):2353-68. doi: 10.1016/S0006-
3495(00)76481-2. PubMed PMID: 11053115; PubMed Central PMCID: PMC1301123. 
30. Discher DE, Janmey P, Wang YL. Tissue cells feel and respond to the stiffness of 
their substrate. Science. 2005;310(5751):1139-43. doi: 10.1126/science.1116995. 
PubMed PMID: 16293750. 
	   123 
31. Pelham RJ, Jr., Wang Y. Cell locomotion and focal adhesions are regulated by 
substrate flexibility. Proc Natl Acad Sci U S A. 1997;94(25):13661-5. PubMed PMID: 
9391082; PubMed Central PMCID: PMCPMC28362. 
32. Lo CM, Wang HB, Dembo M, Wang YL. Cell movement is guided by the rigidity 
of the substrate. Biophys J. 2000;79(1):144-52. PubMed PMID: 
WOS:000088048500011. 
33. Peyton SR, Putnam AJ. Extracellular matrix rigidity governs smooth muscle cell 
motility in a biphasic fashion. Journal of cellular physiology. 2005;204(1):198-209. doi: 
10.1002/jcp.20274. PubMed PMID: 15669099. 
34. Harley BA, Kim HD, Zaman MH, Yannas IV, Lauffenburger DA, Gibson LJ. 
Microarchitecture of three-dimensional scaffolds influences cell migration behavior via 
junction interactions. Biophys J. 2008;95(8):4013-24. doi: 10.1529/biophysj.107.122598. 
PubMed PMID: 18621811; PubMed Central PMCID: PMC2553126. 
35. Stroka KM, Aranda-Espinoza H. Effects of Morphology vs. Cell-Cell Interactions 
on Endothelial Cell Stiffness. Cell Mol Bioeng. 2011;4(1):9-27. doi: 10.1007/s12195-
010-0142-y. PubMed PMID: 21359128; PubMed Central PMCID: PMCPMC3044329. 
36. Stroka KM, Aranda-Espinoza H. Neutrophils display biphasic relationship 
between migration and substrate stiffness. Cell Motil Cytoskeleton. 2009;66(6):328-41. 
doi: 10.1002/cm.20363. PubMed PMID: 19373775. 
37. Chrzanowska-Wodnicka M, Burridge K. Rho-stimulated contractility drives the 
formation of stress fibers and focal adhesions. J Cell Biol. 1996;133(6):1403-15. PubMed 
PMID: 8682874; PubMed Central PMCID: PMCPMC2120895. 
38. Griffin MA, Sen S, Sweeney HL, Discher DE. Adhesion-contractile balance in 
myocyte differentiation. J Cell Sci. 2004;117(Pt 24):5855-63. doi: 10.1242/jcs.01496. 
PubMed PMID: 15522893. 
39. Riveline D, Zamir E, Balaban NQ, Schwarz US, Ishizaki T, Narumiya S, et al. 
Focal contacts as mechanosensors: externally applied local mechanical force induces 
growth of focal contacts by an mDia1-dependent and ROCK-independent mechanism. 
The Journal of cell biology. 2001;153(6):1175-86. PubMed PMID: 11402062; PubMed 
Central PMCID: PMC2192034. 
40. Alenghat FJ, Ingber DE. Mechanotransduction: all signals point to cytoskeleton, 
matrix, and integrins. Science's STKE : signal transduction knowledge environment. 
2002;2002(119):pe6. doi: 10.1126/stke.2002.119.pe6. PubMed PMID: 11842240. 
41. Hinz B, Celetta G, Tomasek JJ, Gabbiani G, Chaponnier C. Alpha-smooth muscle 
actin expression upregulates fibroblast contractile activity. Molecular biology of the cell. 
2001;12(9):2730-41. PubMed PMID: 11553712; PubMed Central PMCID: PMC59708. 
	   124 
42. Friedl P, Alexander S. Cancer invasion and the microenvironment: plasticity and 
reciprocity. Cell. 2011;147(5):992-1009. doi: 10.1016/j.cell.2011.11.016. PubMed 
PMID: 22118458. 
43. Kostic A, Lynch CD, Sheetz MP. Differential matrix rigidity response in breast 
cancer cell lines correlates with the tissue tropism. PloS one. 2009;4(7):e6361. doi: 
10.1371/journal.pone.0006361. PubMed PMID: 19626122; PubMed Central PMCID: 
PMC2709918. 
44. Tilghman RW, Blais EM, Cowan CR, Sherman NE, Grigera PR, Jeffery ED, et al. 
Matrix rigidity regulates cancer cell growth by modulating cellular metabolism and 
protein synthesis. PloS one. 2012;7(5):e37231. doi: 10.1371/journal.pone.0037231. 
PubMed PMID: 22623999; PubMed Central PMCID: PMC3356407. 
45. Tilghman RW, Cowan CR, Mih JD, Koryakina Y, Gioeli D, Slack-Davis JK, et 
al. Matrix rigidity regulates cancer cell growth and cellular phenotype. PloS one. 
2010;5(9):e12905. doi: 10.1371/journal.pone.0012905. PubMed PMID: 20886123; 
PubMed Central PMCID: PMC2944843. 
46. Mardakheh FK, Paul A, Kumper S, Sadok A, Paterson H, McCarthy A, et al. 
Global Analysis of mRNA, Translation, and Protein Localization: Local Translation Is a 
Key Regulator of Cell Protrusions. Developmental cell. 2015;35(3):344-57. doi: 
10.1016/j.devcel.2015.10.005. PubMed PMID: 26555054; PubMed Central PMCID: 
PMC4643311. 
47. Liao G, Simone B, Liu G. Mis-localization of Arp2 mRNA impairs persistence of 
directional cell migration. Exp Cell Res. 2011;317(6):812-22. doi: 
10.1016/j.yexcr.2010.12.002. PubMed PMID: 21146522; PubMed Central PMCID: 
PMCPMC3057629. 
48. Wang G, Huang Z, Liu X, Huang W, Chen S, Zhou Y, et al. IMP1 suppresses 
breast tumor growth and metastasis through the regulation of its target mRNAs. 
Oncotarget. 2016. doi: 10.18632/oncotarget.7464. PubMed PMID: 26910917. 
49. Gu W, Pan F, Singer RH. Blocking beta-catenin binding to the ZBP1 promoter 
represses ZBP1 expression, leading to increased proliferation and migration of metastatic 
breast-cancer cells. J Cell Sci. 2009;122(Pt 11):1895-905. doi: 10.1242/jcs.045278. 
PubMed PMID: 19461076; PubMed Central PMCID: PMCPMC2684840. 
50. Jeffery WR, Tomlinson CR, Brodeur RD. Localization of actin messenger RNA 
during early ascidian development. Dev Biol. 1983;99(2):408-17. PubMed PMID: 
6194032. 
51. Lecuyer E, Yoshida H, Parthasarathy N, Alm C, Babak T, Cerovina T, et al. 
Global analysis of mRNA localization reveals a prominent role in organizing cellular 
architecture and function. Cell. 2007;131(1):174-87. doi: 10.1016/j.cell.2007.08.003. 
PubMed PMID: 17923096. 
	   125 
52. Eberwine J, Belt B, Kacharmina JE, Miyashiro K. Analysis of subcellularly 
localized mRNAs using in situ hybridization, mRNA amplification, and expression 
profiling. Neurochem Res. 2002;27(10):1065-77. PubMed PMID: 12462405. 
53. Martin KC, Zukin RS. RNA trafficking and local protein synthesis in dendrites: 
an overview. J Neurosci. 2006;26(27):7131-4. doi: 10.1523/JNEUROSCI.1801-06.2006. 
PubMed PMID: 16822966. 
54. Blower MD, Feric E, Weis K, Heald R. Genome-wide analysis demonstrates 
conserved localization of messenger RNAs to mitotic microtubules. J Cell Biol. 
2007;179(7):1365-73. doi: 10.1083/jcb.200705163. PubMed PMID: 18166649; PubMed 
Central PMCID: PMCPMC2373496. 
55. Besse F, Ephrussi A. Translational control of localized mRNAs: restricting 
protein synthesis in space and time. Nat Rev Mol Cell Biol. 2008;9(12):971-80. doi: 
10.1038/nrm2548. PubMed PMID: 19023284. 
56. Jambhekar A, Derisi JL. Cis-acting determinants of asymmetric, cytoplasmic 
RNA transport. RNA. 2007;13(5):625-42. doi: 10.1261/rna.262607. PubMed PMID: 
17449729; PubMed Central PMCID: PMCPMC1852811. 
57. Chao JA, Patskovsky Y, Patel V, Levy M, Almo SC, Singer RH. ZBP1 
recognition of beta-actin zipcode induces RNA looping. Genes Dev. 2010;24(2):148-58. 
doi: 10.1101/gad.1862910. PubMed PMID: 20080952; PubMed Central PMCID: 
PMCPMC2807350. 
58. Patel VL, Mitra S, Harris R, Buxbaum AR, Lionnet T, Brenowitz M, et al. Spatial 
arrangement of an RNA zipcode identifies mRNAs under post-transcriptional control. 
Genes Dev. 2012;26(1):43-53. doi: 10.1101/gad.177428.111. PubMed PMID: 22215810; 
PubMed Central PMCID: PMCPMC3258965. 
59. Ding D, Lipshitz HD. Localized RNAs and their functions. Bioessays. 
1993;15(10):651-8. doi: 10.1002/bies.950151004. PubMed PMID: 7506023. 
60. Forrest KM, Gavis ER. Live imaging of endogenous RNA reveals a diffusion and 
entrapment mechanism for nanos mRNA localization in Drosophila. Curr Biol. 
2003;13(14):1159-68. PubMed PMID: 12867026. 
61. Carson JH, Cui H, Barbarese E. The balance of power in RNA trafficking. Curr 
Opin Neurobiol. 2001;11(5):558-63. PubMed PMID: 11595488. 
62. Bullock SL, Nicol A, Gross SP, Zicha D. Guidance of bidirectional motor 
complexes by mRNA cargoes through control of dynein number and activity. Curr Biol. 
2006;16(14):1447-52. doi: 10.1016/j.cub.2006.05.055. PubMed PMID: 16860745. 
	   126 
63. Dynes JL, Steward O. Dynamics of bidirectional transport of Arc mRNA in 
neuronal dendrites. J Comp Neurol. 2007;500(3):433-47. doi: 10.1002/cne.21189. 
PubMed PMID: 17120280. 
64. Krauss J, Lopez de Quinto S, Nusslein-Volhard C, Ephrussi A. Myosin-V 
regulates oskar mRNA localization in the Drosophila oocyte. Curr Biol. 
2009;19(12):1058-63. doi: 10.1016/j.cub.2009.04.062. PubMed PMID: 19481457. 
65. King ML, Messitt TJ, Mowry KL. Putting RNAs in the right place at the right 
time: RNA localization in the frog oocyte. Biol Cell. 2005;97(1):19-33. doi: 
10.1042/BC20040067. PubMed PMID: 15601255. 
66. Becalska AN, Gavis ER. Lighting up mRNA localization in Drosophila 
oogenesis. Development. 2009;136(15):2493-503. doi: 10.1242/dev.032391. PubMed 
PMID: 19592573; PubMed Central PMCID: PMCPMC2709059. 
67. Heym RG, Niessing D. Principles of mRNA transport in yeast. Cell Mol Life Sci. 
2012;69(11):1843-53. doi: 10.1007/s00018-011-0902-4. PubMed PMID: 22159587; 
PubMed Central PMCID: PMCPMC3350770. 
68. Weil TT, Forrest KM, Gavis ER. Localization of bicoid mRNA in late oocytes is 
maintained by continual active transport. Dev Cell. 2006;11(2):251-62. doi: 
10.1016/j.devcel.2006.06.006. PubMed PMID: 16890164. 
69. Huttelmaier S, Zenklusen D, Lederer M, Dictenberg J, Lorenz M, Meng X, et al. 
Spatial regulation of beta-actin translation by Src-dependent phosphorylation of ZBP1. 
Nature. 2005;438(7067):512-5. doi: 10.1038/nature04115. PubMed PMID: 16306994. 
70. Medioni C, Mowry K, Besse F. Principles and roles of mRNA localization in 
animal development. Development. 2012;139(18):3263-76. doi: 10.1242/dev.078626. 
PubMed PMID: 22912410; PubMed Central PMCID: PMCPMC3424039. 
71. Small JV, Resch GP. The comings and goings of actin: coupling protrusion and 
retraction in cell motility. Curr Opin Cell Biol. 2005;17(5):517-23. doi: 
10.1016/j.ceb.2005.08.004. PubMed PMID: 16099152. 
72. Condeelis J, Singer RH. How and why does beta-actin mRNA target? Biol Cell. 
2005;97(1):97-110. doi: 10.1042/BC20040063. PubMed PMID: 15601261. 
73. Poon MM, Choi SH, Jamieson CA, Geschwind DH, Martin KC. Identification of 
process-localized mRNAs from cultured rodent hippocampal neurons. J Neurosci. 
2006;26(51):13390-9. doi: 10.1523/JNEUROSCI.3432-06.2006. PubMed PMID: 
17182790. 
74. Stuart HC, Jia Z, Messenberg A, Joshi B, Underhill TM, Moukhles H, et al. 
Localized Rho GTPase activation regulates RNA dynamics and compartmentalization in 
tumor cell protrusions. J Biol Chem. 2008;283(50):34785-95. doi: 
	   127 
10.1074/jbc.M804014200. PubMed PMID: 18845542; PubMed Central PMCID: 
PMCPMC3259890. 
75. Jakobsen KR, Sorensen E, Brondum KK, Daugaard TF, Thomsen R, Nielsen AL. 
Direct RNA sequencing mediated identification of mRNA localized in protrusions of 
human MDA-MB-231 metastatic breast cancer cells. J Mol Signal. 2013;8(1):9. doi: 
10.1186/1750-2187-8-9. PubMed PMID: 24004954; PubMed Central PMCID: 
PMCPMC3844448. 
76. Thomsen R, Lade Nielsen A. A Boyden chamber-based method for 
characterization of astrocyte protrusion localized RNA and protein. Glia. 
2011;59(11):1782-92. doi: 10.1002/glia.21223. PubMed PMID: 21858875. 
77. Kislauskis EH, Zhu X, Singer RH. Sequences responsible for intracellular 
localization of beta-actin messenger RNA also affect cell phenotype. J Cell Biol. 
1994;127(2):441-51. PubMed PMID: 7929587; PubMed Central PMCID: 
PMCPMC2120214. 
78. Lawrence JB, Singer RH. Intracellular localization of messenger RNAs for 
cytoskeletal proteins. Cell. 1986;45(3):407-15. PubMed PMID: 3698103. 
79. Bassell GJ, Singer RH. Neuronal RNA localization and the cytoskeleton. Results 
Probl Cell Differ. 2001;34:41-56. PubMed PMID: 11288678. 
80. Latham VM, Jr., Kislauskis EH, Singer RH, Ross AF. Beta-actin mRNA 
localization is regulated by signal transduction mechanisms. J Cell Biol. 
1994;126(5):1211-9. PubMed PMID: 8063858; PubMed Central PMCID: 
PMCPMC2120163. 
81. Gu W, Pan F, Zhang H, Bassell GJ, Singer RH. A predominantly nuclear protein 
affecting cytoplasmic localization of beta-actin mRNA in fibroblasts and neurons. J Cell 
Biol. 2002;156(1):41-51. doi: 10.1083/jcb.200105133. PubMed PMID: 11781334; 
PubMed Central PMCID: PMCPMC2173579. 
82. Oleynikov Y, Singer RH. Real-time visualization of ZBP1 association with beta-
actin mRNA during transcription and localization. Curr Biol. 2003;13(3):199-207. 
PubMed PMID: 12573215. 
83. Song T, Zheng Y, Wang Y, Katz Z, Liu X, Chen S, et al. Specific interaction of 
KIF11 with ZBP1 regulates the transport of beta-actin mRNA and cell motility. J Cell 
Sci. 2015;128(5):1001-10. doi: 10.1242/jcs.161679. PubMed PMID: 25588836; PubMed 
Central PMCID: PMCPMC4342582. 
84. Ma B, Savas JN, Yu MS, Culver BP, Chao MV, Tanese N. Huntingtin mediates 
dendritic transport of beta-actin mRNA in rat neurons. Sci Rep. 2011;1:140. doi: 
10.1038/srep00140. PubMed PMID: 22355657; PubMed Central PMCID: 
PMCPMC3216621. 
	   128 
85. Liu G, Grant WM, Persky D, Latham VM, Jr., Singer RH, Condeelis J. 
Interactions of elongation factor 1alpha with F-actin and beta-actin mRNA: implications 
for anchoring mRNA in cell protrusions. Molecular biology of the cell. 2002;13(2):579-
92. doi: 10.1091/mbc.01-03-0140. PubMed PMID: 11854414; PubMed Central PMCID: 
PMC65651. 
86. Welch MD, DePace AH, Verma S, Iwamatsu A, Mitchison TJ. The human 
Arp2/3 complex is composed of evolutionarily conserved subunits and is localized to 
cellular regions of dynamic actin filament assembly. The Journal of cell biology. 
1997;138(2):375-84. PubMed PMID: 9230079; PubMed Central PMCID: PMC2138188. 
87. Mingle LA, Bonamy G, Barroso M, Liao G, Liu G. LPA-induced mutually 
exclusive subcellular localization of active RhoA and Arp2 mRNA revealed by 
sequential FRET and FISH. Histochemistry and cell biology. 2009;132(1):47-58. doi: 
10.1007/s00418-009-0589-x. PubMed PMID: 19365637; PubMed Central PMCID: 
PMC2753266. 
88. Yasuda K, Zhang H, Loiselle D, Haystead T, Macara IG, Mili S. The RNA-
binding protein Fus directs translation of localized mRNAs in APC-RNP granules. J Cell 
Biol. 2013;203(5):737-46. doi: 10.1083/jcb.201306058. PubMed PMID: 24297750; 
PubMed Central PMCID: PMCPMC3857475. 
89. Weber E, Berta G, Tousson A, St John P, Green MW, Gopalokrishnan U, et al. 
Expression and polarized targeting of a rab3 isoform in epithelial cells. The Journal of 
cell biology. 1994;125(3):583-94. PubMed PMID: 8175882; PubMed Central PMCID: 
PMC2119989. 
90. Zahraoui A, Joberty G, Arpin M, Fontaine JJ, Hellio R, Tavitian A, et al. A small 
rab GTPase is distributed in cytoplasmic vesicles in non polarized cells but colocalizes 
with the tight junction marker ZO-1 in polarized epithelial cells. The Journal of cell 
biology. 1994;124(1-2):101-15. PubMed PMID: 8294494; PubMed Central PMCID: 
PMC2119893. 
91. Marzesco AM, Dunia I, Pandjaitan R, Recouvreur M, Dauzonne D, Benedetti EL, 
et al. The small GTPase Rab13 regulates assembly of functional tight junctions in 
epithelial cells. Molecular biology of the cell. 2002;13(6):1819-31. doi: 02-02-0029. 
PubMed PMID: 12058051; PubMed Central PMCID: PMC117606. 
92. Kanda I, Nishimura N, Nakatsuji H, Yamamura R, Nakanishi H, Sasaki T. 
Involvement of Rab13 and JRAB/MICAL-L2 in epithelial cell scattering. Oncogene. 
2008;27(12):1687-95. doi: 10.1038/sj.onc.1210812. PubMed PMID: 17891173. 
93. Ioannou MS, Bell ES, Girard M, Chaineau M, Hamlin JN, Daubaras M, et al. 
DENND2B activates Rab13 at the leading edge of migrating cells and promotes 
metastatic behavior. J Cell Biol. 2015;208(5):629-48. doi: 10.1083/jcb.201407068. 
PubMed PMID: 25713415; PubMed Central PMCID: PMCPMC4347646. 
	   129 
94. Setzer SV, Calkins CC, Garner J, Summers S, Green KJ, Kowalczyk AP. 
Comparative analysis of armadillo family proteins in the regulation of a431 epithelial cell 
junction assembly, adhesion and migration. The Journal of investigative dermatology. 
2004;123(3):426-33. doi: 10.1111/j.0022-202X.2004.23319.x. PubMed PMID: 
15304078. 
95. Wolf A, Keil R, Gotzl O, Mun A, Schwarze K, Lederer M, et al. The armadillo 
protein p0071 regulates Rho signalling during cytokinesis. Nature cell biology. 
2006;8(12):1432-40. doi: 10.1038/ncb1504. PubMed PMID: 17115030. 
96. Hatzfeld M. Plakophilins: Multifunctional proteins or just regulators of 
desmosomal adhesion? Bba-Mol Cell Res. 2007;1773(1):69-77. doi: Doi 
10.1016/J.Bbamcr.2006.04.009. PubMed PMID: WOS:000243733900008. 
97. Papagerakis S, Shabana AH, Depondt J, Gehanno P, Forest N. 
Immunohistochemical localization of plakophilins (PKP1, PKP2, PKP3, and p0071) in 
primary oropharyngeal tumors: correlation with clinical parameters. Human pathology. 
2003;34(6):565-72. PubMed PMID: 12827610. 
98. Dusek RL, Attardi LD. Desmosomes: new perpetrators in tumour suppression. 
Nature reviews Cancer. 2011;11(5):317-23. doi: 10.1038/nrc3051. PubMed PMID: 
21508970; PubMed Central PMCID: PMC3799918. 
99. Lemeer S, Bluwstein A, Wu Z, Leberfinger J, Muller K, Kramer K, et al. 
Phosphotyrosine mediated protein interactions of the discoidin domain receptor 1. 
Journal of proteomics. 2012;75(12):3465-77. doi: 10.1016/j.jprot.2011.10.007. PubMed 
PMID: 22057045. 
100. Vogel WF, Abdulhussein R, Ford CE. Sensing extracellular matrix: an update on 
discoidin domain receptor function. Cellular signalling. 2006;18(8):1108-16. doi: 
10.1016/j.cellsig.2006.02.012. PubMed PMID: 16626936. 
101. Su J, Yu JT, Ren TT, Zhang W, Zhang YQ, Liu XP, et al. Discoidin domain 
receptor 2 is associated with the increased expression of matrix metalloproteinase-13 in 
synovial fibroblasts of rheumatoid arthritis. Mol Cell Biochem. 2009;330(1-2):141-52. 
doi: Doi 10.1007/S11010-009-0127-0. PubMed PMID: WOS:000270687500015. 
102. Ruiz PA, Jarai G. Collagen I Induces Discoidin Domain Receptor (DDR) 1 
Expression through DDR2 and a JAK2-ERK1/2-mediated Mechanism in Primary Human 
Lung Fibroblasts. Journal of Biological Chemistry. 2011;286(15):12912-23. doi: Doi 
10.1074/Jbc.M110.143693. PubMed PMID: WOS:000289282200011. 
103. Vonk LA, Doulabi BZ, Huang CL, Helder MN, Everts V, Bank RA. Collagen-
induced expression of collagenase-3 by primary chondrocytes is mediated by integrin 
alpha 1 and discoidin domain receptor 2: a protein kinase C-dependent pathway. 
Rheumatology. 2011;50(3):463-72. doi: Doi 10.1093/Rheumatology/Keq305. PubMed 
PMID: WOS:000287745600006. 
	   130 
104. Zhang K, Corsa CA, Ponik SM, Prior JL, Piwnica-Worms D, Eliceiri KW, et al. 
The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast 
cancer metastasis. Nature cell biology. 2013;15(6):677-87. doi: 10.1038/ncb2743. 
PubMed PMID: 23644467; PubMed Central PMCID: PMC3794710. 
105. Afonso PV, McCann CP, Kapnick SM, Parent CA. Discoidin domain receptor 2 
regulates neutrophil chemotaxis in 3D collagen matrices. Blood. 2013;121(9):1644-50. 
doi: 10.1182/blood-2012-08-451575. PubMed PMID: 23233663; PubMed Central 
PMCID: PMC3587327. 
106. Fallini C, Zhang H, Su Y, Silani V, Singer RH, Rossoll W, et al. The survival of 
motor neuron (SMN) protein interacts with the mRNA-binding protein HuD and 
regulates localization of poly(A) mRNA in primary motor neuron axons. The Journal of 
neuroscience : the official journal of the Society for Neuroscience. 2011;31(10):3914-25. 
doi: 10.1523/JNEUROSCI.3631-10.2011. PubMed PMID: 21389246; PubMed Central 
PMCID: PMC3070748. 
107. Rossoll W, Jablonka S, Andreassi C, Kroning AK, Karle K, Monani UR, et al. 
Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and 
localization of beta-actin mRNA in growth cones of motoneurons. The Journal of cell 
biology. 2003;163(4):801-12. doi: 10.1083/jcb.200304128. PubMed PMID: 14623865; 
PubMed Central PMCID: PMC2173668. 
108. Bassell GJ, Warren ST. Fragile X syndrome: loss of local mRNA regulation alters 
synaptic development and function. Neuron. 2008;60(2):201-14. doi: 
10.1016/j.neuron.2008.10.004. PubMed PMID: 18957214; PubMed Central PMCID: 
PMCPMC3691995. 
109. Dictenberg JB, Swanger SA, Antar LN, Singer RH, Bassell GJ. A direct role for 
FMRP in activity-dependent dendritic mRNA transport links filopodial-spine 
morphogenesis to fragile X syndrome. Developmental cell. 2008;14(6):926-39. doi: 
10.1016/j.devcel.2008.04.003. PubMed PMID: 18539120; PubMed Central PMCID: 
PMC2453222. 
110. Kao DI, Aldridge GM, Weiler IJ, Greenough WT. Altered mRNA transport, 
docking, and protein translation in neurons lacking fragile X mental retardation protein. 
Proceedings of the National Academy of Sciences of the United States of America. 
2010;107(35):15601-6. doi: 10.1073/pnas.1010564107. PubMed PMID: 20713728; 
PubMed Central PMCID: PMC2932564. 
111. Nagaoka K, Udagawa T, Richter JD. CPEB-mediated ZO-1 mRNA localization is 
required for epithelial tight-junction assembly and cell polarity. Nat Commun. 2012;3. 
doi: Artn 675 
Doi 10.1038/Ncomms1678. PubMed PMID: WOS:000302060100016. 
	   131 
112. Martin TA, Watkins G, Mansel RE, Jiang WG. Loss of tight junction plaque 
molecules in breast cancer tissues is associated with a poor prognosis in patients with 
breast cancer. Eur J Cancer. 2004;40(18):2717-25. doi: Doi 10.1016/J.Ejca.2004.08.008. 
PubMed PMID: WOS:000225993400018. 
113. Ioannidis P, Mahaira L, Papadopoulou A, Teixeira MR, Heim S, Andersen JA, et 
al. CRD-BP: a c-Myc mRNA stabilizing protein with an oncofetal pattern of expression. 
Anticancer research. 2003;23(3A):2179-83. PubMed PMID: 12894594. 
114. Tessier CR, Doyle GA, Clark BA, Pitot HC, Ross J. Mammary tumor induction in 
transgenic mice expressing an RNA-binding protein. Cancer research. 2004;64(1):209-
14. PubMed PMID: 14729626. 
115. Wang T, Hopkins D, Schmidt C, Silva S, Houghton R, Takita H, et al. 
Identification of genes differentially over-expressed in lung squamous cell carcinoma 
using combination of cDNA subtraction and microarray analysis. Oncogene. 
2000;19(12):1519-28. doi: 10.1038/sj.onc.1203457. PubMed PMID: 10734311. 
116. Hwang YS, Xianglan Z, Park KK, Chung WY. Functional invadopodia formation 
through stabilization of the PDPN transcript by IMP-3 and cancer-stromal crosstalk for 
PDPN expression. Carcinogenesis. 2012;33(11):2135-46. doi: 10.1093/carcin/bgs258. 
PubMed PMID: 22859271. 
117. Vikesaa J, Hansen TV, Jonson L, Borup R, Wewer UM, Christiansen J, et al. 
RNA-binding IMPs promote cell adhesion and invadopodia formation. The EMBO 
journal. 2006;25(7):1456-68. doi: 10.1038/sj.emboj.7601039. PubMed PMID: 16541107; 
PubMed Central PMCID: PMC1440323. 
118. Magiera MM, Janke C. Post-translational modifications of tubulin. Curr Biol. 
2014;24(9):R351-4. doi: 10.1016/j.cub.2014.03.032. PubMed PMID: 24801181. 
119. Janke C. The tubulin code: molecular components, readout mechanisms, and 
functions. J Cell Biol. 2014;206(4):461-72. doi: 10.1083/jcb.201406055. PubMed PMID: 
25135932; PubMed Central PMCID: PMCPMC4137062. 
120. Szyk A, Piszczek G, Roll-Mecak A. Tubulin tyrosine ligase and stathmin compete 
for tubulin binding in vitro. J Mol Biol. 2013;425(14):2412-4. doi: 
10.1016/j.jmb.2013.04.017. PubMed PMID: 23624152; PubMed Central PMCID: 
PMCPMC4201589. 
121. Prota AE, Magiera MM, Kuijpers M, Bargsten K, Frey D, Wieser M, et al. 
Structural basis of tubulin tyrosination by tubulin tyrosine ligase. J Cell Biol. 
2013;200(3):259-70. doi: 10.1083/jcb.201211017. PubMed PMID: 23358242; PubMed 
Central PMCID: PMCPMC3563685. 
122. Khawaja S, Gundersen GG, Bulinski JC. Enhanced stability of microtubules 
enriched in detyrosinated tubulin is not a direct function of detyrosination level. J Cell 
	   132 
Biol. 1988;106(1):141-9. PubMed PMID: 3276710; PubMed Central PMCID: 
PMCPMC2114950. 
123. Webster DR, Wehland J, Weber K, Borisy GG. Detyrosination of alpha tubulin 
does not stabilize microtubules in vivo. J Cell Biol. 1990;111(1):113-22. PubMed PMID: 
1973168; PubMed Central PMCID: PMCPMC2116167. 
124. Cook TA, Nagasaki T, Gundersen GG. Rho guanosine triphosphatase mediates 
the selective stabilization of microtubules induced by lysophosphatidic acid. J Cell Biol. 
1998;141(1):175-85. PubMed PMID: 9531557; PubMed Central PMCID: 
PMCPMC2132729. 
125. Nagasaki T, Gundersen GG. Depletion of lysophosphatidic acid triggers a loss of 
oriented detyrosinated microtubules in motile fibroblasts. J Cell Sci. 1996;109 ( Pt 
10):2461-9. PubMed PMID: 8923207. 
126. Jiang K, Akhmanova A. Microtubule tip-interacting proteins: a view from both 
ends. Curr Opin Cell Biol. 2011;23(1):94-101. doi: 10.1016/j.ceb.2010.08.008. PubMed 
PMID: 20817499. 
127. Bieling P, Kandels-Lewis S, Telley IA, van Dijk J, Janke C, Surrey T. CLIP-170 
tracks growing microtubule ends by dynamically recognizing composite EB1/tubulin-
binding sites. J Cell Biol. 2008;183(7):1223-33. doi: 10.1083/jcb.200809190. PubMed 
PMID: 19103809; PubMed Central PMCID: PMCPMC2606963. 
128. Roll-Mecak A, Vale RD. Structural basis of microtubule severing by the 
hereditary spastic paraplegia protein spastin. Nature. 2008;451(7176):363-7. doi: 
10.1038/nature06482. PubMed PMID: 18202664; PubMed Central PMCID: 
PMCPMC2882799. 
129. Liao G, Gundersen GG. Kinesin is a candidate for cross-bridging microtubules 
and intermediate filaments. Selective binding of kinesin to detyrosinated tubulin and 
vimentin. J Biol Chem. 1998;273(16):9797-803. PubMed PMID: 9545318. 
130. Langley RR, Fidler IJ. Tumor cell-organ microenvironment interactions in the 
pathogenesis of cancer metastasis. Endocr Rev. 2007;28(3):297-321. Epub 2007/04/06. 
doi: er.2006-0027 [pii] 
10.1210/er.2006-0027. PubMed PMID: 17409287. 
131. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat 
Med. 2006;12(8):895-904. Epub 2006/08/08. doi: nm1469 [pii] 
10.1038/nm1469. PubMed PMID: 16892035. 
132. Weiss L, Grundmann E, Torhorst J, Hartveit F, Moberg I, Eder M, et al. 
Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. 
J Pathol. 1986;150(3):195-203. Epub 1986/11/01. doi: 10.1002/path.1711500308. 
PubMed PMID: 3806280. 
	   133 
133. Mukhopadhyay R, Theriault RL, Price JE. Increased levels of alpha6 integrins are 
associated with the metastatic phenotype of human breast cancer cells. Clin Exp 
Metastasis. 1999;17(4):325-32. Epub 1999/11/02. PubMed PMID: 10545019. 
134. Owens DM, Romero MR, Gardner C, Watt FM. Suprabasal alpha6beta4 integrin 
expression in epidermis results in enhanced tumourigenesis and disruption of TGFbeta 
signalling. J Cell Sci. 2003;116(Pt 18):3783-91. Epub 2003/08/07. doi: 
10.1242/jcs.00725 
jcs.00725 [pii]. PubMed PMID: 12902406. 
135. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of 
metastasis in primary solid tumors. Nat Genet. 2003;33(1):49-54. Epub 2002/12/07. doi: 
10.1038/ng1060 
ng1060 [pii]. PubMed PMID: 12469122. 
136. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat 
Rev Genet. 2002;3(6):415-28. Epub 2002/06/04. doi: 10.1038/nrg816 
nrg816 [pii]. PubMed PMID: 12042769. 
137. Chuang HY, Lee E, Liu YT, Lee D, Ideker T. Network-based classification of 
breast cancer metastasis. Mol Syst Biol. 2007;3:140. Epub 2007/10/18. doi: msb4100180 
[pii] 
10.1038/msb4100180. PubMed PMID: 17940530. 
138. Khuon S, Liang L, Dettman RW, Sporn PH, Wysolmerski RB, Chew TL. Myosin 
light chain kinase mediates transcellular intravasation of breast cancer cells through the 
underlying endothelial cells: a three-dimensional FRET study. J Cell Sci. 2010;123(Pt 
3):431-40. doi: 10.1242/jcs.053793. PubMed PMID: 20067998; PubMed Central 
PMCID: PMCPMC2816188. 
139. Weis S, Cui J, Barnes L, Cheresh D. Endothelial barrier disruption by VEGF-
mediated Src activity potentiates tumor cell extravasation and metastasis. J Cell Biol. 
2004;167(2):223-9. Epub 2004/10/27. doi: jcb.200408130 [pii] 
10.1083/jcb.200408130. PubMed PMID: 15504909. 
140. Zhang Q, Liu T, Qin J. A microfluidic-based device for study of transendothelial 
invasion of tumor aggregates in realtime. Lab Chip. 2012;12(16):2837-42. Epub 
2012/06/01. doi: 10.1039/c2lc00030j. PubMed PMID: 22648473. 
141. Heyder C, Gloria-Maercker E, Entschladen F, Hatzmann W, Niggemann B, 
Zanker KS, et al. Realtime visualization of tumor cell/endothelial cell interactions during 
transmigration across the endothelial barrier. J Cancer Res Clin Oncol. 
2002;128(10):533-8. Epub 2002/10/18. doi: 10.1007/s00432-002-0377-7. PubMed 
PMID: 12384796. 
142. Fazakas C, Wilhelm I, Nagyoszi P, Farkas AE, Hasko J, Molnar J, et al. 
Transmigration of melanoma cells through the blood-brain barrier: role of endothelial 
	   134 
tight junctions and melanoma-released serine proteases. PLoS One. 2011;6(6):e20758. 
Epub 2011/06/16. doi: 10.1371/journal.pone.0020758 
PONE-D-11-01986 [pii]. PubMed PMID: 21674054. 
143. Brandt B, Heyder C, Gloria-Maercker E, Hatzmann W, Rotger A, Kemming D, et 
al. 3D-extravasation model -- selection of highly motile and metastatic cancer cells. 
Semin Cancer Biol. 2005;15(5):387-95. Epub 2005/08/02. doi: S1044-579X(05)00039-8 
[pii] 
10.1016/j.semcancer.2005.06.006. PubMed PMID: 16054390. 
144. Mierke CT, Zitterbart DP, Kollmannsberger P, Raupach C, Schlotzer-Schrehardt 
U, Goecke TW, et al. Breakdown of the endothelial barrier function in tumor cell 
transmigration. Biophys J. 2008;94(7):2832-46. doi: 10.1529/biophysj.107.113613. 
PubMed PMID: 18096634; PubMed Central PMCID: PMCPMC2267111. 
145. Iwanicki MP, Davidowitz RA, Ng MR, Besser A, Muranen T, Merritt M, et al. 
Ovarian cancer spheroids use myosin-generated force to clear the mesothelium. Cancer 
Discov. 2011;1(2):144-57. Epub 2012/02/04. doi: 10.1158/2159-8274.CD-11-0010. 
PubMed PMID: 22303516. 
146. Mierke CT. Cancer cells regulate biomechanical properties of human 
microvascular endothelial cells. J Biol Chem. 2011;286(46):40025-37. Epub 2011/09/24. 
doi: M111.256172 [pii] 
10.1074/jbc.M111.256172. PubMed PMID: 21940631. 
147. Wittchen ES, Worthylake RA, Kelly P, Casey PJ, Quilliam LA, Burridge K. Rap1 
GTPase inhibits leukocyte transmigration by promoting endothelial barrier function. J 
Biol Chem. 2005;280(12):11675-82. Epub 2005/01/22. doi: M412595200 [pii] 
10.1074/jbc.M412595200. PubMed PMID: 15661741. 
148. Mckenzie JAG, Ridley AJ. Roles of Rho/ROCK and MLCK in TNF-alpha-
induced changes in endothelial morphology and permeability. Journal of Cellular 
Physiology. 2007;213(1):221-8. PubMed PMID: ISI:000249292000025. 
149. Jannat RA, Robbins GP, Ricart BG, Dembo M, Hammer DA. Neutrophil 
adhesion and chemotaxis depend on substrate mechanics. J Phys Condens Matter. 
2010;22(19):194117. Epub 2010/05/18. doi: 10.1088/0953-8984/22/19/194117. PubMed 
PMID: 20473350. 
150. Oakes PW, Patel DC, Morin NA, Zitterbart DP, Fabry B, Reichner JS, et al. 
Neutrophil morphology and migration are affected by substrate elasticity. Blood. 
2009;114(7):1387-95. Epub 2009/06/06. doi: blood-2008-11-191445 [pii] 
10.1182/blood-2008-11-191445. PubMed PMID: 19491394. 
151. Stroka KM, Aranda-Espinoza H. A biophysical view of the interplay between 
mechanical forces and signaling pathways during transendothelial cell migration. FEBS 
Journal. 2010;277(5):1145-58. PubMed PMID: ISI:000274312700010. 
	   135 
152. Mierke CT. Role of the endothelium during tumor cell metastasis: is the 
endothelium a barrier or a promoter for cell invasion and metastasis? J Biophys. 
2008;2008:183516. doi: 10.1155/2008/183516. PubMed PMID: 20107573; PubMed 
Central PMCID: PMCPMC2809021. 
153. Wang Y, Pelham R. Preparation of a flexible, porous polyacrylamide substrate for 
mechanical studies of cultured cells. Methods in Enzymology. 1998;298:489-96. PubMed 
PMID: ISI:000076246300039. 
154. Stroka KM, Levitan I, Aranda-Espinoza H. OxLDL and substrate stiffness 
promote neutrophil transmigration by enhanced endothelial cell contractility and ICAM-
1. J Biomech. 2012;45:1828-34. Epub 2012/05/09. doi: S0021-9290(12)00230-8 [pii] 
10.1016/j.jbiomech.2012.04.011. PubMed PMID: 22560286. 
155. Stroka KM, Vaitkus JA, Aranda-Espinoza H. Endothelial cells undergo 
morphological, biomechanical, and dynamic changes in response to tumor necrosis 
factor-alpha. European Biophysics Journal with Biophysics Letters. 2012;41(11):939-47. 
doi: Doi 10.1007/S00249-012-0851-3. PubMed PMID: ISI:000310074900002. 
156. Norman LL, Aranda-Espinoza H. Cortical Neuron Outgrowth is Insensitive to 
Substrate Stiffness. Cellular and Molecular Bioengineering. 2010;3(4):398-414. doi: Doi 
10.1007/S12195-010-0137-8. PubMed PMID: ISI:000285211500009. 
157. Norman LL, Oetama RJ, Dembo M, Byfield F, Hammer DA, Levitan I, et al. 
Modification of Cellular Cholesterol Content Affects Traction Force, Adhesion and Cell 
Spreading. Cellular and Molecular Bioengineering. 2010;3(2):151-62. PubMed PMID: 
ISI:000277368900006. 
158. Stroka KM, Aranda-Espinoza H. Effects of Morphology vs. Cell-Cell Interactions 
on Endothelial Cell Stiffness. Cellular and Molecular Bioengineering. 2011;4(1):9-27. 
Epub 2011/03/02. doi: 10.1007/s12195-010-0142-y. PubMed PMID: 21359128; PubMed 
Central PMCID: PMC3044329. 
159. Shaw SK, Bamba PS, Perkins BN, Luscinskas FW. Real-time imaging of vascular 
endothelial-cadherin during leukocyte transmigration across endothelium. J Immunol. 
2001;167(4):2323-30. Epub 2001/08/08. PubMed PMID: 11490021. 
160. Norman L, Sengupta K, Aranda-Espinoza H. Blebbing dynamics during 
endothelial cell spreading. Eur J Cell Biol. 2011;90(1):37-48. Epub 2010/11/20. doi: 
10.1016/j.ejcb.2010.09.013 
S0171-9335(10)00204-9 [pii]. PubMed PMID: 21087809. 
161. Norman LL, Brugues J, Sengupta K, Sens P, Aranda-Espinoza H. Cell blebbing 
and membrane area homeostasis in spreading and retracting cells. Biophys J. 
2010;99(6):1726-33. Epub 2010/09/23. doi: 10.1016/j.bpj.2010.07.031 
S0006-3495(10)00903-3 [pii]. PubMed PMID: 20858416. 
	   136 
162. Norman LL, Oetama RJ, Dembo M, Byfield F, Hammer DA, Levitan I, et al. 
Modification of Cellular Cholesterol Content Affects Traction Force, Adhesion and Cell 
Spreading. Cell Mol Bioeng. 2010;3(2):151-62. doi: 10.1007/s12195-010-0119-x. 
PubMed PMID: 21461187; PubMed Central PMCID: PMCPMC3066088. 
163. Hayenga HN, Aranda-Espinoza H. Stiffness Increases Mononuclear Cell 
Transendothelial Migration. Cellular and Molecular Bioengineering. 2013;6(3):253-65. 
doi: Doi 10.1007/S12195-013-0284-9. PubMed PMID: ISI:000323109400001. 
164. Breviario F, Caveda L, Corada M, Martin-Padura I, Navarro P, Golay J, et al. 
Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an 
endothelium-specific cadherin. Arterioscler Thromb Vasc Biol. 1995;15(8):1229-39. 
Epub 1995/08/01. PubMed PMID: 7627717. 
165. Navarro P, Caveda L, Breviario F, Mandoteanu I, Lampugnani MG, Dejana E. 
Catenin-dependent and -independent functions of vascular endothelial cadherin. J Biol 
Chem. 1995;270(52):30965-72. Epub 1995/12/29. PubMed PMID: 8537353. 
166. Mierke CT. Endothelial cell's biomechanical properties are regulated by invasive 
cancer cells. Molecular Biosystems. 2012;8(6):1639-49. doi: Doi 10.1039/C2mb25024a. 
PubMed PMID: ISI:000303776200004. 
167. Lapis K, Paku S, Liotta LA. Endothelialization of embolized tumor cells during 
metastasis formation. Clin Exp Metastasis. 1988;6(1):73-89. Epub 1988/01/01. PubMed 
PMID: 3335082. 
168. Crissman JD, Hatfield J, Schaldenbrand M, Sloane BF, Honn KV. Arrest and 
extravasation of B16 amelanotic melanoma in murine lungs. A light and electron 
microscopic study. Lab Invest. 1985;53(4):470-8. Epub 1985/10/01. PubMed PMID: 
4046557. 
169. Schmidt A, Ladage D, Steingen C, Brixius K, Schinkothe T, Klinz FJ, et al. 
Mesenchymal stem cells transmigrate over the endothelial barrier. Eur J Cell Biol. 
2006;85(11):1179-88. Epub 2006/07/11. doi: S0171-9335(06)00108-7 [pii] 
10.1016/j.ejcb.2006.05.015. PubMed PMID: 16824647. 
170. Langer HF, Stellos K, Steingen C, Froihofer A, Schonberger T, Kramer B, et al. 
Platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem 
cells in vitro. J Mol Cell Cardiol. 2009;47(2):315-25. Epub 2009/03/31. doi: S0022-
2828(09)00116-3 [pii] 
10.1016/j.yjmcc.2009.03.011. PubMed PMID: 19328809. 
171. Teo GS, Ankrum JA, Martinelli R, Boetto SE, Simms K, Sciuto TE, et al. 
Mesenchymal stem cells transmigrate between and directly through tumor necrosis 
factor-alpha-activated endothelial cells via both leukocyte-like and novel mechanisms. 
Stem Cells. 2012;30(11):2472-86. Epub 2012/08/14. doi: 10.1002/stem.1198. PubMed 
PMID: 22887987; PubMed Central PMCID: PMC3479371. 
	   137 
172. Zervantonakis IK, Hughes-Alford SK, Charest JL, Condeelis JS, Gertler FB, 
Kamm RD. Three-dimensional microfluidic model for tumor cell intravasation and 
endothelial barrier function. Proc Natl Acad Sci U S A. 2012;109(34):13515-20. Epub 
2012/08/08. doi: 1210182109 [pii] 
10.1073/pnas.1210182109. PubMed PMID: 22869695; PubMed Central PMCID: 
PMC3427099. 
173. Strell C, Lang K, Niggemann B, Zaenker KS, Entschladen F. Surface molecules 
regulating rolling and adhesion to endothelium of neutrophil granulocytes and MDA-
MB-468 breast carcinoma cells and their interaction. Cellular and Molecular Life 
Sciences. 2007;64(24):3306-16. doi: Doi 10.1007/S00018-007-7402-6. PubMed PMID: 
ISI:000252219000015. 
174. Ghislin S, Obino D, Middendorp S, Boggetto N, Alcaide-Loridan C, Deshayes F. 
LFA-1 and ICAM-1 expression induced during melanoma-endothelial cell co-culture 
favors the transendothelial migration of melanoma cell lines in vitro. BMC cancer. 
2012;12:455. doi: 10.1186/1471-2407-12-455. PubMed PMID: 23039186; PubMed 
Central PMCID: PMC3495854. 
175. van Grevenstein WM, Hofland LJ, Jeekel J, van Eijck CH. The expression of 
adhesion molecules and the influence of inflammatory cytokines on the adhesion of 
human pancreatic carcinoma cells to mesothelial monolayers. Pancreas. 2006;32(4):396-
402. doi: 10.1097/01.mpa.0000220865.80034.2a. PubMed PMID: 16670622. 
176. Zaman MH, Trapani LM, Sieminski AL, Mackellar D, Gong H, Kamm RD, et al. 
Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-
matrix adhesion and proteolysis. Proc Natl Acad Sci U S A. 2006;103(29):10889-94. 
Epub 2006/07/13. doi: 0604460103 [pii] 
10.1073/pnas.0604460103. PubMed PMID: 16832052; PubMed Central PMCID: 
PMC1544144. 
177. Alcaide P, Martinelli R, Newton G, Williams MR, Adam A, Vincent PA, et al. 
p120-Catenin prevents neutrophil transmigration independently of RhoA inhibition by 
impairing Src dependent VE-cadherin phosphorylation. Am J Physiol Cell Physiol. 
2012;303(4):C385-95. Epub 2012/06/01. doi: ajpcell.00126.2012 [pii] 
10.1152/ajpcell.00126.2012. PubMed PMID: 22648953; PubMed Central PMCID: 
PMC3422989. 
178. Stroka KM, Hayenga HN, Aranda-Espinoza H. Human neutrophil cytoskeletal 
dynamics and contractility actively contribute to trans-endothelial migration. PLoS One. 
2013;8(4):e61377. doi: 10.1371/journal.pone.0061377. PubMed PMID: 23626676; 
PubMed Central PMCID: PMCPMC3634075. 
179. Vainer G, Vainer-Mosse E, Pikarsky A, Shenoy SM, Oberman F, Yeffet A, et al. 
A role for VICKZ proteins in the progression of colorectal carcinomas: regulating 
	   138 
lamellipodia formation. J Pathol. 2008;215(4):445-56. doi: 10.1002/path.2376. PubMed 
PMID: 18535985; PubMed Central PMCID: PMCPMC3148580. 
180. Li Z, Wang L, Hays TS, Cai Y. Dynein-mediated apical localization of crumbs 
transcripts is required for Crumbs activity in epithelial polarity. J Cell Biol. 
2008;180(1):31-8. doi: 10.1083/jcb.200707007. PubMed PMID: 18195099; PubMed 
Central PMCID: PMCPMC2213619. 
181. Nagaoka K, Udagawa T, Richter JD. CPEB-mediated ZO-1 mRNA localization is 
required for epithelial tight-junction assembly and cell polarity. Nat Commun. 
2012;3:675. doi: 10.1038/ncomms1678. PubMed PMID: 22334078; PubMed Central 
PMCID: PMCPMC4334452. 
182. Ridley AJ. Life at the leading edge. Cell. 2011;145(7):1012-22. doi: 
10.1016/j.cell.2011.06.010. PubMed PMID: 21703446. 
183. Lo CM, Wang HB, Dembo M, Wang YL. Cell movement is guided by the rigidity 
of the substrate. Biophys J. 2000;79(1):144-52. doi: 10.1016/S0006-3495(00)76279-5. 
PubMed PMID: 10866943; PubMed Central PMCID: PMCPMC1300921. 
184. Hamilla SM, Stroka KM, Aranda-Espinoza H. VE-cadherin-independent cancer 
cell incorporation into the vascular endothelium precedes transmigration. PLoS One. 
2014;9(10):e109748. doi: 10.1371/journal.pone.0109748. PubMed PMID: 25275457; 
PubMed Central PMCID: PMCPMC4183660. 
185. Dembo M, Wang YL. Stresses at the cell-to-substrate interface during locomotion 
of fibroblasts. Biophysical journal. 1999;76(4):2307-16. doi: 10.1016/S0006-
3495(99)77386-8. PubMed PMID: 10096925; PubMed Central PMCID: PMC1300203. 
186. Munevar S, Wang Y, Dembo M. Traction force microscopy of migrating normal 
and H-ras transformed 3T3 fibroblasts. Biophys J. 2001;80(4):1744-57. PubMed PMID: 
11259288; PubMed Central PMCID: PMCPMC1301364. 
187. Park HY, Trcek T, Wells AL, Chao JA, Singer RH. An unbiased analysis method 
to quantify mRNA localization reveals its correlation with cell motility. Cell Rep. 
2012;1(2):179-84. doi: 10.1016/j.celrep.2011.12.009. PubMed PMID: 22832165; 
PubMed Central PMCID: PMCPMC4079260. 
188. Tseng Q, Duchemin-Pelletier E, Deshiere A, Balland M, Guillou H, Filhol O, et 
al. Spatial organization of the extracellular matrix regulates cell-cell junction positioning. 
Proc Natl Acad Sci U S A. 2012;109(5):1506-11. doi: 10.1073/pnas.1106377109. 
PubMed PMID: 22307605; PubMed Central PMCID: PMCPMC3277177. 
189. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, et al. 
Tensional homeostasis and the malignant phenotype. Cancer Cell. 2005;8(3):241-54. doi: 
10.1016/j.ccr.2005.08.010. PubMed PMID: 16169468. 
	   139 
190. Jaalouk DE, Lammerding J. Mechanotransduction gone awry. Nature reviews 
Molecular cell biology. 2009;10(1):63-73. doi: 10.1038/nrm2597. PubMed PMID: 
19197333; PubMed Central PMCID: PMC2668954. 
191. McGrail DJ, Kieu QM, Dawson MR. The malignancy of metastatic ovarian 
cancer cells is increased on soft matrices through a mechanosensitive Rho-ROCK 
pathway. J Cell Sci. 2014;127(Pt 12):2621-6. doi: 10.1242/jcs.144378. PubMed PMID: 
24741068; PubMed Central PMCID: PMC4058108. 
192. Kovacs M, Toth J, Hetenyi C, Malnasi-Csizmadia A, Sellers JR. Mechanism of 
blebbistatin inhibition of myosin II. J Biol Chem. 2004;279(34):35557-63. doi: 
10.1074/jbc.M405319200. PubMed PMID: 15205456. 
193. Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M, et al. 
Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. 
Mol Pharmacol. 2000;57(5):976-83. PubMed PMID: 10779382. 
194. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell 
lineage specification. Cell. 2006;126(4):677-89. doi: 10.1016/j.cell.2006.06.044. PubMed 
PMID: 16923388. 
195. Gundersen GG, Bulinski JC. Selective stabilization of microtubules oriented 
toward the direction of cell migration. Proc Natl Acad Sci U S A. 1988;85(16):5946-50. 
PubMed PMID: 3413068; PubMed Central PMCID: PMCPMC281882. 
196. Guo WH, Frey MT, Burnham NA, Wang YL. Substrate rigidity regulates the 
formation and maintenance of tissues. Biophysical journal. 2006;90(6):2213-20. doi: 
10.1529/biophysj.105.070144. PubMed PMID: 16387786; PubMed Central PMCID: 
PMC1386800. 
197. Gu W, Katz Z, Wu B, Park HY, Li DL, Lin S, et al. Regulation of local 
expression of cell adhesion and motility-related mRNAs in breast cancer cells by 
IMP1/ZBP1. J Cell Sci. 2012;125(1):81-91. doi: 10.1242/jcs.086132. PubMed PMID: 
WOS:000300329100009. 
198. Grinnell F, Rhee SM, Jiang HM, Ho CH. Microtubule function in fibroblast 
spreading is modulated according to the tension state of cell-matrix interactions. Faseb J. 
2007;21(5):A635-A6. PubMed PMID: WOS:000245708505191. 
199. Svitkina TM, Verkhovsky AB, McQuade KM, Borisy GG. Analysis of the actin-
myosin II system in fish epidermal keratocytes: mechanism of cell body translocation. J 
Cell Biol. 1997;139(2):397-415. PubMed PMID: 9334344; PubMed Central PMCID: 
PMCPMC2139803. 
200. Palazzo AF, Cook TA, Alberts AS, Gundersen GG. mDia mediates Rho-regulated 
formation and orientation of stable microtubules. Nat Cell Biol. 2001;3(8):723-9. doi: 
10.1038/35087035. PubMed PMID: 11483957. 
	   140 
201. Palazzo AF, Joseph HL, Chen YJ, Dujardin DL, Alberts AS, Pfister KK, et al. 
Cdc42, dynein, and dynactin regulate MTOC reorientation independent of Rho-regulated 
microtubule stabilization. Curr Biol. 2001;11(19):1536-41. PubMed PMID: 11591323. 
202. Fonrose X, Ausseil F, Soleilhac E, Masson V, David B, Pouny I, et al. 
Parthenolide inhibits tubulin carboxypeptidase activity. Cancer Res. 2007;67(7):3371-8. 
doi: 10.1158/0008-5472.CAN-06-3732. PubMed PMID: 17409447. 
203. Palazzo AF, Eng CH, Schlaepfer DD, Marcantonio EE, Gundersen GG. Localized 
stabilization of microtubules by integrin- and FAK-facilitated Rho signaling. Science. 
2004;303(5659):836-9. doi: 10.1126/science.1091325. PubMed PMID: 14764879. 
204. Even-Ram S, Doyle AD, Conti MA, Matsumoto K, Adelstein RS, Yamada KM. 
Myosin IIA regulates cell motility and actomyosin-microtubule crosstalk. Nat Cell Biol. 
2007;9(3):299-309. doi: 10.1038/ncb1540. PubMed PMID: 17310241. 
205. Arakawa Y, Bito H, Furuyashiki T, Tsuji T, Takemoto-Kimura S, Kimura K, et 
al. Control of axon elongation via an SDF-1alpha/Rho/mDia pathway in cultured 
cerebellar granule neurons. J Cell Biol. 2003;161(2):381-91. doi: 10.1083/jcb.200210149. 
PubMed PMID: 12707308; PubMed Central PMCID: PMCPMC2172896. 
206. Wen Y, Eng CH, Schmoranzer J, Cabrera-Poch N, Morris EJ, Chen M, et al. EB1 
and APC bind to mDia to stabilize microtubules downstream of Rho and promote cell 
migration. Nat Cell Biol. 2004;6(9):820-30. doi: 10.1038/ncb1160. PubMed PMID: 
15311282. 
207. Wozniak MA, Desai R, Solski PA, Der CJ, Keely PJ. ROCK-generated 
contractility regulates breast epithelial cell differentiation in response to the physical 
properties of a three-dimensional collagen matrix. The Journal of cell biology. 
2003;163(3):583-95. doi: 10.1083/jcb.200305010. PubMed PMID: 14610060; PubMed 
Central PMCID: PMC2173660. 
208. Parekh A, Weaver AM. Regulation of cancer invasiveness by the physical 
extracellular matrix environment. Cell adhesion & migration. 2009;3(3):288-92. PubMed 
PMID: 19458499; PubMed Central PMCID: PMC2712813. 
209. Parri M, Chiarugi P. Rac and Rho GTPases in cancer cell motility control. Cell 
communication and signaling : CCS. 2010;8:23. doi: 10.1186/1478-811X-8-23. PubMed 
PMID: 20822528; PubMed Central PMCID: PMC2941746. 
210. Badiola I, Villace P, Basaldua I, Olaso E. Downregulation of discoidin domain 
receptor 2 in A375 human melanoma cells reduces its experimental liver metastasis 
ability. Oncology reports. 2011;26(4):971-8. doi: 10.3892/or.2011.1356. PubMed PMID: 
21701781. 
211. Valiathan RR, Marco M, Leitinger B, Kleer CG, Fridman R. Discoidin domain 
receptor tyrosine kinases: new players in cancer progression. Cancer metastasis reviews. 
	   141 
2012;31(1-2):295-321. doi: 10.1007/s10555-012-9346-z. PubMed PMID: 22366781; 
PubMed Central PMCID: PMC3351584. 
212. Walsh LA, Nawshad A, Medici D. Discoidin domain receptor 2 is a critical 
regulator of epithelial-mesenchymal transition. Matrix biology : journal of the 
International Society for Matrix Biology. 2011;30(4):243-7. doi: 
10.1016/j.matbio.2011.03.007. PubMed PMID: 21477649; PubMed Central PMCID: 
PMC3114285. 
213. Whipple RA, Matrone MA, Cho EH, Balzer EM, Vitolo MI, Yoon JR, et al. 
Epithelial-to-mesenchymal transition promotes tubulin detyrosination and microtentacles 
that enhance endothelial engagement. Cancer research. 2010;70(20):8127-37. doi: 
10.1158/0008-5472.CAN-09-4613. PubMed PMID: 20924103; PubMed Central PMCID: 
PMC3123454. 
214. Whipple RA, Balzer EM, Cho EH, Matrone MA, Yoon JR, Martin SS. Vimentin 
filaments support extension of tubulin-based microtentacles in detached breast tumor 
cells. Cancer research. 2008;68(14):5678-88. doi: 10.1158/0008-5472.CAN-07-6589. 
PubMed PMID: 18632620; PubMed Central PMCID: PMC2859318. 
215. Marella NV, Malyavantham KS, Wang J, Matsui S, Liang P, Berezney R. 
Cytogenetic and cDNA microarray expression analysis of MCF10 human breast cancer 
progression cell lines. Cancer research. 2009;69(14):5946-53. doi: 10.1158/0008-
5472.CAN-09-0420. PubMed PMID: 19584277; PubMed Central PMCID: 
PMC2826242. 
216. Kadota M, Yang HH, Gomez B, Sato M, Clifford RJ, Meerzaman D, et al. 
Delineating genetic alterations for tumor progression in the MCF10A series of breast 
cancer cell lines. PloS one. 2010;5(2):e9201. doi: 10.1371/journal.pone.0009201. 
PubMed PMID: 20169162; PubMed Central PMCID: PMC2821407. 
217. Tang B, Vu M, Booker T, Santner SJ, Miller FR, Anver MR, et al. TGF-beta 
switches from tumor suppressor to prometastatic factor in a model of breast cancer 
progression. The Journal of clinical investigation. 2003;112(7):1116-24. doi: 
10.1172/JCI18899. PubMed PMID: 14523048; PubMed Central PMCID: PMC198530. 
218. Soule HD, Maloney TM, Wolman SR, Peterson WD, Jr., Brenz R, McGrath CM, 
et al. Isolation and characterization of a spontaneously immortalized human breast 
epithelial cell line, MCF-10. Cancer research. 1990;50(18):6075-86. PubMed PMID: 
1975513. 
219. Dawson PJ, Wolman SR, Tait L, Heppner GH, Miller FR. MCF10AT: a model 
for the evolution of cancer from proliferative breast disease. The American journal of 
pathology. 1996;148(1):313-9. PubMed PMID: 8546221; PubMed Central PMCID: 
PMC1861604. 
	   142 
220. Santner SJ, Dawson PJ, Tait L, Soule HD, Eliason J, Mohamed AN, et al. 
Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial 
MCF10AT cells. Breast cancer research and treatment. 2001;65(2):101-10. PubMed 
PMID: 11261825. 
221. Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, Wedge DC, et al. 
The landscape of cancer genes and mutational processes in breast cancer. Nature. 
2012;486(7403):400-4. doi: 10.1038/nature11017. PubMed PMID: 22722201; PubMed 
Central PMCID: PMC3428862. 
222. Cancer Genome Atlas N. Comprehensive molecular portraits of human breast 
tumours. Nature. 2012;490(7418):61-70. doi: 10.1038/nature11412. PubMed PMID: 
23000897; PubMed Central PMCID: PMC3465532. 
223. Hayakawa K, Sato N, Obinata T. Dynamic reorientation of cultured cells and 
stress fibers under mechanical stress from periodic stretching. Exp Cell Res. 
2001;268(1):104-14. doi: 10.1006/excr.2001.5270. PubMed PMID: 11461123. 
224. Kaunas R, Nguyen P, Usami S, Chien S. Cooperative effects of Rho and 
mechanical stretch on stress fiber organization. Proc Natl Acad Sci U S A. 
2005;102(44):15895-900. doi: 10.1073/pnas.0506041102. PubMed PMID: 16247009; 
PubMed Central PMCID: PMCPMC1276069. 
225. Bulinski JC, Gundersen GG. Stabilization of post-translational modification of 
microtubules during cellular morphogenesis. Bioessays. 1991;13(6):285-93. doi: 
10.1002/bies.950130605. PubMed PMID: 1892478. 
226. Sabeh F, Shimizu-Hirota R, Weiss SJ. Protease-dependent versus -independent 
cancer cell invasion programs: three-dimensional amoeboid movement revisited. J Cell 
Biol. 2009;185(1):11-9. doi: 10.1083/jcb.200807195. PubMed PMID: 19332889; 
PubMed Central PMCID: PMCPMC2700505. 
 
